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CHAPTER 1: INTRODUCTION 
1.1 Summary  
In this chapter, an overview of protein synthesis, classification of the aminoacyl-
tRNA-synthetases (aaRSs), the direct and indirect aminoacylation pathways for the 
synthesis of Asn-tRNAAsn and Gln-tRNAGln, and the mechanisms that organisms using  
indirect aminoacyation pathways apply to achieve translational accuracy will be 
discussed. In addition, the roles of aminoacyl-tRNAs in processes other than translation 
will be presented. Finally, a summary of the dissertation research and its importance to 
the understanding of novel mechanisms developed by the human pathogenic bacterium 
Helicobacter pylori (H. pylori), to achieve translational fidelity will be discussed. 
1.2 An overview of protein biosynthesis  
Protein synthesis is a central process accomplished by ribosomes, which utilizes 
aminoacyl-tRNAs (aa-tRNAs) to read the codons in mRNA to translate them into their 
corresponding polypeptide sequences. Generally, the aa-tRNAs are produced by a 
reaction catalyzed by one of the aaRSs (Fig 1a). Each aaRS recognizes its cognate 
amino acid and tRNA(s) from a pool of competing reactants within the cell. Once the aa-
tRNAs are formed, an elongation factor (EF-Tu in bacteria, EF-1 in archaea and 
eukaryotes, (1)), which is GTP bound, will bind and load the aa-tRNAs onto the 
ribosome (Fig 1b). This process occurs with high fidelity and there are different 
proofreading checkpoints throughout that help maintain translational accuracy (2-4).  
In eukaryotes and some bacteria (e.g. E. coli), tRNA aminoacylation is 
accomplished by 20 precise aaRSs (direct aminoacylation). However, not all organisms 
have a full set of twenty aaRSs. For example, Helicobacter pylori, an obligate human 
pathogen, is missing both glutaminyl- and asparaginyl-tRNA synthetases (GlnRS and 
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AsnRS, respectively) (1-4). Consequently, H. pylori follows an indirect aminoacylation 
pathway to generate Gln-tRNAGln and Asn-tRNAAsn. Both direct and indirect 
aminoacylation will be discussed in more detail below in this introductory chapter. Given 
the pernicious nature of H. pylori infection and its impact on human health (5,6), 
achieving a deeper understanding of the distinct biochemistry of this pathogen is of 
utmost importance. Understanding the novel mechanisms that this bacterium employs in 
protein biosynthesis will be beneficial to expand our knowledge of species differentiation 
and for the development of clade-specific antibacterial therapies.  
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Fig 1.1. Steps in ribosomal protein biosynthesis. Each aaRSs selects its cognate tRNA 
and amino acid (from the cellular pool of tRNAs and amino acids) and catalyzes the 
formation of an aminoacyl-ester bond to produce its cognate aa-tRNA. (a) The aa-tRNAs are 
delivered to the ribosome in a complex with an elongation factor and GTP (EF-Tu, shown 
here, is the elongation factor used in bacteria). (b) The amino acids are transferred from the 
aa-tRNAs to the nascent polypeptide chain during protein synthesis (4).  
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1.3 Classification of the aaRSs 
The aaRSs are major components of the translational machinery. These 
essential enzymes are found in all forms of life and are responsible for aminoacylating 
their cognate tRNA(s) with their cognate amino acid. The aaRSs are divided into two 
structurally distinct classes: class I and class II (Table 1.1) (7,8). This classification is 
based on the topology of the different catalytic domains (9-11). Class I aaRSs all contain 
a nucleotide-binding Rossman fold, with two signature sequences motifs, KMSKS and 
HIGH (10). On the other hand, the catalytic domains of class II aaRSs are defined by 
their seven stranded, anti-parallel beta-fold with three signature motifs (motif 1, 2, and 3) 
(10). In both classes, the catalytic domain binds ATP, the amino acid and the 3’ terminus 
of tRNA. Because of these structural differences, the mode of binding with ATP and 
tRNA are class specific. The class I aaRSs tend to bind ATP in an extended 
conformation and the active site docks to the 3’ end of the tRNA from the minor groove 
side. However, class II aaRSs bind ATP in a bent conformation and approach the 3’ end 
of the tRNA from the major groove (12,13).   
 The two classes are further divided with respect to their aminoacylation 
mechanisms and amino acid activation. The esterification of amino acid can occur at 
either the 2′- or 3′-hydroxyl oxygen atom in the 3′-A76 tRNA nucleotide (Fig 1.2). Class I 
aaRSs almost exclusively aminoacylate the 2’ hydroxyl group of the tRNA, and the 
activated amino acid is later passively transferred to the 3’ hydroxyl group prior to 
binding to the ribosome. In contrast, class II aaRSs aminoacylate the 3’ hydroxyl group 
of the tRNA. Also, class I aaRSs are functional in their monomeric form and class II 
aaRSs are usually dimeric or multimeric (8).  
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Table 1.1: Classification of the aaRSs. The aaRSs are divided into two classes, Class 
I and class II, based on the topologies of their active sites. LysRS is the only aaRS with 
examples that fall into both classes. Most organisms have a non-canonical class II 
LysRS; class I LysRS is found in some bacteria and archaea (8-11). 
 
Class I Class II 
ArgRS AlaRS  
CysRS AsnRS  
GlnRS AspRS 
GluRS GlyRS 
LeuRS HisRS 
IleRS LysRS(II) 
LysRS(I) PheRS 
MetRS ProRS 
TyrRS SerRS 
TrpRS ThrRS 
ValRS  
 
 
 
6 
 
 
 
 
1.4 Direct aminoacylation 
Most aa-tRNAs are synthesized by direct aminoacylation of each tRNA with its 
cognate amino acid; this two-step reaction is catalyzed by all known aaRSs (Fig 1.2). 
The first step is the activation of amino acid with ATP to form an aminoacyl-adenylate 
(aa-AMP) intermediate. The second step is the subsequent transfer of the aa-AMP to the 
last nucleotide of tRNA, which involves the nucleophilic attack of either the 2’ or 3’ 
hydroxyl group from the 3’ adenosine in the tRNA onto the aa-AMP to form the cognate 
aa-tRNA ester linkage (Fig 1.2). This ester is protected from hydrolysis when the aa-
tRNA binds to EF-Tu•GTP (2,12,15,16).  
 It is critical to maintain accuracy during aminoacylation for faithful translation of 
the genetic code during protein synthesis. Translational fidelity is between 10-5 to 10-3 
 
Fig 1.2. General aminoacylation mechanism. A. The first step of the tRNA aminoacylation 
reaction is the activation of the cognate amino acid using ATP to synthesize an aminoacyl-
AMP (aa-AMP) intermediate. B. The second step is nucleophilic attack by the 2’ or 3’ OH 
group of the 3’-adenosine in the tRNA onto the aa-AMP, to generate the final aminoacyl-tRNA 
(aa-tRNA) (14) and release AMP. 
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per codon (the frequency of incorporation of misacylated aa-tRNA is 1 in 1000 to 
100,000) (17-22). The aaRSs are partially responsible for this high level of quality control 
and define the genetic code by specifically selecting their cognate tRNA and amino acid 
substrates from the pool of structurally similar metabolites. For example, argininyl-tRNA 
synthetase (ArgRS) aminoacylates tRNAArg (its cognate tRNA substrate) over tRNAAsp (a 
closely related non-cognate tRNA) with about 10,000 folds folds greater efficiency (23). 
This specificity is achieved by a recognition mechanism involving a series of interactions 
between each aaRS and tRNA pair. Each aaRS specifically recognizes the positive 
recognition elements of the substrate tRNA. In addition, non-cognate tRNAs carry anti-
determinants (negative elements) that limit recognition by a specific aaRSs and prevent 
misaminoacylation (24).  
 In contrast, compared to tRNAs, the amino acid substrates for the aaRSs are 
small and structurally similar, making successful discrimination challenging. For 
example, isoleucyl-tRNA synthetase (IIeRS) recognizes isoleucine over valine with a 
discrimination frequency of only ~1:180 (25). Consequently, IIeRS has an additional 
editing mechanism for amino acid selection and activation, which minimizes the 
misincorporation of valine at isoleucine codons to a frequency of 1:3000 (25-27). Editing 
either occurs at the active site of IleRS by hydrolyzing the non-cognate aminoacyl-
adenylate Val-AMP (pre-transfer editing) or at a separate editing site by deacylation of 
Val-tRNAIle (post-transfer editing). In general when measured in vitro with a purified 
aaRS, the fidelity of aminoacylation is better than 10−4 (in other words, the frequency of 
misaminoacylation is 1 in 10,000) (20).  
 
 
8 
 
 
 
1.5 Indirect aminoacylation 
 Since there are 20 standard encoded amino acids, 20 aaRSs were expected. 
This assumption was contradicted as early as 1968 when Wilcox and Nirenberg reported 
that GlnRS is missing in Bacillus subtilis (B. subtilis) and this bacterium relies on an 
indirect pathway for Gln-tRNAGln biosynthesis (28-30). Additional evidence 
demonstrating that other organisms are missing one or more aaRSs emerged from 
advancements in genome sequencing techniques and the availability of complete 
microbial genomes (31-35). In 1996, the complete genome of the hyperthermophilic 
archaeon Methanococcus jannaschii (M. jannaschii) was sequenced and revealed only 
16 aaRSs (32). Recognizable genes encoding CysRS, GlnRS, AsnRS, and LysRS were 
missing. However, it was later discovered that M. jannaschii carries a novel lysS gene, 
which has no similarity to the known bacterial or eukaryotic lysS gene (33). This 
archaeal LysRS contains amino acid motifs characteristic of the class I aaRS Rossmann 
dinucleotide binding domain, in contrast to the know examples of class II LysRS. Other 
examples of this class I LysRS were later identified in ε–proteobacteria and spirochetes 
(33). As described in the next few sections, in the absence of CysRS, AsnRS, and 
GlnRS, the corresponding aa-tRNAs (Cys-tRNACys, Asn-tRNAAsn, and Gln-tRNAGln) are 
all produced via indirect tRNA aminoacylation pathways.   
1.5.1 Indirect aminoacylation to produce Cys-tRNACys 
 At the time that it was discovered that M. jannaschii lacks CysRS, a non-
canonical mechanism for the formation of Cys-tRNACys was a mystery. An indirect 
pathway for Cys-tRNACys biosynthesis was later uncovered in methanogens lacking a 
canonical CysRS, including M. jannaschii. The first step involves aminoacylation of 
tRNACys with O-phosphorylserine (Sep), by O-phosphorylseryl-tRNA synthetase 
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(SepRS). Next, sulfhydrylation of Sep bound to tRNACys produces Cys-tRNACys, this 
reaction is catalyzed by Sep-tRNA:Cys-tRNA synthetase (SepCysS). This last step is a 
PLP-mediated and in vitro sulfide is a sufficient sulfur donor. However, the sulfur donor 
in vivo remains unknown (36,37).  
1.5.2 Indirect aminoacylation to produce Asn-tRNAAsn and Gln-tRNAGln 
 The M. jannaschii genome also lacks genes encoding AsnRS and GlnRS: Asn-
tRNAAsn and Gln-tRNAGln are generated by two closely related indirect pathways (Fig 
1.3). For Asn-tRNAAsn production, a non-discriminating-AspRS (ND-AspRS) produces 
Asp-tRNAAsn, which is subsequently converted to Asn-tRNAAsn by a heterotrimeric 
glutamine-dependent amidotransferase called AdT or GatCAB (Fig 1.3). As the name 
suggests, ND-AspRS is non-discriminating in nature, which means that it aminoacylates 
both tRNAAsp and tRNAAsn to produce cognate Asp-tRNAAsp and non-cognate Asp-
tRNAAsn (23).  
An analogous pathway exists for the formation of Gln-tRNAGln; a misacylating 
non-discriminating glutamyl-tRNA synthetase (ND-GluRS) generates Glu-tRNAGln, which 
is converted to Gln-tRNAGln by the same AdT (Fig 1.3). Like ND-AspRS, ND-GluRS 
generates both Glu-tRNAGlu and Glu-tRNAGln (23). 
The work presented herein focuses on the gram-negative bacterium H. pylori, 
which was the first bacterium identified to be missing both AsnRS and GlnRS (7,23,38). 
As in M. jannaschii, H. pylori ND-AspRS compensates for the lack of AsnRS by 
misacylating tRNAAsn with aspartate to generate Asp-tRNAAsn (Fig 1.3B) (38-40). In 
contrast to M. jannaschii, the H. pylori genome has two copies of the gene encoding for 
GluRS (GluRS1 and GluRS2). GluRS1 is a canonical discriminating GluRS, which 
specifically recognizes and aminoacylates tRNAGlu isoacceptors only. In contrast, 
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GluRS2 is unique and participates in indirect tRNA aminoacylation by specifically 
misacylating tRNAGln to form misacylated Glu-tRNAGln (Fig 1.3A) (38,41). Finally, AdT 
repairs both the misacylated tRNA intermediates (Glu-tRNAGln and Asp-tRNAAsn) into 
Gln-tRNAGln and Asn-tRNAAsn respectively. To compensate missing GlnRS, H. pylori 
genome have two copies of the gene encoding for GluRS which are referred to as 
GluRS1 and GluRS2. GluRS1 is a canonical discriminating GluRS, which specifically 
recognizes and aminoacylates tRNAGlu isoacceptors only. In contrast, GluRS2 is unique 
and helps compensates for the missing GlnRS, by specifically misacylating tRNAGln to 
form Glu-tRNAGln (Fig 1.3A) (38,41). H. pylori also lacks an asparagine synthetase; 
indirect biosynthesis of Asn-tRNAAsn is the only route to asparagine. 
 Interestingly, both the direct and indirect pathways for the synthesis of aa-tRNAs 
are found in some organisms. For example, the Deinococcus radiodurans (D. 
radiodurans) genome encodes for GlnRS, AsnRS, a discriminating-GluRS (D-GluRS), 
an ND-AspRS, and AdT. D. radiodurans does not utilize asparagine synthetase (42). 
The direct aminoacylation pathway for Asn-tRNAAsn formation, using AsnRS, was 
suggested to be redundant, with the sole route for asparagine synthesis dependent on 
ND-AspRS and AdT (42).  
Another example is Gln-tRNAGln synthesis in Lactobacillus bulgaricus: even 
though genome sequence analysis revealed the presence of GlnRS, no GlnRS activity 
was detected (43). Instead, this organism uses the indirect pathway for Gln-tRNAGln 
production, beginning with natural mischarging followed by subsequent transamidation 
(43). 
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Fig 1.3. Indirect aminoacylation pathway for the biosynthesis of Asn-tRNAAsn and Gln-
tRNAGln. Direct (top part of each panel) and indirect (AdT-mediated) pathways (bottom part 
of each panel) for the biosynthesis of A. Gln-tRNAGln and B. Asn-tRNAAsn. ND stands for 
non-discriminating (23). 
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1.6 Structure and function of non-canonical aaRSs: ND-AspRS, ND-GluRS, and 
GluRS2 
 As described above, not all organisms have a full set of 20 aaRSs. Instead, many 
rely on non-canonical aaRSs for the production of certain aa-tRNAs (44,45). H. pylori is 
missing both AsnRS and GlnRS and Asn-tRNAAsn and Gln-tRNAGln production takes 
place via the use of non-canonical aaRSs (Fig 1.3). In the following sections, evolution, 
structural, and biochemical analysis of these non-canonical aaRSs will be discussed.  
1.6.1 Evolution, structural and biochemical analysis of AsnRS and D- and ND-
AspRS in different organisms 
 AsnRS is more widespread among bacteria than GlnRS is, but it is still absent in 
a number of different types of organisms. Examples of bacteria that are missing AsnRS 
include H. pylori, Aquifex aeolicus, Chlamydia trachomatis, Mycobacterium tuberculosis, 
and Mycobacterium leprae (23). AsnRS is present in all eukaryotes but is found in only 
two archaeal clades, the Pyrobacula and Pyrococci (23).  
As described above, in organisms lacking AsnRS, Asn-tRNAAsn is produced via 
the ND-AspRS and AdT-mediated indirect pathway (Fig 1.3). ND-AspRS is capable of 
recognizing and aminoacylating both tRNAAsp and tRNAAsn. This ability is achieved by the 
presence of an AsnRS-like-loop in ND-AspRS, which recognizes the last nucleotides of 
the two tRNA anticodons: C36 in the GUC anticodon of tRNAAsp and U36 in the GUU 
anticodon of tRNAAsn (46,47). Presumably, insertion of this AsnRS-like-loop in D-AspRS 
resulted in ND-AspRS (48).  
Additional details of the mechanism of tRNA recognization were revealed by 
analysis of the anticodon-binding domain of both D-AspRS and ND-AspRS. Site-directed 
mutagenesis of the ND-AspRS from the pathogenic bacterium Pseudomonas 
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aeruginosa PAO1 (P. aeruginosa PAO1) at two conserved residues H31 and G83 (H31L 
and G83K) and the double mutant H31L/G83K showed changes in ND-AspRS tRNA 
substrate specificity. When tested with total tRNA from E. coli, the three mutants showed 
greater specificity for tRNAAsp over tRNAAsn. However, when assayed with total tRNA 
from P. aeruginosa PAO1, no significant discrimination for tRNAAsp over tRNAAsn was 
observed (49).  
Based on their evolutionary origins, there are actually two types of ND-AspRS, 
bacterial and archaeal. The crystal structure of Mycobacterium Smegmatis (M. 
Smegmatis) ND-AspRS (bacterial type) was solved to 2.6 Å resolution (50). A structural 
alignment of M. Smegmatis ND-AspRS revealed the presence of an insertion domain 
(~140 amino acids long) compared to an archaeal-type ND-AspRS (e.g. T. thermophilus) 
(Fig 1.5). This domain can be used to determine whether a given AspRS is bacterial or 
archaeal in origin but it cannot provide insight into discriminating or non-disciminating 
tRNA recognition. 
The bacterial and archaeal types of ND-AspRS are believed to have evolved 
separately into modern day D- and ND-AspRS orthologs via parallel pathways (Fig 1.4). 
D-AspRS being discriminating and recognizes only tRNAAsp, whereas ND-aspRS 
recognizes both tRNAAsp and tRNAAsn.  
There are several organisms whose genomes encode for both a D- and an ND-
AspRS. For example, T. thermophilus has AspRS1 and AspRS2: AspRS1 is a bacterial-
type D-AspRS and AspRS2 is an archaeal-type ND-AspRS. These two aaRSs differ by 
their tRNA substrate specificity: AspRS1 specifically aminoacylates tRNAAsp, while 
AspRS2 is non-discriminating and aminoacylates both tRNAAsp and tRNAAsn (30,44,51). 
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Fig 1.4. A proposed evolutionary model for AspRS, GluRS, and GlnRS. A. First an 
ancestral ND-AspRS diverged into archaeal and bacterial ND-AspRS, which further diverged 
into discriminating and non-discriminating AspRS variants. B. D-GluRS and D-GlnRS were 
evolved from an ancestral ND-GluRS (39,48).    
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H. pylori ND-AspRS was characterized for the first time in 2006. This enzyme 
efficiently catalyzes aminoacylation of tRNAAsp over tRNAAsn (8). By comparing the 
sequences of the anticodon binding domain of several bacterial D- and ND-AspRS to the 
available crystal structure of E. coli D-AspRS, three mutants were generated: namely, 
L81N, L86M, and the L81N/L86M double mutant. An increase in specificity for tRNAAsp 
over tRNAAsn was observed for all three mutants. For example, the specificity constant 
 
Fig 1.5. The bacterial AspRS contain a large insertion domain (red). A structural 
alignment of the crystal structure of M. smegmatis ND-AspRS (cyan and red) (PDB: 402D) 
and T. thermophilus (green) (PDB: 1N9W) ND-AspRS is shown. The insertion domain is 
found in both discriminating and non-discriminating bacterial-type AspRSs but it is not 
present in the archaeal-type D- or ND-AspRSs (50). 
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(kcat/KM) for tRNAAsp over tRNAAsn was doubled for the L83M mutant (from 2.9 to 5.8 M-1 
s-1) (3). In contrast, site-directed mutagenesis of T. Kodakaraensis D-AspRS (archaeal-
type) revealed that a single mutation (either W26H and K85P) is sufficient to completely 
convert this discriminating enzyme into a non-discriminating AspRS (Fig 1.6) (52).  
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Fig 1.6. The crystal structure of Thermococcus kodakarensis D-AspRS (PDB: 3NEN) 
(G44). Mutating residues W26 or K85 (W26H or K85P) completely converted T. 
kodakarensis D-AspRS into a ND-AspRS (52). 
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1.6.2 Evolution, structural and biochemical analysis of GlnRS and D- and ND-
GluRS in different organisms 
GlnRS is rare and is found in only few microorganisms (23). In fact, indirect 
biosynthesis pathway for Gln-tRNAGln synthesis is abundant in bacteria and ubiquitous in 
archaea. Most microorganisms use ND-GluRS to produce both Glu-tRNAGlu and Glu-
tRNAGln. The non-discriminating behavior of ND-GluRS was confirmed by biochemical 
analysis using B. subtilis ND-GluRS: this enzyme is capable of recognizing and 
glutamylating both B. subtilis tRNAGlu and tRNAGln. However, when E. coli tRNAs were 
tested, B. subtilis ND-GluRS only glutamylated E. coli tRNAGln1, but not tRNAGln2 or 
tRNAGlu. B. subtilis ND-GluRS discriminates between the two E. coli tRNAGln 
isoacceptors by discriminating against the 5-methylaminomethyl-2-thiouridine at position 
34 in tRNAGln2 and tRNAGlu (5). In contrast, D-GluRS can strongly discriminate against 
the third nucleotide of the tRNAGln anticodon over tRNAGlu (54). 
 Evolutionary examinations suggest that modern D-GluRS and D-GlnRS evolved 
through an ancestral gene duplication event from an ND-GluRS (Fig 1.4B) (38,55). 
Interestingly, all known D-GlnRS in bacteria and archaea originated from eukaryotes 
through horizontal gene transfer events (36,55).  
GluRS2, found in ε–proteobacteria, including H. pylori and Acidithiobacillus 
ferrooxidans (A. ferrooxidans), is functionally different from ND-GluRS. GluRS2 
originated via gene duplication of an ND-gltX gene (encoding ND-GluRS), ultimately 
producing two genes that encode for GluRS1 and GluRS2 (40,52). These two proteins 
share 38% sequence identity and 60% similarity (based on the H. pylori sequences). 
Unlike ND-GluRS, H. pylori GluRS2 is a distinct, discriminating enzyme, which 
specifically recognizes and misacylates only tRNAGln with glutamic acid. H. pylori 
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GluRS1 functions as a D-GluRS, glutamylating both isoacceptors of tRNAGlu (tRNAGlu1 
and tRNAGlu2) to generate cognate Glu-tRNAGlu. In contrast, A. ferrooxidans GluRS1 
glutamylates tRNAGlu and the tRNAGln with the CUG anticodon, displaying flexibility in 
tRNA substrate specificity (38,59). Like H. pylori, A. ferrooxidans GluRS2 was specific 
solely for tRNAGln with the UUG anticodon (38,56).  
 H. pylori GluRS2 shares 37% sequence identity with B. subtilis ND-GluRS 
(38,59) and its active site domain is only distantly related to eukaryotic GlnRS. GluRS2 
can be defined as a intermediate between an ancestral ND-GluRS and a future bacterial 
D-GlnRS or GluGlnRS. It was proposed that H. pylori GluRS1 and GluRS2 represent an 
intermediate stage of evolution toward specific D-GluRS and D-GlnRS enzymes of 
bacterial origin: GluRS1 has evolved into a modern D-GluRS, and GluRS2 may be 
evolving into a new, modern D-GlnRS (38).  
 A crystal structure of ND-GluRS from Thermosynechococcus elongatus (T. 
elongatus) is available. This enzyme shares structural similarity with T. thermophilus D-
GluRS (57). As expected, biochemical analysis demonstrated that T. elongatus GluRS is 
non-discriminating and generates both Glu-tRNAGln and Gln-tRNAGln. Arg358 of T. 
thermophilus D-GluRS is replaced by a Gly at position 366 in T. elongatus ND-GluRS. 
This Arg to Gly replacement allows T. elongatus ND-GluRS to accommodate the 
pyrimidine base C36 in the anticodon of tRNAGlu as well as the G26 in the anticodon of 
tRNAGln (Fig 1.7).  
 The mechanism of tRNAGln recognition by H. pylori GluRS2 was evaluated in 
2004 (55). H. pylori GluRS2 recognizes only tRNAGln to produce Glu-tRNAGln and does 
not produce Glu-tRNAGlu. Based on the crystal structure of T. thermophilus D-GluRS in 
complex with tRNAGlu, two anticodon-binding domain mutants (Gly417Thr and 
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Glu334Arg) were generated. The Gly417Thr mutant showed weak activity toward 
tRNAGlu1, while the Glu334Arg mutant showed a decrease in catalytic efficiency towards 
tRNAGln. Interestingly, the double mutant (Gly417Thr/Glu334Arg) specifically preferred 
tRNAGlu1 to tRNAGln for aminoacylation. These results suggest that both GluRS1 and 
GluRS2 evolved from a common ancestral ND-GluRS.  
 
Fig 1.7. The crystal structure of T. thermophilus D-GluRS in complex with tRNAGln 
(PDB: 1G59). The nucleotide C36 and U35 (blue and red) in the anticodon loop of tRNAGln 
(purple) showed specific interactions with Arg358 (green) in the anticodon-binding domain of 
D-GluRS (raspberry) (57).  
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1.7 The tRNA-dependent Asp/Glu amidotransferase 
 In microorganisms and eukaryotic organelles (e.g. mitochondria, chloroplast) that 
utilize the indirect aminoacylation pathway for the biosynthesis of Asn-tRNAAsn and Gln-
tRNAGln, it is important that these two misacylated aa-tRNAs be immediately repaired. 
Otherwise, if captured by EF-Tu, their use would lead to misincorporation of Asp and Glu 
into proteins at Asn and Gln codons. AdT is responsible for efficiently converting these 
two misacylated aa-tRNAs into their correctly aminoacylated tRNAs in order to maintain 
the fidelity of protein synthesis. Three orthologs of AdT have been identified: bacterial 
(GatCAB), archaeal (GatDE), and organellar (GatFAB).  
1.7.1 The reactions catalyzed by AdT 
GatCAB, GatFAB, and GatDE all catalyze the same series of reactions to convert 
Asp-tRNAAsn (GatCAB and GatFAB) and Glu-tRNAGln (GatCAB, GatFAB, and GatDE) 
into Asn-tRNAAsn and Gln-tRNAGln (Fig 1.8). In the active sites of GatA and GatD, 
glutamine is hydrolyzed to produce glutamate and ammonia. Ammonia migrates through 
a tunnel to the GatB/GatE active sites, where each misacylated tRNA is activated by 
phosphorylation for subsequent reaction with ammonia to complete the transamidation 
reaction.  
 
 
 
 
 
 
22 
 
 
 
1.7.2 The bacterial AdT: GatCAB 
The bacterial AdT is a heterotrimeric protein, composed of three subunits, 
namely GatA, GatB, and GatC; also known as GatCAB. Most bacteria, organelles and 
some archaea utilize GatCAB. The gatA, gatB, and gatC genes are organized in an 
 
 
Fig 1.8. The three chemical reactions catalyzed by the GatA/D and GatB/E subunits of 
GatCAB and GatDE. A. Glutaminase. The GatA/D subunit hydrolyzes glutamine 
generating glutamic acid and ammonia. The ammonia is transferred to the GatB active site 
through a tunnel. B. Kinase. GatB/E uses ATP and catalyzes the phosphorylation of Glu-
tRNAGln to synthesize phosphoryl-Glu-tRNAGln. C. Transamidase. GatB/E uses the 
ammonia from GatA to convert the phosphoryl-Glu-tRNAGln into Gln-tRNAGln. An analogous 
pathway exists for Asn-tRNAAsn biosynthesis.  
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operon in some organisms. In B. subtilis, expression of GatA requires a gatCA operon 
(29). However, GatB does not have any such a requirement and can be expressed alone 
(29). Unlike B. subtilis, in certain organisms like H. pylori, the three genes are not in an 
operon and are scattered throughout the genome (29). 
GatA is an amidase homolog and has glutaminase activity, i.e it generates 
ammonia from glutamine hydrolysis (Fig 1.8A) (30,58,59). This ammonia is then 
transported to the GatB active site through an ammonia tunnel. GatB performs the 
kinase and transamidation reactions (Fig 1.8B and C) needed for the overall AdT 
reaction. In the GatB active sites, tRNA is activated with ATP to generate γ–phosphoryl-
aa-tRNA (kinase reaction), followed by transamidation by addition of ammonia to 
synthesize the correctly acylated aa-tRNAs.  
 B. subtilis requires GatCAB only for the conversion of Asp-tRNAAsn to Asn-
tRNAAsn because it has a gene encoding GlnRS for the direct synthesis of Gln-tRNAGln. 
However, the H. pylori genome lacks both GlnRS and AsnRS and relies on AdT for the 
biosynthesis of Gln-tRNAGln and Asn-tRNAAsn. This dual functionality was first discovered 
for the GatCAB enzymes from Acidithiobacillus ferrooxidans (A. ferrooxidans) and 
Chlamydia trachomatis (C. trachomatis) (60,61). Similar to H. pylori, the A. ferrooxidans 
and C. trachomatis genomes lack the genes encoding GlnRS and AsnRS (60,61).  
Like B. subtilis, T. thermophilus has a GlnRS and is missing AsnRS, and 
therefore requires GatCAB only for the modification of Asp-tRNAAsn. However, 
biochemical analysis of T. thermophilus GatCAB demonstrated that it is capable of 
transamidating both misacylated aa-tRNAs, Glu-tRNAGln and Asp-tRNAAsn, in vitro (62). 
A truncated GatCAB (deleting the C-terminal 44 amino acids from GatB) inhibited 
24 
 
 
 
synthesis only of Asn-tRNAAsn, revealing that the two catalytic functions of GatCAB can 
be separated (62).  
1.7.3 Crystal structure of Staphylococcus aureus GatCAB 
 The crystal structure of Staphylococcus aureus (S. aureus) GatCAB has been 
reported, revealing details of the ammonia tunnel connecting the GatA and GatB active 
sites (63) (Fig 1.9). Ammonia tunnels in all other known glutamine-dependent 
amidotransferases are mainly hydrophobic (e.g. asparagine synthetase B, glutamine 
phosphoribosylpyrophosphate amidotransferase, carbamoyl phosphate synthase etc), 
compared to this bacterial AdT, which is largely hydrophilic and highly solvated (64,65-
68). In the absence of bound misacylated tRNA, the tunnel of GatCAB is discontinuous, 
~37 Å long, and is lined with conserved polar and ionic amino acids that show 
interactions with bound ordered water molecules within the tunnel.  
Based on the tunnel’s hydrophilicity, a proton-relay mechanism was proposed for 
ammonia delivery. The delivery of ammonia from GatA to GatB was proposed to be 
regulated by a gate controlled by residue E125, located at the GatA and GatB interface 
(Fig 1.9). It was also proposed that binding of Glu-tRNAGln at the GatB active site would 
cause conformational changes that trigger the opening of this gate to make the tunnel 
continuous for ammonia delivery from GatA to GatB (63). The GatC subunit (~100 amino 
acids long) is predicted to play only a structural role, stabilizing the GatAB complex by 
wrapping around the interface of GatA and GatB.  
In our lab, H. pylori AdT has been biochemically characterized, in part to 
understand the mechanism of ammonia delivery. Conserved residues lining the 
ammonia tunnel were mutated and the effects of these mutations on GatB’s 
phosphorylation capabilities were evaluated: a significant decrease in kinase activity was 
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observed for two residues, Thr149 (in GatA) and Lys89 (at the interface of GatA and 
GatB). These results suggested that these two residues play an important role in 
interdomain communication. This hypothesis was also supported by results from 
molecular dynamics simulation studies that identified a putative pathway for 
communication between GatA and GatB (69).  
In the absence of a crystal structure with Glu-tRNAGln bound to GatCAB, the 
mechanism for how AdT recognizes tRNAGln remains somewhat poorly understood. Site-
directed mutagenesis in tRNAGln demonstrated that interactions between GatB and U1-
A72 base pair in the D-loop of the tRNA are critical for recognition (70). As described in 
detail in a later section, a crystal structure for a macromolecular complex called the 
transamidosome has been reported: This structure contains tRNAAsn bound to GatCAB. 
This crystal structure revealed that the recognition if tRNAAsn is achieved by the 
interaction of 5’ terminal phosphate of tRNA with side chains of Ser211 and Arg160 and 
amino group of Lys213 of GatB C-terminal. These interactions bring Pro180 and Phe212 
in close proximity to U1 of tRNAAsn, positioning U1 for transamidation while A72 is 
contacted by any residue.   
26 
 
 
 
 
1.7.4 The organellar AdT: GatFAB 
 The organellar AdT, named GatFAB, is heterotrimeric like bacterial GatCAB and 
the GatA and GatB subunits of GatFAB are homologous to those of GatCAB (71). The 
third subunit, GatF, is found in place of bacterial GatC. GatC and GatF share poor 
 
Fig 1.9. A cartoon representation of the crystal structure of S. aureus GatCAB (PDB: 
2G5H). The three subunits of GatCAB are color coded, GatA in lime, GatB in purple, and 
GatC in black. The proposed gate residue, E125 is shown in red spheres. The binding of 
tRNAGln to GatB may cause conformational changes which will trigger opening of the putative 
gate, E125 (60).  
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sequence homology and GatF is approximately twice as long as GatC (66). GatFAB is 
capable of converting mitochondrial Glu-mtRNAGln to Gln-mtRNAGln in yeast (71). 
However, whether GatFAB converts Asp-tRNAAsn to Asn-tRNAAsn or not like H.pylori or 
T. thermophilus GatCAB is not known yet.  
1.7.5 Crystal structure of Saccharomyces cerevisiae GatFAB 
In Saccharomyces cerevisiae (S. cerevisiae or yeast), mitochondrial Gln-tRNAGln 
is synthesized via an indirect pathway involving cytosolic ND-GluRS and GatFAB. The 
cytosolic GluRS is imported to mitochondria, where this enzyme behaves as an ND-
GluRS and misacylates mitochondrial mtRNAGln to generate Glu-mtRNAGln. This Glu-
mtRNAGln is subsequently converted to Gln-mtRNAGln by the transamidation reaction 
catalyzed by GatFAB.  
The crystal structure of S. cerevisiae mGatFAB at 2.0 Å resolution was recently 
reported (Fig 1.10) (71). GatF is twice the size of GatC (Fig 1.11). The C-terminal 
domain (CTD) of GatF is similar to bacterial GatC and, like GatC, surrounds the area 
between GatA and GatB for GatFAB trimer stability. Unlike GatC, the N-terminal domain 
(NTD) of GatF extends into the glutaminase active site of GatA.  
To understand the role of this N-terminal domain, a truncated version of GatFAB 
was created, and its ability to generate ammonia (glutaminase activity) and use of 
ammonia for Gln-mtRNAGln synthesis (transamidation activity) were evaluated. Deletion 
of NTD impacted growth but was not lethal; it also decreased both the glutaminase and 
transamidation activities of GatFAB. Interestingly, this deletion mutant showed an 
increased rate in transamidation when ammonium chloride (NH4Cl) was used as an 
ammonia donor, suggesting its role in controlling the use of free ammonia (71).  
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Fig 1.10. A cartoon representation of the crystal structure of S. cerevisiae 
mitochondrial GatFAB (PDB: 4N0H). The three subunits of GatFAB are color coded as 
follows: GatA in yellow, GatB in purple, and GatF in orange (71). 
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1.7.6 The archaeal AdT: GatDE 
The archaeal AdT is heterodimeric and containing GatD and GatE (GatDE) subunits. 
Unlike GatCAB, GatDE is monofunctional and can only catalyze the transamidation of 
Glu-tRNAGln (30). Archaea can have GatCAB, GatDE or both, depending on which 
transamidation reactions are needed (40,72). GatD is structurally different, but 
functionally equivalent, to GatA (GatD is an L-asparaginase homolog); like GatA, GatD 
has glutaminase activity, i.e it generates ammonia from glutamine hydrolysis (Fig 1.8A) 
(30,58,59). The ammonia generated in the GatD active site is then transported to the 
 
Fig 1.11. A structural comparision of S. cerevisiae mitochondrial GatF (PDB: 4N0H) 
with the S. aureus bacterial GatC (PDB: 2G5H). Gat F is colored in orange and GatC is 
colored in black (66,69). NTD: N-terminal domain (71). 
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GatE active site through an ammonia tunnel that is noticeably less hydrophilic than its 
GatCAB counterpart. GatE and GatB are functionally and evolutionary related to each 
other. Like GatB, GatE performs the phosphorylation and transamidation reactions (Fig 
1.8B and C) needed for the overall AdT reaction. GatE is capable of producing γ–
phosphoryl-Glu-tRNAGln in the absence of GatD; however, GatB requires the presence of 
both GatA and Glu-tRNAGln binding for activity (64).  
1.7.7 Crystal structure of Pyrococcus abyssi GatDE 
The first GatDE crystal structure, for the hyperthermophilic archaeon Pyrococcus 
abyssi (P. abyssi) enzyme, was published in 2005 (Fig 1.12) (39). The structure 
revealed that GatDE forms an ᾳ2β2 tetramer (40). The crystal structure of M. 
thermautotrophicus GatDE bound to tRNAGln revealed deeper information on how 
tRNAGln is recognized by GatE (70). GatE binding to tRNA is similar to EF-Tu binding to 
aminoacyl-tRNAs (56,73). GatE showed interactions with only the upper half of tRNAGln, 
including the accepter stem, TψC arm, and the D-loop (74,75).  
 Unlike GatCAB, GatDE is monofunctional, converting only Glu-tRNAGln to Gln-
tRNAGln. This specificity for tRNAGln over tRNAAsn is achieved by specific interactions 
between GatE and the D-loop of the tRNAGln. Specific contacts between G52 and A73 in 
tRNAGln and Asp463 and Gln240 in GatE are crucial (Fig 1.11). Like GatCAB, GatDE 
contains a hydrophilic ammonia tunnel that is lined with conserved residues (70). The 
ammonia generated in the GatD active site is transported to the active site of GatE 
through this tunnel.  
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Fig 1.12. A cartoon representation of the crystal structure of M. thermautotrophicus 
GatDE (PDB: 2D6F). The GatDE subunits are color coded as follows: GatD is in yellow and 
GatE is in cyan; tRNAGln is shown in green. Interactions between amino acid residues 
Asp463 and Gln 240 (orange) in GatDE with nucleotides A73 and G52 (red) in tRNAGln are 
important for tRNAGln recognization (70).  
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1.8 A variety of mechanisms to prevent misuse of Asp-tRNAAsn and Gln-tRNAGln in 
translation 
Capture of misacylated Asp-tRNAAsn and Glu-tRNAGln by EF-Tu and their 
subsequent delivery to the ribosome would likely lead to translational errors. EF-Tu plays 
a crucial role as a checkpoint to prevent the loading of misacylated aa-tRNAs onto the 
ribosome. However, EF-Tu not sufficient to prohibit accidental entry of either of these 
two misacylated tRNAs into nascent proteins (76-79). Some organisms employing a 
strategy that involves formation of a ribonucleoprotein complex called the 
transamidosome that further limits misuse of these misacylated tRNAs. The roles of EF-
Tu and the transamidosome will be discussed in subsequent sections.  
1.8.1 Role of EF-Tu in discriminating against misacylated aa-tRNAs 
EF-Tu has the ability to discriminate against these aa-tRNAs to an extent that is 
mostly sufficient to prevent misincorporation of amino acids into the proteome (12,76-
79). Earlier EF-Tu was thought to be a non-specific binding protein because it binds all 
aa-tRNAs with almost the same affinity, despite differences in size, charge and 
hydrophobicity of the esterified amino acids as well as the wide variety of tRNA 
sequences. More recently, it has been established experimentally that both the amino 
acid and the tRNA thermodynamically contribute to binding to EF-Tu and they can 
compensate for each other. Therefore, all cognate aa-tRNAs have essentially uniform 
affinities for EF-Tu.  
The amino acids and tRNAs are classified as ‘weak’ and ‘strong’ on the basis of 
their thermodynamic contribution to EF-Tu binding. Thus, a ‘strong’ tRNA is usually 
aminoacylated with a ‘weak’ amino acid and vice versa (75). As a result, aa-tRNAs 
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containing either a weak amino acid and a strong tRNA or a strong amino acid and a 
weak tRNA will show the same binding affinity for EF-Tu.  
Our lab showed that, on this basis, EF-Tu discriminates against Glu-tRNAGln and 
Asp-tRNAAsn to prevent their access to the ribosome (78). However, it is well established 
that overexpression of misacylating aaRSs (e. g. ND-GluRS and GluRS2) is toxic to E. 
coli due to the absence of AdT and the misincorporation of glutamate at glutamine codon 
via use of Glu-tRNAGln (80,81). Consequently, even though EF-Tu does not tightly bind 
Glu-tRNAGln, sufficient binding still occurs to produce toxicity caused by misincorporation 
(38,39,80,81). Similarly, when ND-AspRS was overexpressed in E. coli, misincorporation 
of aspartic acid at asparagine codons was observed (62,82). It appears that EF-Tu’s 
proofreading capacity is challenged in vivo, where the concentration of EF-Tu is high 
(~170 µM), allowing EF-Tu to bind Glu-tRNAGln and Asp-tRNAAsn to an extent that is 
sufficient to deliver these misacylated tRNAs to the ribosome for protein synthesis 
(78,83).  
Even though EF-Tu plays an important role in discriminating against misacylated 
aa-tRNAs, it is clearly not sufficient to safeguard the genetic code (78,83). Apart from 
EF-Tu, the ribosome also plays a crucial role in maintaining the accuracy of translation, 
governing correct anticodon-codon interactions during aa-tRNA accommodation. 
However, ribosomes do not screen for accuracy with respect to the esterified amino acid 
on each aa-tRNA. Consequently, the problem remains that additional mechanisms must 
exist to sequester Asp-tRNAAsn and Glu-tRNAGln away from the ribosome until they are 
converted to Asn-tRNAAsn and Gln-tRNAGln by AdT. 
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1.8.2 Formation of transamidosome complexes facilitate indirect synthesis of Asn-
tRNAAsn and Gln-tRNAGln 
Bacteria that rely on indirect aminoacylation pathways require additional 
mechanisms to prevent the uptake of misacylated tRNAs into the ribosome and their 
misuse in translation For example, M. jannaschii prevents the delivery of misacylated 
Sep-tRNACys to ribosomes by employing a strategy that involves sequestering Sep-
tRNACys in a tight ribonucleoprotein complex, composed of O-phosphoseryl-tRNA 
synthetase (SepRS), Sep-tRNA-Cys-tRNA synthetase (SepCysS), and Sep-tRNACys. 
This complex allows M. jannaschii to trap this misacylated tRNA until it is converted to 
Cys-tRNACys (84).  
Similarly, organisms have adapted mechanisms that prevent the 
misincorporation of glutamate and aspartate into nascent polypeptides. In 2007, a new 
ribonucleoprotein complex, the Asn-transamidosome, was discovered in T. 
thermophilus. This stable ternary complex containing tRNAAsn, ND-AspRS, and AdT 
facilitates the indirect synthesis of Asn-tRNAAsn (Fig 1.13) (85). This complex sequesters 
Asp-tRNAAsn (generated by ND-AspRS within the complex) and transfers it directly to the 
active site of AdT for conversion to Asn-tRNAAsn. This substrate channeling through the 
transamidosome provides two advantages to organisms that are dependent on indirect 
aminoacylation. The transamidosome traps the Asp-tRNAAsn until it is repaired and 
converted to Asn-tRNAAsn, preserving the accuracy of protein synthesis. The Asn-
transamidosome also increases the overall efficiency of Asn-tRNAAsn synthesis by 
preventing premature release of Asp-tRNAAsn.  
35 
 
 
 
Likewise, to maintain translational accuracy during indirect synthesis of Gln-
tRNAGln, formation of a Gln-transamidosome between misacylating ND-GluRS (or 
GluRS2) and AdT would be beneficial. 
1.8.2.1 Crystal structure of the Thermus thermophilus Asn-transamidosome  
A crystal structure of the T. thermophilus transamidosome has been resolved 
and contains four copies of tRNAAsn, two copies of AdT, and two dimeric copies of ND-
AspRS (Fig 1.13) (77,86). Of the four tRNAAsn, only two are positioned to serve as 
catalytic substrates (cattRNAAsn). The other two tRNAs acts as scaffolds (scaftRNAAsn), 
holding the two AdT enzymes together. Each cattRNAAsn acceptor end is anchored in a 
GatB active site. The 3’CCA end of the cattRNAAsn binds the ND-AspRS active site and is 
aspartylated; then, the accepter end of the tRNA shifts ~35 Å from the active site of ND-
AspRS to the active site of GatB for transamidation. This shift is similar to that which 
occurs during post-transfer editing in some aaRSs: For example, the editing domain of 
IleRS is 34 Å away from the active site (77,87,88). Release of Asn-tRNAAsn promotes 
dissociation of the complex and leads to assembly of a new transamidosome with free 
tRNAAsn for the next round of catalysis. The final product, Asn-tRNAAsn, is captured by 
EF-Tu and is delivered to the ribosome for protein synthesis.  
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1.8.2.2 Crystal structure of the Thermotoga maritima Gln-transamidosome 
A Thermotoga maritima (T. maritima) Gln-transamidosome, consisting of ND-
GluRS, AdT, and tRNAGln, has been characterized (Fig 1.14) (89). Unlike the T. 
thermophilus Asn-transamidosome, the T. maritima Gln-transamidosome is 
asymmetrical and less complex. The accepter stem of tRNAGln is bound to the active site 
of ND-GluRS in a productive orientation. In contrast, AdT is bound in a non-productive 
orientation with ND-GluRS. The GatB C-terminal region is in contact with the elbow of 
tRNAGln and is not in contact with the accepter stem, which would make the transfer of 
the Glu-tRNAGln intermediate from ND-GluRS to AdT difficult. ND-GluRS and AdT 
 
Fig 1.13. The cartoon representation of the crystal structure of T. thermophilus Asn-
transamidosome (PDB: 3KFU). The AdT subunits GatA, GatB, and GatC are color coded as 
yellow, purple, and orange respectively. The ND-AspRS, cattRNAAsn, and scaftRNAAsn are shown 
in red, blue, and green respectively (86).  
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compete for the accepter stem of the tRNA and cannot adopt their productive states 
simultaneously or in synchronicity. Instead, the two enzymes appear to work 
cooperatively and adopt their productive and non-productive conformations in 
sequentially. First, ND-GluRS is in the productive state and generates Glu-tRNAGln, 
which initiates a series of conformational changes in the two enzymes facilitating AdT to 
adopt its productive state. Next, Glu-tRNAGln is transferred to the GatB active site for 
transamidation. It is assumed that most probably the complex dissociates, releasing the 
final product and the two enzymes are again available for the next round of catalysis 
(89). However, it remains unclear whether the similar assembly and mechanism of Gln-
tRNAGln generation can be applied to other organisms carrying structural orthologs of 
ND-GluRS like GluRS2.  
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Fig 1.14. A cartoon representation of the T. maritima Gln-transamidosome (PDB: 
3AL0). The AdT subunits GatA, GatB, and GatC are color coded in purple, lime, and orange, 
respectively. ND-GluRS and tRNAGln are shown in magenta and green, respectively. ND-
GluRS is in its productive state with the tRNAGln accepter arm in its active site (89).    
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Recently, efforts for isolation of a Gln-transamidosome from the archaeon 
Methanothermobacter thermautotrophicus (M. thermautotrophicus) were unsuccessful 
(90). Pre-steady state experiments demonstrated that the two enzymes, ND-GluRS and 
GatDE, function independently. The Glu-tRNAGln intermediate dissociates from ND-
GluRS and rebinds to GatDE, where it is converted to Gln-tRNAGln, negating the 
requirements for a Gln-transamidosome (89). These observations argue that substrate 
channeling via a  Gln-transamidosome may not be essential (90).  
The first biochemical evidence for the formation of a Gln-transamidosome in an 
archaeaon was reported for M. thermautotrophicus, in which formation of a binary 
complex between ND-GluRS and GatDE was observed (91). In comparison to the T. 
thermophilus Gln-transamidosome, this M. thermoautotrophicus complex is tRNAGln 
independent and the impacts on the glutamylation and transamidation reactions 
catalyzed by ND-GluRS and AdT were minimal (92).   
1.8.2.3 Biochemical evidence for the existence of H. pylori Asn- and Gln-
transamidosomes 
In 2007, the first biochemical evidence of Asn-transamidosome existence in H. 
pylori was reported, when an increase in the affinity of AdT for Asp-tRNAAsn was 
observed in the presence of physiological concentrations of ND-AspRS (93). An 
extensive biochemical analysis of the H. pylori Asn-transamidosome was published in 
2012. Based on quantitative steady-state kinetic analyses, it was argued that H. pylori 
ND-AspRS, AdT, and tRNAAsn assemble into a dynamic, transient Asn-transamidosome. 
In the proposed mechanism, AdT binds to tRNAAsn (tRNA-presenting complex, tRNAPC) 
first and presents it to ND-AspRS; the affinity of tRNAAsn for AdT is 10-fold higher than it 
is for ND-AspRS. In this tRNAPC complex, aspartylation of tRNAAsn by ND-AspRS is 
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accelerated, compared to aminoacylation in the absence of AdT. Next, the accepter arm 
of the Asp-tRNAAsn is transferred to the transamidation site of AdT. ND-AspRS is 
released from this complex, making it ready for the next catalytic cycle. Another 
proposed mechanism suggests that ND-AspRS binds to tRNAAsn first and then is 
aminoacylated before transfer to AdT. ND-AspRS releases Asp-tRNAAsn at a much 
slower rate than usual, allowing AdT to bind Asp-tRNAAsn and convert it to Asn-tRNAAsn 
(94).  
The possible existence of an H. pylori Gln-transamidosome consisting of AdT, 
GluRS2, and tRNAGln was examined in 2011. This complex is significantly more dynamic 
and less stable than any other previously reported transamidosome (91). The integrity of 
this complex depends on an optimum concentration of tRNAGln, to maintain the 1:1:1 
stoichiometry of the AdT/GluRS2/tRNAGln ternary complex. Formation of two separate 
binary complexes, AdT/tRNAGln and GluRS2/tRNAGln, was observed when the 
concentration of tRNAGln exceeded this optimum concentration. It was also proposed 
that GluRS2 itself hydrolyzes excess Glu-tRNAGln when the concentration of tRNAGln 
exceeds a certain level, to promote the integrity of the genetic code (91).  
Kinetic and binding analyses of the putative H. pylori Gln-transamidosome 
revealed that tRNAGln functions as a scaffold tRNA which facilitates the assembly of the 
transamidosome through independent and transient interactions with both AdT and 
GluRS2. In the absence of tRNAGln, interactions between AdT and GluRS2 are weak 
(KD=40 ± 5 µM), but they do contribute to the stability of the transamidosome (91). Given 
the precise conditions needed to produce this Gln-transamidosome, its biological 
relevance remains unclear. 
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In M. thermautotrophicus, the binary complex between ND-GluRS and GatDE 
has a KD of 100 nM, forming a stable complex in vitro (91). In addition, M. 
thermautotrophicus Gln-transamidosome assembly is facilitated by protein-protein 
interactions between ND-GluRS and GatDE. In contrast, T. thermophilus employs RNA-
protein interactions for the stable assembly of the Asn-transamidosome (77,92). It 
seems that H. pylori represents a hybrid state between the M. thermautotrophicus and T. 
thermophilus transamidosomes, employing both protein-protein and RNA-protein 
interactions for the assembly of a Gln-transamidosome. However, neither the H. pylori 
Asn- or the Gln-transamidosome are stable (91,94). 
Cleary, some organisms like T. thermophilus use transamidosomes to prevent 
translational errors. Formation of such complexes in organisms like H. pylori is 
challenging. Unlike T. thermophilus, which utilizes an archaeal-type ND-AspRS, H.pylori 
utilizes a bacterial-type ND-AspRS, contain a ~140 amino acid insertion domain that 
should sterically interfere with transamidosome formation (Fig 1.5) (78,86). This 
insertion domain may account for the unstable interactions between AdT and ND-
AspRS.  
In addition, H. pylori is missing both AsnRS and GlnRS, and requires AdT for 
transamidation of both Asp-tRNAAsn and Glu-tRNAGln. This dual substrate specificity adds 
another layer of complexity in H. pylori. Thus, the possibility that other protein or enzyme 
partners are involved in the stable assembly of a functional transamidosome sees likely. 
Considering the evidence that H. pylori Asn- and Gln-transamidosomes are dynamic and 
transient, this organism may utilize an alternative mechanism to facilitate assembly of 
one or both transamidosomes to maintain translational fidelity.  
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1.9 Involvement of accessory proteins in protein translation  
Involvement of accessory proteins to maintain the translational accuracy has 
been observed in may organisms. For several aaRSs, due to the similarity in amino acid 
side chains, the extent of misacylation of a cognate tRNA with a non-cognate amino acid 
is high and, if left uncorrected, proves detrimental to protein synthesis and cell viability. 
Consequently, some aaRSs utilize editing mechanisms to hydrolyze misacylated tRNAs. 
For example, class II prolyl-tRNA synthetase (ProRS) has pre- and post-transfer editing 
activities, which hydrolyze the alanyl adenylate (Ala-AMP) intermediate and Ala-tRNAPro, 
respectively. In some cases, these editing reactions are catalyzed by an editing domain 
(INS) in ProRS. However, in 34% of bacteria, ProRS is missing this INS domain; these 
organisms rely on the editing function of a protein called ProXp-ala, an INS-like protein 
that hydrolyzes Ala-tRNAPro in trans. In addition to alanine, ProRS cannot discriminate 
against Cys, and it also makes Cys-tRNAPro. ProXp-ala hydrolyzes Ala-tRNAPro but not 
Cys-tRNAPro. In this case, another single-domain homolog of ProRS INS, YbaK, clears 
Cys-tRNAPro in trans. Interestingly, YbaK lacks the capability for specific tRNA 
recognition, and it cannot compete with EF-Tu for Cys-tRNAPro, which means that YbaK 
needs to hydrolyze Cys-tRNAPro before it is released from ProRS. Formation of a ternary 
complex between ProRS, YbaK, and tRNAPro enables hydrolysis before EF-Tu can 
interfere (95-100). Like ProXp-ala and YbaK, other proteins have been discovered to 
play important roles in protein translation when tRNA misacylation might occur. YqeY is 
another example; it enhances the ability of tRNAGln binding to AdT (101). 
In certain organisms, accessory proteins are found in association with the tRNA 
aminoacylation machinery, helping to form a macromolecular complex called the multi-
synthetase complex. For example, Arc1p, a non-catalytic tRNA binding protein, 
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facilitates assembly of multi-synthetase complexes in prokaryotes and some eukaryotes 
(102). In yeast, Arc1p copurified with cytosolic GluRS and methionyl-tRNA synthetase 
(MetRS), the first example of a multi-synthetase complex in unicellular eukaryotes. 
Arc1p has two different and independent interaction sites in its N-terminal region. The N-
terminal domain of Arc1p interacts with the N-terminal region of GluRS and MetRS and 
this complex also forms in vivo (103,104). The binary complexes of Arc1p GluRS and 
MetRS, as well as the ternary complex involving Arc1p/GluRS/MetRS, form in vitro. The 
middle and C-terminal domains of Arc1p interact individually with tRNAGlu and tRNAMet 
with low affinity, but with both domains, Arc1p binds tRNA strongly with a Kd of 10 nM. 
Arc1p also enhances the activity of both aaRSs by increasing the effective local 
concentration of substrate tRNA. The catalytic efficiency of MetRS increases by 300-fold 
with a 5-fold increase in kcat. In addition, a 10-fold increase in aminoacylation activity for 
GluRS with a 100-fold increase in affinity for tRNAGlu was observed in the presence of 
Arc1p.  
Formation of multi-synthetase complex utilizing non-aaRS accessory protein is 
observed in higher eukaryotes too. For example, in metazoa, a large multi-synthetase 
complex containing nine aaRSs and three accessory proteins has been reported. The 
complex includes the bifunctional GluRSProRS, AspRS, GlnRS, ArgRS, LeuRS, IleRS, 
LysRS, MetRS and the accessory proteins p18, p38, and p43 (103-106).  
All three accessory proteins in this complex have been broadly studied. 
Mammalian p18 is a 174 amino acid protein with a glutathione S-transferase (GST) fold. 
p18 shows sequence homology with human N-terminal polypeptide extension of valyl-
tRNA synthetase (ValRS) (107). Together with MetRS, IleRS, LeuRS, and GluProRS, 
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p18 constitutes a sub-complex that is associated with other sub-complex (p43, ArgRS, 
and GlnRS) of the multi-synthetase complex via p38 (102).  
Human p38 is a 320 amino acid protein, with an N-terminal leucine-zipper motif 
and C-terminal GST-like motif. Y2H analysis revealed that p38 associates with most of 
the proteins in the multi-synthetase complex, suggesting that it might function as a core 
scaffold protein. p38 showed the strongest interactions with p43, LysRS, and AspRS 
(102).  
p43 is a 312 amino acid protein and is the mammalian homolog of Arc1p. Like 
Arc1p, p43 interacts with both tRNA and a few aaRSs in the multi-synthetase complex. 
In the absence of p43, both ArgRS and GlnRS are detached from the complex. 
Therefore, it appears that p43 is the central component of the sub-complex involving 
ArgRS and GlnRS, and is responsible for anchoring this sub-complex to the rest of the 
multi-synthetase complex via its interaction with p38 (102).  
An archaeal multi-synthetase complex has been reported from M. 
thermautotrophicus, containing three aaRSs (LysRS, LeuRS, and ProRS) and 
elongation factor-1α (EF-1α) (108). EF-1α associates with this complex through 
interactions with LeuRS. There are functional advantages of such complex: the catalytic 
efficiency of LeuRS is increased in the presence of EF-1α; also the aminoacylation 
efficiency of the other two aaRSs of this complex (LysRS and ProRS) is increased in the 
presence of LeuRS (108).  
 The existence of a multi-synthetase complex in bacteria is controversial. In 
bacteria, binary complexes that are functionally affiliated in tRNA aminoacylation and 
editing are more common (109). In 2009, S. Kühner and co workers used tandem affinity 
purification-mass spectrometric (TAP-MS) to study the proteome organization in 
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Mycoplasma pneumoniae. They showed physical connection between six aaRSs (MetG, 
TyrS, PheS, ThrS, PheT, and GltX) and four other proteins (Fth, Fba, NrdF, and MgpA), 
providing the first evidence that higher order multi-synthetase complexs in bacteria might 
exist (110). 
Studies with known multi-synthetase complexes suggest that these complexes 
contribute to overall efficiency and accuracy of protein synthesis by facilitating substrate 
channeling. However, the exact roles of these multi-synthetase complexes are not well 
established. The discovery of new proteins in translation has encouraged us to extend 
the boundaries of classical protein translation in order to make room for key new players. 
Nevertheless, there is no direct evidence of assembly of a multi-synthetase complex in 
H. pylori. 
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Association of accessory proteins in the multi-synthetase complexes lead us to 
the hypothesis that in H. pylori novel proteins may participate in indirect biosynthesis of 
Gln-tRNAGln and Asn-tRNAAsn. These accessory proteins either facilitate 
transamidosome assembly or deliver the misacylated aa-tRNA from the respective 
Association of accessory proteins in multi-synthetase complexes led us to hypothesize 
that novel proteins may participate in indirect biosynthesis of Gln-tRNAGln and Asn-
tRNAAsn in H. pylori. These accessory proteins could either facilitate transamidosome 
assembly and efficacy or deliver the misacylated aa-tRNA from the respective aaRSs 
(ND-AspRS and GluRS) to AdT. We identified possible protein partners from a Y2H 
profile of the H. pylori proteome. Several proteins of unknown function were identified 
based on their intriguing Y2H interactions with components of the indirect 
aminoacylation machinery (ND-AspRS, GluRS2, and AdT) (Fig 1.15) (111). Hp0100, 
Hp1259 and Hp0495 were selected as targets. Hp0100 and Hp1259 connect either ND-
AspRS or GluRS2 to AdT; Hp0495 was selected because of its interaction with EF-Tu. 
 
 
Fig 1.15. Three proteins, Hp0495, Hp0100 and Hp1259, showed interesting interactions 
with proteins involved in indirect aminoacylation: Hp0100 showed a weak interaction with 
GatCAB and a moderate interaction with ND-AspRS. Hp1259 showed weak interactions with 
both GatCAB and GluRS2. Hp0495 showed the strongest interaction with EF-Tu. In the box, 
the color code for the strength of observed interactions are shown from red (strongest) to 
peach (weakest) (111). 
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Experiments described in this dissertation focused on characterizing all three of these 
proteins of unknown function. 
Hp0100, a 368 amino acid (43 kDa) protein, was selected for additional studies 
because of its intriguing interactions with the GatA subunit of AdT and ND-AspRS (Fig 
1.15) (111). We hypothesized that Hp0100 could be a player in indirect biosynthesis of 
Asn-tRNAAsn. Also, an amino acid sequence analysis of Hp0100 revealed that it contains 
a putative ATP-binding motif that belongs to the alpha adenine hydrolase-like (AANH) 
superfamily (112). A BLAST search analysis to determine the distribution of Hp0100 in 
different bacterial clades showed that full-length Hp0100 (368 amino acid) is only found 
in Ɛ–proteobacteria (e.g. H. pylori). Outside this clade many bacterial genomes contain 
genes encoding only N-terminal half of Hp0100 (e. g. E. coli) (112). Our lab has 
demonstrated in vitro that Hp0100 is a component of a tRNA-independent Asn-
transamidosome complex. This complex enhances the rate of AdT’s transamidation of 
Asp-tRNAAsn by ~35 fold and Glu-tRNAGln by ~3 fold. Hp0100 also hydrolyzes ATP in the 
presence of either Asp-tRNAAsn or Glu-tRNAGln and this hydrolysis drives the acceleration 
of AdT with both tRNA substrates (112). 
Similarly, Hp1259, another protein of unknown function, was selected for 
additional studies based on its Y2H interactions with GluRS2 and AdT (Fig 1.15) (111). 
Hp1259, a 205 amino acid (25 kDa) protein, contains a putative NAD+ binding domain 
and shares homology with the Sir2/CobB family of deacetylases. We hypothesized that 
Hp1259 may play a role in the indirect biosynthesis of Gln-tRNAGln because of these 
interactions.  
The observed interactions between Hp0100, Hp1259 and different enzymes of 
indirect aminoacylation were generally weak. One possibility is that these interactions 
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would be strengthened in the presence of the appropriate H. pylori tRNA. For example, 
tRNAAsn is required for the assembly of the T. thermophilus Asn-transamidosome 
(85,86). The observed network of interactions involving Hp0100, Hp1259, ND-AspRS, 
GluRS2, and AdT also suggests the possibility that these components assemble into a 
large multi-synthetase complex in H. pylori. In this complex, Hp0100 and Hp1259 may 
act as accessory proteins facilitating and stabilizing the assembly of the transamidosome 
and delivery of Asp-tRNAAsn and Glu-tRNAGln from their respective aaRSs to AdT.  
Hp0495, a small 86 amino acid (10 kDa) protein, was selected as a protein of 
target for studies because of its strong interaction with EF-Tu by Y2H (Fig 1.15) (111). In 
2007, Dr. Seo and coworkers solved the solution NMR structure of Hp0495, which 
revealed that it contains four β sheets and two ᾳ helices with sequence homology to 
nucleic acid binding proteins (113,114). In addition, homologs of Hp0495 are found only 
in organisms having GluRS2, indicating the possibility that these two proteins are 
involved in the indirect biosynthesis of Glu-tRNAGln.  
We are currently investigating the roles of Hp0100, Hp1259, and Hp0495 indirect 
aminoacylation for the biosynthesis of Glu-tRNAGln and Asn-tRNAAsn. Elucidation of the 
potential role/s for these proteins will help us to resolve the mystery of the dual 
functionality of AdT. Also, it will give us a more complete picture of the mechanisms 
which H. pylori employs to achieve translational efficiency and accuracy even in the 
absence of two seemingly essential aaRS (AsnRS and GlnRS). The discovery of novel 
mechanisms will expand our knowledge of protein biosynthesis and ultimately may 
enable us to design clade-specific drugs.   
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1.10 Role of aa-tRNAs outside of translation 
Other proteins, beyond the aaRSs and EF-Tu, interact with aa-tRNAs. The 
diversity of functions known for different aa-tRNAs (described in the next few 
paragraphs) also led us to hypothesize that Hp0100, Hp1259, and Hp0495 may be 
involved in pulling aa-tRNAs away from translation for non-canonical functions. aa-
tRNAs are amino acid donors for ribosomal protein synthesis, but aa-tRNAs are also 
involved in a number of other non-ribosomal biosynthetic pathways. Particularly in 
bacteria, aa-tRNAs are sequestered away from translation and are involved in 
peptidoglycan biosynthesis, membrane lipid modification, protein tagging, antibiotic 
synthesis, tetrapyrrole synthesis, etc. (115). 
In Streptococcus pneumonia, Ser-tRNASer and Ala-tRNAAla are substrates for 
MurM and MurN, two tRNA-dependent aminoacyl-ligases. MurM and MurN are 
responsible for formation of dipeptide substrates for cross-linking required during 
peptidoglycan biosynthesis. MurM uses Ser-tRNASer and Ala-tRNAAla to add L-Ser or L-
Ala as the first amino acid and MurN adds L-Ala as the second amino, acid using Ala-
tRNAAla. To date no MurMN specific tRNA isoacceptors have been discovered (116,117).  
In Staphylococcus aureus, the protein products of the femXAB gene cluster catalyze a 
three-step reaction to form pentaglycine for cross-linking in peptidoglycan biosynthesis. 
All three enzymes FemX (FhmB), FemA and FemB use Gly-tRNAGly as the amino acid 
donor. In order to balance the supply of Gly-tRNAGly between translation and cell wall 
synthesis, these enzymes use only three out of five tRNAGly isoacceptors (118,119).  
Aminoacyl-tRNAs are also substrates for aminoacyl-phosphatidylglycerol 
synthases (aa-PGSs). For example, in some bacteria (e.g. S. aureus, M. tuberculosis), 
aa-PGS uses Lys-tRNALys to transfer the Lys to phosphatidylglycerol. The net positive 
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charge of the cell membrane increases because of the introduction of Lys, which in turn 
lowers cell permeability to cationic molecules, subsequently enhancing antibiotic 
resistance (120,121). 
Glu-tRNAGlu is also a substrate for glutamyl-tRNA reductase (GluTR), the 
enzyme that catalyzes the first step in tetrapyrrole (e.g heme and chlorophyll) 
biosynthesis. In organisms like A. ferrooxidans, a large amount of chlorophyll is required, 
so GluTR competes with EF-Tu for Glu-tRNAGlu. Three isoaccepters of tRNAGlu are 
encoded by the genome of A. ferrooxidans, two of which are the substrates of GluTR. 
This bifurcation helps maintain a balance between protein synthesis and a high demand 
for heme production (122).  
To date, approximately half of the 20 cognate aa-tRNAs required for protein 
translation are also involved in alternative cellular processes (115). Many proteins have 
been identified which pull these aa-tRNAs into other pathways and many more are likely 
to be discovered, giving us reasons for also investigating the role of Hp0100, Hp1259, 
and Hp0495 of unknown function outside of indirect aminoacylation in H. pylori.  
1.11 Helicobacter pylori: the only known carcinogenic bacterium 
 The work presented in this dissertation primarily focuses on the indirect 
aminoacylation mechanisms for Asn-tRNAAsn and Gln-tRNAGln biosynthesis in the human 
gastric pathogen H. pylori. H. pylori infection causes chronic gastritis, peptic ulcer 
disease, and stomach ulcers (123). Epidemiological studies showed that H. pylori 
infection also causes gastric cancer and gastric mucosa-associated lymphoid tissue 
lymphoma and is involved in pancreatic and colon cancer (5,6,124-128). Recently, H. 
pylori involvement in other gastric pathologies like autoimmune gastritis and pernicious 
anemia has been recognized (129). H. pylori is the only known carcinogenic bacterium, 
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Barry Marshall and Robin Warren discovered it more than 20 year ago. They were able 
to successfully culture and isolate this bacterium from human stomach. For their 
discovery of the gastric pathogen H. pylori, they won the Nobel Prize in 
Physiology/Medicine in 2005.  
Compared to other bacteria, H. pylori manage to survive in extreme acidic 
environments (130). H. pylori colonizes the human gastric mucosa during childhood. 
Survival and pathogenesis in harsh acidic environments requires high-level production of 
the enzyme urease. Urease converts urea and water into ammonia and carbon dioxide 
to neutralize the gastric juice, which allows the bacteria to survive during colonization. 
The ammonia generated by urease buffers the gastric juice, which enables the bacteria 
to reach the stomach epithelial lining where the pH is neutral. The helical shape and 
flagellar movement of H. pylori helps to overcome the physical barrier imposed by the 
thick mucus layer which protects the epithelial cells lining the stomach. Next, H. pylori 
sticks to the epithelial cells and pathogenesis in the host proceeds by damaging the 
stomach epithelial lining (Fig 1.16) (130). Even though urease is known to be the major 
contributor to pathologies induced by H. pylori, new urease independent acid-tolerant 
mechanisms have recently been discovered in urease negative strains (131), showing 
how flexible and versatile H. pylori is and why it is important to understand the biology of 
this carcinogen. 
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It is estimated that two-thirds of the world’s population harbor H. pylori, with 
infections that are of particular risk to public health. Given the pernicious nature of H. 
pylori infection and its impact on human health, achieving a deeper understanding of the 
distinct biochemistry of this pathogen and carcinogen is of utmost importance. For the 
discovery of novel therapeutics and prevention strategies against H. pylori, it is important 
to better understand the mechanisms of H. pylori pathogenesis and drug resistance.  
 In addition, H. pylori is the first organism identified that uses indirect 
aminoacylation for the synthesis of both Asn-tRNAAsn and Gln-tRNAGln (132). Therefore, 
a better understanding of the novel mechanisms of aminoacylation will be beneficial for 
the development of novel, clade-specific targets for new antibiotics.    
1.12 Dissertation research  
 As previously stated, H. pylori, the model organism for our studies, has two 
misacylating aaRSs and does not appear to use a canonical Asn-transamidosome or 
 
 
Fig 1.16. The mechanism of H. pylori infection. Urease hydrolyzes urea to generate 
ammonia and carbon dioxide. The ammonia generated is converted to ammonium ion and 
buffers the acidic envirinment in the stomach mucosa, allowing H. pylori to survive in the 
acidic pH until it reaches the epithelial cells where the pH is neutral.  
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Gln-transamidosome. Consequently, H. pylori likely requires at least one additional 
mechanism for efficient delivery of misacylated tRNAs from its misacylating aaRSs to 
AdT. Presumably, such a mechanism would also prevent the entry of these misacylated 
tRNAs into the ribosome via weak binding to EF-Tu by sequestering the misacylated 
tRNAs prior to transamidation. Our hypothesis is that the involvement of accessory 
proteins or enzymes contributes to the assembly of a new type of transamidosome or 
delivers each misacylated tRNA from the aaRS to AdT. These hypothetical proteins can 
come into play at different stages and can contribute to maintaining translational fidelity.  
H. pylori is an ε-proteobacterium, and an obligate human pathogen, which can 
cause gastric problems like gastritis, gastric carcinoma and lymphoma (133). A protein-
protein interaction map of the H. pylori proteome was assembled from a Y2H screen 
(111). Our strategy is to focus on proteins of unknown function that showed interactions 
with one or more components of the indirect aminoacylation machinery by Y2H (GluRS2, 
ND-AspRS, AdT and EF-Tu). The three proteins of particular interest herein are Hp0495, 
Hp0100, and Hp1259 (Fig 1.15). 
 Hp0495, was selected as a potential new player because of it strong, A-level 
interaction with EF-Tu. We have reproduced this interaction in vitro. Chapter 2 describes 
the characterization of Hp0495 in H. pylori. Hp0495 binds ATP, glutamate, and either 
tRNAGlu1 or tRNAGln. It also forms a complex with EF-Tu and a tRNAGln-dependent 
complex with GluRS2. These results suggest that Hp0495 plays a role in preventing Glu-
tRNAGln complex formation with EF-Tu or in directing either Glu-tRNAGln or Glu-tRNAGlu1 
to an alternative function.  
 Hp0100 showed Y2H interactions with ND-AspRS and AdT, while Hp1259 
showed interaction with GluRS2 and AdT. Thus, these two proteins of unknown function 
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suggest pathways to connect each misacylating aaRS to AdT to facilitate the efficient 
repair of Asp-tRNAAsn and Glu-tRNAGln. Interestingly, no protein of unknown function was 
observed connecting AdT to GluRS1, despite the fact, that GluRS1 (not a misacylating 
aaRS) shares 60% similarity with GluRS2. The existence of these proteins of unknown 
function and their interactions with components of the translation machinery demonstrate 
that the classical boundaries of the field of tRNA aminoacylation need to be expanded. 
Chapter 3 describes interaction studies done to understand the assembly of an 
Asn-transamidosome that contains Hp0100 and the possible role of this protein as 
kinase. Surface plasmon resonance was used to evaluate binary interactions between 
Hp0100 and ND-AspRS, AdT and tRNAAsn. The Pro-Q diamond in gel staining method 
was used to study the possible kinase activity of Hp0100.  
Chapter 4 describes genetic experiments done to check the essentiality of 
Hp0100.  
Chapter 5 describes preliminary results showing the involvement of Hp1259 in H. 
pylori aminoacylation. Hp1259 is a potential candidate for the assembly of a Gln-
transamidosome, which could ensure the efficient delivery of Glu-tRNAGln from GluRS2 
to AdT.  
Two appendices are included at the end of this dissertation, which describe the 
results obtained for smaller, side projects. Appendix A describes site directed 
mutagenesis used to introduce point mutations into the GatA subunit of AdT to study this 
enzyme’s ammonia tunnel. Appendix B describes the assessment of a series of small 
molecules developed as potential GlnRS enzyme inhibitors.  
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CHAPTER 2: HP0495 INTERACTS WITH EF-TU, GLURS2 AND SMALL 
MOLECULES 
2.1 Summary 
We are examining proteins of unknown functions that were identified by Y2H as 
potential new players in tRNA aminoacylation (both direct and indirect) and fidelity. 
These efforts identified Hp0495 as a possible participant. Hp0495 was selected because 
of its strong Y2H interaction with EF-Tu. Interactions between Hp0495 and EF-Tu were 
confirmed both in vitro and in vivo, and the stoichiometry of this complex was determined 
to be 1:1. Hp0495 preferentially form a complex with the GTP bound state of the EF-Tu 
(over EF-Tu•GDP). It also forms a complex with GluRS2 in a tRNAGln-dependent 
manner. Hp0495 binds glutamate in the presence of either tRNAGlu1 or tRNAGln and 
requires ATP for glutamate binding. Hp0495 has the hallmarks of a general tRNA 
binding protein; it showed independent interactions with tRNAGln, tRNAGlu1, tRNAGlu2, 
tRNAAsp, and tRNAAsn, and the corresponding aa-tRNAs, Glu-tRNAGln, Glu-tRNAGlu1, Glu-
tRNAGlu2, Asp-tRNAAsp, Asp-tRNAAsn. However, Hp0495 showed a slight specificity for 
binding to tRNAGlu1 and Glu-tRNAGlu1, which led us to hypothesize that its function, is to 
direct Glu-tRNAGlu1 into a role beyond protein translation. Why and how such a small 
protein (86 amino acid long) interacts with EF-Tu, GluRS2, tRNAs/aa-tRNAs, and 
different small molecules (glutamate and ATP) is still not clear.  
2.2 Introduction 
2.2.1 Sequence and structural analysis of Hp0495 
The H. pylori genomes of two prototype strains, 26695 and J99 (among others) 
have been sequenced (132,133). In these genomes, 499 open reading frames (ORFs) 
are annotated as hypothetical proteins whose functions are not known, including 
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Hp0495. Interestingly, Hp0495 is only found in ɛ-proteobacteria, the same organisms 
that have GluRS2 (134). Furthermore, the Y2H profile of the H. pylori proteome showed 
that Hp0495 interacts strongly with EF-Tu (111), suggesting that Hp0495 may play a role 
in protein translation in the ɛ-proteobacteria. 
Hp0495 is a small, 86 residue protein with two alpha helices, four beta sheets 
(βαββαβ), and an N-terminal tail (Fig 2.1). A solution NMR structure of Hp0495 is 
available and it revealed some structure and sequence conservation with different 
nucleic acid binding proteins (135,136). Hp0495 shares only very weak sequence 
homology with proteins of unknown function from several other bacteria. Therefore, 
based on sequence homology, the function of Hp0495 cannot be identified (136).  
A structural homology search with Hp0495 using the program DALI (137) 
revealed multiple hits to a variety of proteins. Out of 261 hits, 20 proteins had Z-scores 
higher than 5.0. These proteins include the NikR protein from Pyrococcus horokoshii 
(nickel responsive repressor; PDB: 2BZ9, Z-score = 7.0, RMSD = 2.9 Å), LrpA from T. 
thermophilus (transcriptional regulator, PDB: 1RIS, Z-score = 5.9, RMSD = 2.9 Å), the 
S6 protein from Archaeoglobus fulgidus (ribosomal protein; PDB: 1Y7P, Z-score = 5.5, 
RMSD = 2.9 Å), the ACT domain of GTP pyrophosphokinase from Chlorobium tepidum 
(GTP pyrophosphokinase; PDB: 3IBW, Z-score = 5.3, RMSD = 2.45 Å), and the YbeD 
protein from Escherichia coli (unknown function; PDB: 1RWU, Z-score = 5.1, RMSD = 
3.6 Å) (Fig 2.2A to D).  
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Fig 2.1. Solution NMR structure of Hp0495. A. A cartoon representation of 
Hp0495 (PDB: 2H9Z). B. Surface distribution of charged residues on two 
distinct faces of Hp0495. Positively charged residues are shown in blue, and 
negatively charged residues are shown in red. The figure was generated 
using PyMol (135,136). 
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Fig 2.2. Structural alignments of Hp0495 with ACT domains of different proteins. 
Hp0495 alignment with the ACT domains of A. P. horokoshii NikR (PDB: 2BJ9). B T. 
thermophilus LrpA (PDB: 1RIS). C. A. fulgidus S6 (PDB: 1Y7P). D. C. tepidum GTP 
pyrophosphokinase (PDB: 3IBW) (137). 
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In 1999, Aravind and Koonin performed a PSI-Blast (position-specific iterating-
Blast) using the small subunit of acetolactate synthase (IlvN) and identified a group of 
proteins with ACT domains (138). These proteins were regulated by specific amino acids 
and were involved in either amino acid or nucleotide metabolism. They named this 
proposed domain the ACT domain after the first letters of three proteins, aspartate 
kinase-chorismate mutase-tyrA (prephenate dehydrogenase) (138). 
These proteins, including Hp0495, contain βαββαβ-folds, which is a common 
regulatory structure and represents the archetypical ACT domain. The ACT domain is a 
structural motif in proteins of 70-80 amino acids and is often involved in allosteric 
regulation (negative feedback) of amino acids and nucleotide metabolism (138-142). The 
first structure of an ACT domain was determined when the crystal structure of E. coli D-
3-phosphoglycerate dehydrogenase (SerA) was reported in 1995 (143). SerA is a 
tetrameric protein with one ACT domain in each subunit (Fig 2.3A and B). The SerA 
crystal structure revealed two domains in this enzyme: a flexible hinge connects these 
catalytic and regulatory (ACT) domains. This enzyme catalyzes the rate-limiting first step 
in serine biosynthesis. When the effector molecule serine binds to the αβ-sandwich of 
the ACT-domain, the hinge region induces allosteric regulation by slight interdomain 
rearrangement, which eventually down regulates the catalytic activity of the enzyme 
(143-146). 
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The ACT domain is also found in transcription factors and as stand-alone 
modules. In 2001, the crystal structure of the first transcription factor, LrpA from P. 
furiosus, with its ACT domain was published (147). A PSI-Blast analysis of its sequence 
revealed a novel type of ACT domain, which was named the RAM domain, for regulator 
of amino acid acid metabolism (140). Even though the LrpA-like transcriptional regulator 
contains an ACT domain fold (βαββαβ), sequence alignment revealed different 
conserved residues with a different location for the ligand-binding site. The ACT domains 
of SerA and LrpA superimpose very well (RMSD = 1.8 Å), but close examination 
revealed that the dimer interfaces of each ACT domains were significantly different. The 
ACT domain dimer of SerA forms a side-by-side structure creating an extended 8-
stranded β sheet, whereas the β sheets of the ACT domain dimers of LrpA have a face-
 
Fig 2.3. The ACT domain fold. A. A single ACT domain from E. coli D-3-phosphoglycerate 
dehydrogenase showing the βαββαβ motif (PDB: 1PSD). B. A diagram showing the 
arrangement of the βαββαβ motif, the triangles point up and down to indicate the direction of 
the strand in the β sheet. Numbers progress from N terminus to C terminus (143,146). 
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to-face configuration. These keen observations defined the basis of the proposed 
division of ACT and RAM domains (146). In addition, the SerA ACT domain has a glycyl 
residue at the turn between the first β strand and the first α helix, which coincides with 
the L-serine binding site (143). Based on this observation, a common ligand-binding 
mode for all ACT domains has been proposed. However, the RAM domain is missing the 
glycyl residue in this location; instead, the RAM ligand binding site is defined by the 
presence of another highly conserved glycine in the loop between the β2 and β3 strand 
(147). Since the effector binding site of both domains are significantly different, it was 
assumed that ACT and RAM domains originated from a common ancestor, but their 
ligand binding sites have evolved independently. Interestingly, Hp0495 shows structural 
similarities with both ACT (e.g. GTP pyrophosphokinase) and RAM (e.g. LrpA) domains, 
but does not share either conserved glycyl residue, making it hard to predict the ligand-
binding site of Hp0495 (137).  
A majority of ACT-domain proteins bind with amino acids and are involved in 
regulation of amino acid metabolism (140-146). However, in recent years, exceptions to 
this generality have been revealed. For example, the NikR transcriptional regulator binds 
nickel and regulates intracellular nickel levels (148). The nickel ion binds at the loop 
between β2 and β3, as described for LrpA (RAM domain), but instead of a glycyl residue 
at this location, NikR has a histidine at the analogous position and nickel chelates to the 
side chain of this histidine. Another example is YkoF, a protein that binds thiamine and is 
proposed to be involved in thiamine transport (149). Table 2.1 summarizes the known 
ACT domains and their regulatory ligands. To date, 10 ACT-domain containing protein 
structures have been identified, and five structures have been solved with ligand bound 
(146).  
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There is one example of an ACT domain that binds multiple ligands. The 
Arabidopsis aspartate kinase binds L-lysine at the loop between β1 and α1 with the 
specific glycine residue proposed for ACT domains (150). It also binds S-
adenosylmethionine (SAM) at the second site located in the β3-α2 loop. SAM binding 
seems to act synergistically with lysine (150).  
Table 2.1. Proteins containing an ACT domain and their regulatory ligands (146). 
Ligand Metabolic enzymes Ligand 
Transcription 
regulators 
Ser 
Phosphoglycerate 
dehydrogenase 
Val 
LrpA-like transcription 
regulator 
Lys Aspartokinase Tyr 
TyrR transcription 
regulator 
Val 
Acetohydroxyacid 
synthase 
Gly 
Glycine cleavage 
system repressor 
Phe 
Phenylalanine 
hydroxylase 
Nickel 
NikR transcription 
regulator 
Met, Gly 
Formyltetrahydrofolate 
deformylase 
Ligand Others 
His 
ATP-phosphoribosyl 
transferase 
Thiamine YkoF protein 
Thr 
Homoserine 
dehydrogenase 
? ACR protein 
Leu 
Isopropylmalate 
synthase 
? YbeD protein 
Phe Chorismate mutase 
 
Ile Threonine deaminase 
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It is noteworthy that RNA binding proteins also possess the same βαββαβ fold 
like the ACT domain (151,152). These proteins did not bind small molecules in loop 
regions, but rather bind RNA through interactions at the face of their β sheet structure. 
The evolutionary relationship between these proteins with very similar domains is not 
clear yet. From surface charge patterns, Hp0495 was suggested to be a nucleic acid 
binding protein (135,136) while a structural alignment revealed similarities between 
Hp0495 with ACT and RAM domains that are usually ligand bound (137). Hp0495 
seems to represent a hybrid state between an RNA binding protein and ACT or RAM 
domain-containing proteins.  
In addition to metabolic and transcriptional ACT domains, stand-alone ACT 
domains are also known. Examples of these include E. coli YbeD, B. subtilis YkoF, and 
Hp0495 (149). YkoF is a thiamine binding protein. One postulated function for YkoF is 
that it may function as a ligand transporter. Alternatively, it may sequester this ligand 
until it is needed (149). In a DALI search, Hp0495 showed structural similarity to E.coli 
YbeD, a protein of unknown function (Fig 2.4A to C) (137). Hp0495 and YbeD only 17% 
sequence identity (Fig 2.4D). YbeD is close in size (87 amino acid) to Hp0495 (86 amino 
acid). Also, like Hp0495 YbeD showed interactions with E. coli EF-Tu by Y2H (153). 
These observations led us to a hypothesized that maybe YbeD is a functional homolog 
of Hp0495 in E. coli.  
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Like Hp0495, an NMR structure of YbeD has been solved (154). YbeD is a 
conserved bacterial protein located in the dacA-lipB intergenic region (154). The dacA 
gene encodes for a D-alanyl-D-alanine carboxypeptidase involved in peptidoglycan 
biosynthesis and the lip operon contains genes that are responsible for lipoic acid 
biosynthesis. For YbeD, a structural homology search using DALI showed the highest Z-
score, 6.1, for the regulatory domain of the SerA protein, hinting that its role may be in 
the allosteric regulation of lipoic acid biosynthesis or the glycine cleavage system. The 
hp0495 gene is in an operon with mraY (the gene encoding phosphor-N-acetylmuramoyl 
pentapeptide transferase) and murD (the gene encoding UDP-N-acetylmuramoyl-L-
Fig 2.4. Structural and sequence alignment of H. pylori Hp0495 and E. coli YbeD. A.  A 
cartoon representation of Hp0495, shown in cyan (PDB: 2H9Z). B. A cartoon representation 
of YbeD, shown in orange (PDB: 1RWU). C. A superimposition of the Hp0495 and YbeD 
structures. D. A sequence alignment of Hp0495 and YbeD (135,136,154).  
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alanyl-D-glutamate synthetase) (Fig 2.5). These enzymes are involved in cell wall 
biosynthesis, hinting that the role of Hp0495 may be in H. pylori cell wall biosynthesis.  
 
Although YbeD showed the highest structural similarity with the SerA ACT 
domain, it showed the highest sequence conservation in its β2-β3 loop, the ligand-
binding site for RAM domains. Consequently, YbeD was later classified as a stand-alone 
RAM domain protein. Also, the β2-β3 loop of YbeD was speculated to be the most likely 
binding site for any potential effector. In the NMR structure of YbeD, this region was not 
well structured, but it may adopt a more rigid conformation upon ligand binding. Unlike 
Hp0495, YbeD was excluded from the possibility of being an RNA-binding protein 
because of the absence of patches of positively charged and aromatic residues that are 
characteristic of nucleotide-binding domains and RNA recognition motifs (154).  
Nevertheless, because of the intriguing similarities between YbeD and Hp0495, 
E. coli YbeD was cloned and expressed in our lab and experiments performed with 
YbeD will be discussed later in this chapter.  
The βαββαβ-motif appears to be a common regulatory structure in transcriptional 
regulators and amino acid metabolic enzymes. The RAM and the ACT domains share 
this fold and are often coupled to proteins that are involved in amino acid metabolism, 
 
Fig 2.5. Schemetic of part of the H. pylori 26695 DNA region surrounding Hp0495. 
Hp0495 is immediately downstream of the genes for mraY and murD.   
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either as part of transcriptional regulators, as part of enzymes, or as stand-alone small 
molecule binding domains. It is to be noted that the ACT domain is often found as a 
regulatory motif in metabolic enzymes, whereas the RAM domains are mainly linked with 
transcriptional regulators (140). The ACT and RAM domains appear to be an example of 
domain evolution in which structural similarity has been retained while losing sequence 
similarity. The structural and functional similarities between the two domains may be 
useful for speculating the function of uncharacterized RAM and ACT domains, especially 
the stand-alone versions of RAM domains (e.g. Hp0495 and YbeD). Still, the functions of 
single stand-alone RAM domains have not been identified.  
2.2.2 EF-Tu interactions with proteins outside of the protein translational 
machinery 
Since Hp0495 showed interactions with EF-Tu by Y2H, we reviewed what is 
known about EF-Tu’s interactions with other proteins beyond the aaRSs, other 
elongation factors (e.g. EF-Ts), and the ribosome. EF-Tu is ubiquitous in all kingdoms of 
life and is the most abundant protein in bacteria (5-10% of total proteins) (155). Its 
concentration is equivalent to total aa-tRNAs (0.1-0.2 mM) and ~10 fold higher than that 
of ribosomes (156,157). EF-Tu is a member of the guanosine triphosphatase 
superfamily of proteins and exists in active and inactive forms depending on the 
phosphorylation status of the guanine nucleotide bound to it. In its active GTP bound 
state, EF-Tu acts as a carrier of aa-tRNAs to the A-site of the ribosome for protein 
synthesis (see Fig 1.1). After hydrolysis of GTP, EF-Tu loses its aa-tRNA binding 
capacity and the resulting GDP needs to be replaced by GTP; this reaction is achieved 
by the EF-Ts-mediated guanine-nucleotide exchange reaction (156).    
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EF-Tu undergoes post-translational modifications: its N-terminus is acetylated 
and the non-conserved Lys56 can be mono- or dimethylated in vivo (158,159). 
Phosphorylation of the strictly conserved Thr382 residue in EF-Tu has also been 
reported in vivo (160,161). In vitro, a ribosome-associated kinase can phosphorylate EF-
Tu (161). This phosphorylation is enhanced by EF-Ts and phosphorylation abolishes EF-
Tu’s ability to bind kirromycin, an antibiotic known to block EF-Tu function. Most 
interestingly, phosphorylated EF-Tu cannot bind aa-tRNAs. Structural analyses have 
demonstrated that introduction of the phosphate charge changes the interaction between 
domains 1 and 3 in EF-Tu (Thr382 is located at the interface of these two domains). This 
change leads to an opening of EF-Tu to a conformation that resembles the GDP bound 
conformation, thus preventing aa-tRNA binding. It has been proposed that 
phosphorylation of EF-Tu has a regulatory role in protein synthesis (161).   
Earlier, ribosome-associated kinases were shown to phosphorylate EF-Tu (161). 
But recently, a new protein kinase known as Doc was discovered that phosphorylates 
Thr382 in EF-Tu and inhibits bacterial translation (162,163). Doc is a representative 
member of the Fic (filamentation induced by cyclic AMP) family of enzymes (164-166). 
The Fic proteins are ubiquitous in all domains of life and catalyze AMPylation of target 
proteins (164-169). In contrast to AMPylating activity, Doc catalyzes phosphorylation of 
EF-Tu (162,163). After phosphorylation by Doc, EF-Tu is unable to bind aa-tRNAs and 
preferentially binds GDP (162,163). In the context of toxin-antitoxin modules, it was 
proposed that the fraction of phosphorylated EF-Tu increases in the cell (160), reaching 
an extent that is incompatible with efficient translation, eventually bringing the cell to a 
dormant state. EF-Tu dephosphorylation by a specialized as of yet unknown 
phosphatase might bring the cell back from dormancy (163). It was also proposed that 
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Doc might catalyze the dephosphorylation of EF-Tu as well (163). However, these 
speculations require further investigation.  
Another serine-threonine (Ser/Thr) kinase in E. coli, HipA, was discovered 
(170,171) that inhibits cell growth and induces persistence. In 2009, based on in vitro 
experiments it was proposed that HipA inhibits cell growth and confers persistence by 
the phosphorylation of EF-Tu (171). However, EF-Tu phosphorylation by HipA did not 
explain the inhibition of replication and transcription observed after hipA induction (172). 
Moreover, induction also stimulates RelA dependent synthesis of (p)ppGpp (173), 
suggesting the possibility of an additional cellular target for HipA. The HipA-induced 
persistence mechanism was reexamined and it was discovered that GluRS is the target 
of HipA (174,175). HipA inhibits GluRS by phosphorylation of conserved Ser239 in the 
KLSKR motif of the enzyme. Interestingly, HipA can phosphorylate GluRS only when it is 
bound to tRNAGlu. The conformational change induced by binding of tRNAGlu to GluRS 
makes Ser239 more exposed. The introduction of a negative charge by phosphorylation 
at this position leads to the catalytic inactivation of GluRS. In fact, a Ser239Asp mutation 
also inactivated GluRS, supporting this regulatory mechanism. A molecular model 
explaining the cellular consequences of GluRS phosphorylation by HipA was proposed. 
When HipA is present, GluRS is inactivated by phosphorylation causing accumulation of 
uncharged tRNAGlu. This uncharged tRNAGlu is loaded onto empty A-sites in ribosome, 
which in turn triggers the release and activation of RelA (176). RelA activation 
dramatically increases the (p)ppGpp levels, causing inhibition of multiple essential 
cellular processes (replication, transcription, translation, and cell wall synthesis). This 
cascade of events subsequently leads to slow cell growth and persistence (multidrug 
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tolerance). All together, these results show that HipA does not phosphorylate EF-Tu, and 
instead it inhibits translation by phosphorylation of GluRS (174,175). 
An essential Ser/Thr protein kinase in Mycobacterium tuberculosis, PKnB, also 
phosphorylates EF-Tu (176). This phosphorylation decreases the affinity of EF-Tu for 
GTP, causing reductions in protein synthesis. Multiple residues of EF-Tu were 
phosphorylated including: Thr9, Thr17, Thr29, Thr46, Thr64, Thr74, and Thr118 in 
domain I; Thr227, Thr256, and Thr259 in domain II; and Thr337 and Ser362 in domain 
III. In Mycobacterium smegmatis, overexpression of PKnB led to a decrease in protein 
synthesis (176).  
EF-Tu also plays a second important role beyond protein translation by 
participating in the maintenance of cell wall shape. In the bacterium B. subtilis, EF-Tu 
localizes in a helical pattern just under the cytoplasmic membrane and colocalizes with 
an ortholog of actin, known as MerB (177). MerB is essential for viability and forms 
magnesium and ATP or GTP dependent filaments in vitro (178-180). EF-Tu and MerB 
interact with each other both in vivo and in vitro (177). A decrease in EF-Tu 
concentration had a minor effect on translation but a strong impact on the localization of 
MerB and on cell shape (176). This discovery of the dual function of EF-Tu in a 
bacterium led us to hypothesize that Hp0495 may be involved in sequestering EF-Tu for 
some function outside of protein translation. Our hypothesis is supported by the fact that 
the hp0495 gene is in an operon with mraY and murD, genes encoding enzymes 
involved in cell wall biosynthesis.  
In this chapter, the functional characterization of Hp0495 will be discussed.  
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2.3 Results and discussion 
2.3.1 Hp0495 interacts with EF-Tu in 1:1 stoichiometry in vitro  
The Y2H analysis of the H. pylori proteome suggested that Hp0495 interacts with 
EF-Tu with strong affinity in vivo. Our initial efforts focused on validating this interaction 
in vitro and examining it in vivo in E. coli, with the specific goal of determining the 
stoichiometry of the EF-Tu•Hp0495 complex. Association of the two proteins was 
previously demonstrated by native gel electrophoresis (Terry Cathopoulis, data not 
shown), but the stoichiometry was indeterminate. To address this issue, Hp0495 and H. 
pylori EF-Tu were purified and complex formation was examined by size exclusion 
chromatography (SEC), and mass spectrometry. 
In SEC, Hp0495 elutes as a monomer, with an observed molecular weight (MW) 
of 9 kDa (Fig 2.6, middle panel). EF-Tu was analyzed alone for comparison and it 
showed one major peak corresponding to a MW of 41 kDa (Fig 2.6, top panel). For 
comparison, the calculated MW for Hp0495 and EF-Tu are 10.3 and 45.1 g/mol, 
respectively. When EF-Tu and Hp0495 were co-injected, a shift in the EF-Tu peak 
towards a higher molecular weight was observed, along with the disappearance of the 
Hp0495 peak (Fig 2.6, bottom panel). This larger complex had a calculated MW of 52 
kDa, consistent with rate formation of a 1:1 EF-Tu•Hp0495 (MWs were calculated by 
comparison to the elution times of molecular weight standards, data not shown).  
Fractions corresponding to each peak were collected and analyzed by 15% SDS-
PAGE, (Fig 2.6, insets). This presence of EF-Tu and Hp0495 in the same fraction, 
further confirmed that the 52 g/mole peak represents a complex formation between EF-
Tu and Hp0495.  
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Fig 2.6. Size exclusion chromatography of the EF-Tu and Hp0495 complex. The top two 
panels show SEC traces for EF-Tu and Hp0495, respectively. The bottom panel shows the 
trace obtained from a mixture of EF-Tu and Hp0495. The calculated molecular mass of the 
complex was 52 kDa, which is equal to formation of a 1:1 complex of EF-Tu•Hp0495. 
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To further confirm that EF-Tu•Hp0495 assembles into a 1:1 stoichiometry, EF-Tu 
alone and in complex with Hp04945 were analyzed by electrospray ionization mass 
spectrometry (ESI-MS) (Fig 2.7) by Dr. Keng-Ming Chang in collaboration with the 
Trimpin group. Addition of Hp0495 to EF-Tu induced an increase in the observed 
mass/charge states as compared to EF-Tu alone. Multiple charge states were observed 
with both samples. Deconvolution of the EF-Tu•Hp0495 complex mass spectrum gave 
an observed molecular mass of 55.5 kDa (compared to 45.6 g/mol for EF-Tu alone), 
which is equivalent to the calculated MW for the 1:1 EF-Tu•Hp0495 complex (55.4 kDa). 
These results unequivocally demonstrate that EF-Tu forms a 1:1 complex with Hp0495. 
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2.3.2 Hp0495 interacts with EF-Tu in vivo  
To confirm that the EF-Tu•Hp0495 complex is formed in vivo, FLAG-tagged 
Hp0495 was separately co-expressed with E. coli and H. pylori His6-tagged EF-Tu. Each 
variant of EF-Tu was purified by Ni2+-affinity chromatography and the purified protein 
was analyzed by SDS-PAGE α-FLAG Western blot to determine whether or not Hp0495 
was co-purified via its association with EF-Tu (Fig 2.8). Purification of H. pylori EF-Tu 
resulted in the co-purification of substantial amounts of Hp0495; Hp0495 was readily 
observed in the Coomassie stained and its identity was confirmed by Western blot 
shown (lane 1 in both images of Fig 2.8). Purification of E. coli EF-Tu also resulted in the 
 
Fig 2.7. The EF-Tu•Hp0495 complex was examined by ESI-MS. The top and bottom 
panels are for EF-Tu and EF-Tu•Hp0495 complex, respectively. Upon addition of Hp0495 
the peaks for EF-Tu induced an increase in charge states, and deconvolution of EF-
Tu•Hp0495 complex spectrum gave molecular mass of 55.5 kDa. 
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co-purification of Hp0495 (lane 2 in both images of Fig 2.8), however yields of both EF-
Tu and Hp0495 were significantly lower. These results clearly demonstrate that an EF-
Tu•Hp0495 complex is formed in vivo. They also indicate that Hp0495 forms a complex 
with E. coli EF-Tu in a similar fashion, even though E. coli does not have an ortholog of 
full length Hp0495. Hp0495 interacts with E. coli EF-Tu presumably because H. pylori 
and E. coli EF-Tu are 74% identical. 
The above data validate the yeast two-hybrid protein-protein interaction result 
and they demonstrate complex formation between EF-Tu and Hp0495. Furthermore, the 
stoichiometry of this complex is 1:1 by mass spectrometry and SEC. All the above 
experiments were done with the GDP-bound state of EF-Tu.  
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2.3.3 Binding and kinetic analyses of Hp0495 interaction to EF-Tu•GTP and EF-
Tu•GDP using surface Plasmon resonance  
Surface plasmon resonance (SPR) was chosen to study the binary interactions 
between Hp0495 and EF-Tu•GTP, and EF-Tu•GDP because it is an ideal technique for 
monitoring interactions between macromolecules in real time. SPR involves 
immobilization of one of the interacting partners (the ligand: Hp0495 in our case) on the 
sensor chip and then passing the other partner (the analyte: EF-Tu•GTP or EF-Tu•GDP) 
over the surface. 
 
 
 
 
Fig 2.8. Co-purification of EF-Tu and Hp0495. Eluate was analyzed by 15% SDS-PAGE (left) and 
anti-FLAG Western blot (right). Ni-NTA purification of H. pylori EF-Tu (lane 1) and E. coli EF-Tu (lane 
2) with co-purification of  Hp0495. The presence of FLAG-tagged Hp0495 was confirmed by anti–
FLAG Western blot.  
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2.3.3.1 Immobilization of Hp0495 onto a CM5 sensor chip using amine coupling for 
real time binding assays  
SPR experiments were performed at 25 °C using the Biacore 2000 system in the 
WSU chemistry department’s RNA center. A CM5 was used for the immobilization of 
Hp0495 protein through amine coupling. The dextran surface of the chip was activated 
using a 1-ethyl-3-(3-dimethyl-aminopropyl)-carbodimide hydrochloride (EDC) and N-
hydroxysuccinimide (NHS), which led to the formation of a highly reactive reactive 
succinamide ester. Next, the ligand (Hp0495) was injected over the chip and the 
expected 3000 response units (RUs) of surface coverage were acheived. In this way, 
Hp0495 was immobilized on this chip by formation of amide linkages between the amino 
groups of lysine side chains on the surface of Hp0495 and the carboxyl groups on the 
surface of the chip. Excess remaining reactive groups on the surface of the chip was 
surface was deactivated by treatment with ethanolamine hydrochloride-NaOH. Fig 2.9 
shows a sensorgram from immobilization of 0.1 mg/mL Hp0495 on the chip.  
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Fig 2.9. Hp0495 immobilization on a CM5 sensor chip via amine coupling. A. 
Schematic of the series of steps involved amine coupling: 1. Activation: EDC/NHS 
treatment activates the chip surface forming a highly reactive succiniamide ester. 2. Ligand 
contact: Coupling of ligands occurs through primary amine groups. 3. Blocking: 
Ethanolamine treatment blocks the remaining carboxyl groups on the dextran surface of the 
chip. B. Sensorgram obtained during immobilization of Hp0495, showing the change 
in RU’s that occurred for each corresponding step.  
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2.3.3.2 Hp0495 preferentially binds EF-Tu•GTP over EF-Tu•GDP 
EF-Tu has two functionally relevant forms, GTP-bound and GDP-bound: EF-
Tu•GTP is the active state for translation. Complex formation between Hp0495 and both 
forms of EF-Tu were examined using SPR against EF-Tu•GDP and EF-Tu•GTP. 
Increasing concentration of EF-Tu•GTP (0-1 µM) and EF-Tu•GDP (0-5 µM) were passed 
over the sensor chip with immobilized Hp0495. The resulting sensorgrams depict an 
increase in RUs as the analytes binds to Hp0495 until equilibrium is reached, at which 
point the response ideally becomes constant over time. To measure dissociation, 
running buffer was passed over the chip without analyte and showed a decrease in RUs 
with a return to basal levels. This data profile of association, equilibrium, and 
dissociation was used to calculate the dissociation constant (Kd) of the interaction 
partners. 
The resulting sensorgrams and the corresponding binding plots are shown in Fig 
2.10 and 2.11. Equilibrium RUs were obtained from the sensograms (Fig 2.10A and Fig 
2.11A) and binding plots (Fig 2.10B and Fig 2.11B) were created by plotting the 
equilibrium RUs versus EF-Tu•GTP or EF-Tu•GDP concentration and fitted to the 
equation H•A = [A0]•RMax/(Kd + [A0]) in Kaleidagraph, v. 4.0. In this equation, H•A 
represents the complex between Hp0495 (as H) and the analyte (as A), [A0] represents 
the initial concentration of the analyte in solution and RMax is the theoretical response 
units that would be obtained upon 100% complex formation.  
Interestingly, Hp0495 binds EF-Tu•GTP strongly with a nanomolar Kd = 284 ± 18 
nM, as compared to its binding to EF-Tu•GDP, for which the Kd obtained was in the 
micromolar range (Kd = 3.6 ± 0.2 µM). These observations argue that Hp0495 prefers to 
form a complex with EF-Tu•GTP.  
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Fig 2.10. Hp0495 binds EF-Tu•GTP with nanomolar affinity. Hp0495 was immobilized on 
a CM5 sensor chip and increasing concentrations of EF-Tu•GTP (0-1 µM) were delivered as 
analyte. Equilibrium response unit were obtained from the sensorgrams shown in panel A 
and plotted against the EF-Tu•GTP concentration. The binding plot is shown in panel B and 
was used to calculate the dissociation constant; Kd = 284 ± 18 nM.  
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Fig 2.11. Hp0495 binds EF-Tu•GDP with micromolar affinity. Hp0495 was immobilized 
on a CM5 sensor chip and increasing concentrations of EF-Tu•GDP (0-5 µM) were delivered 
as analyte. Equilibrium response unit were obtained from the sensorgrams shown in panel A 
and plotted against the EF-Tu•GDP concentration. This binding plot is shown in panel B and 
was used to calculate the dissociation constant; Kd = 3.6 ± 0.2 µM.  
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2.3.4 Summary of experiments and results obtained by Dr. Keng-Ming Chang for 
Hp0495 (50) 
2.3.4.1 Effect of Hp0495 is specific to Glx (Glu + Gln) system (50) 
Since Hp0495 is rigorously conserved in ɛ-proteobacteria in which GluRS2 is 
also uniquely found. Dr. Keng-Ming Chang, a former graduate student of our group, 
examined the impact of EF-Tu•Hp0495 complex on tRNA aminoacylation using GluRS1, 
GluRS2, and ND-AspRS with their corresponding aa-tRNAs (tRNAGlu1/Glu2, tRNAGln, and 
tRNAAsp/Asn, respectively). These assays were not performed under initial rate conditions 
and it was assumed that the observed plateau levels reflect equilibrium between 
aminoacylation and deacylation (the forward and reverse reactions). These experiments 
demonstrated that, like EF-Tu, Hp0495 alone can subtly drive aminoacylation forward. 
However, the impacts of EF-Tu and Hp0495 were additive and not synergistic. 
Furthermore, the effects of Hp0495 were more higher for the aminoacylation of tRNAGlu 
and tRNAGln compared to tRNAAsp and tRNAAsn (data not shown).  
2.3.4.2 Hp0495 causes a high Y-intercept in initial rate assays (50) 
Dr. Chang also performed initial rate aminoacylation assays with GluRS1, 
GluRS2, and ND-AspRS in the presence vs. absence of Hp0495. The addition of 
Hp0495 introduced the formation of a non-zero Y-intercept for all assays. The intensity 
of this intercept increased in correlation with Hp0495 but had a negligible effect on 
reaction rate (slope). 
In order to further elucidate the origin of this observed non-zero y-intercept, each 
reaction component was omitted one at a time. Surprisingly, these results revealed that 
radiolabelled Glu precipitated in trichloroacetic acid in the presence of Hp0495, even in 
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the absence of each aaRS, demonstrating that this precipitation was uniquely Hp0495-
dependent.  
2.3.4.3 Hp0495 binds glutamate in the presence of tRNAGlu1 or tRNAGln (50) 
Remarkably, binding assays by Dr. Chang revealed that Hp0495 binds Glu in the 
presence of tRNAGlu1 or tRNAGln when incubated in standard aminoacylation buffer. In 
the presence of other tRNAs (tRNAGlu2, tRNAAsp, and tRNAAsn), Glu binding was nominal.  
2.3.4.4 Hp0495 requires ATP to bind glutamate (50) 
Elimination of ATP from the buffer led to loss of Glu binding. Replacement of 
ATP with other nucleotides (GTP, CTP, or UTP) or deoxy-ATP did not restore Glu-
binding. Therefore, Hp0495 glutamate binding is ATP-dependent.  
2.3.4.5 L-Glu is the optimal amino acid ligand for Hp0495 (50) 
Hp0495 was tested with other amino acids to see if its amino acid interaction was 
specific for L-glutamate. A competition assay was designed in which Hp0495 was 
incubated with 3H-Glu in the presence of different equimolar, unlabeled amino acids, 
performed in the presence of tRNAGlu1and ATP. TCA precipitation of the 3H-Glu was 
measured. The addition of unlabeled Glu caused a drop in the observed binding of 
radiolabelled Glu, as expected (positive control). None of the nineteen other standard 
amino acids or D-Glu were competitive against L-Glu binding to Hp0495. These results 
showed that L-Glu is the optimal amino acid ligand for Hp0495. 
2.3.4.6 Orthologs of Hp0495 outside of the ɛ-proteobacteria (50) 
Based on sequence analysis and a BLAST genome search, Hp0495 homologs 
were only found in the ɛ-proteobacteria. As discussed in the introduction, Hp0495 
showed structural similarities with several proteins, including E. coli YbeD (7). Because 
of intriguing observed similarities between the two proteins, including size, interaction 
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with EF-Tu by Y2H assay, and the presence of a βαββαβ motif, we set out to determine 
whether or not YbeD is a functional homolog of Hp0495. E. coli GST-YbeD was cloned 
and expressed by Dr. Keng-Ming Chang in our lab. He examined the interactions 
between YbeD with E.coli EF-Tu using a GST-pull down assay; no interaction between 
YbeD and EF-Tu was observed. Next, the Glu binding ability of YbeD was tested in the 
presence and absence of ATP and tRNAGln. These experiments revealed that YbeD 
does not bind Glu, at least under the conditions optimized for Hp0495. From these 
results, we concluded that YbeD is not a homolog of Hp0495 in E. coli.  
These results revealed that Hp0495 binds Glu in the presence of tRNAGlu1/Gln in 
an ATP-dependent manner. Interestingly, Hp0495’s ligands are analogous to the 
substrates required for aminoacylation of tRNAs by aaRSs (amino acids, ATP and 
tRNA). Attempts to discover whether Hp0495 hydrolyzes ATP or covalently attaches Glu 
to a tRNA were inconclusive and will be discussed in later sections. In total, these results 
are consistent with Hp0595 acting as a regulatory ACT or RAM domain. To our 
knowledge, this is the first example of such a domain having three ligands: L-Glu, ATP, 
and tRNAGlu1 or tRNAGln.   
2.3.5 Effect of Hp0495 on glutamylation kinetics for tRNAGln by GluRS2 
Since Hp0495 has a greater impact on tRNA glutamylation activity (vs 
aspartylation) (ref), we evaluated the effect of Hp0495 on GluRS2 kinetics. The KM and 
Kcat/KM were determined for tRNAGln aminoacylation by GluRS2 in the presence and 
absence of Hp0495 (Fig 2.12). Hp0495 had no effect on the kinetics of aminoacylation. 
(KM = 13.5 ± 4.9 vs. 13.4 ± 5.7 µM kcat/KM = 3.5 x 10-4 vs. 4.3 x 10-4 s-1 M-1 with and 
without Hp0495, respectively). 
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Fig 2.12. Effect of Hp0495 on GluRS2 kinetics for tRNAGln. A. Aminoacylation by GluRS2 
(25 nM) in the absence of Hp0495 at different concentration of tRNAGln (2-40 µM). B. 
Aminoacylation by GluRS2 (25 nM) in the presence of Hp0495 (25 nM) at different 
concentration of tRNAGln (2-40 µM). C. Michaelis-Menton kinetics for GluRS2 in the presence 
and the absence of Hp0495. D. Table of kinetic parameters for GluRS2 in the presence and 
absence of Hp0495. 
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2.3.6 Identification of protein partner of Hp0495 by size exclusion chromatography 
Since Hp0495 seems to be specific for Glx system, we examined the possibility 
of other protein partners of Hp0495. We tested Hp0495 interaction with EF-Tu, GluRS2, 
and AdT as binary and ternary complexes (combination shown in Table 2.2). For 
complex formation in each combination shown in Table 2.2, proteins were mixed in 
equimolar concentrations  and after, 30 min incubation, the solutions were injected on a 
ȀKTA FPLC system (Amersham) using a Superdex 200 gel filtration column 
(Amersham). Fractions were collected corresponding to each peak and were analysed 
by SDS-PAGE, shown in each inset next to the SEC traces (Fig 2.6 and Fig 2.13 to 
2.17). No interactions were observed between Hp0495 and any other protein except EF-
Tu. However, we know that tRNA is an important player so our revised hypothesized 
was that these interactions might require tRNA. We tested these interactions in the 
presence of different tRNAs using a GST-pull down assay, discussed in detail in the next 
section. 
Table 2.2. Combination of proteins analyzed for interactions with Hp0495 using 
size exclusion chromatography. 
Hp0495 EF-Tu GluRS2 AdT 
Result Figure 
X X   Interactions observed Fig 2.6 
X  X  No interactions Fig 2.13 
X   X No interactions Fig 2.14 
X X X  No interactions Fig 2.15 
X  X X No interactions Fig 2.16 
X X  X No interactions Fig 2.17 
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Fig 2.13. SEC analyses of AdT and Hp0495 interactions. The top two panels show SEC 
traces for AdT and Hp0495, respectively. The bottom panel shows the trace obtained from a 
mixture of AdT and Hp0495. Two peaks were observed for AdT with calculated molecular 
mass of ~132 kDa (AdT monomer) and ~422 kDa (AdT oligomers). The calculated molecular 
mass for Hp0495 was ~10 kDa. Fractions were collected for each peak and analyzed by SDS-
PAGE: these gels are shown in the inset next to each trace, lane numbers corresponds to 
peaks. No complex formation between AdT and Hp0495 was observed. MWs were calculated 
by comparison to the elution times of molecular weight standards, data not shown. 
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Fig 2.14. SEC analyses of GluRS2 and Hp0495 interactions. The top two panels show SEC 
traces for GluRS2 and Hp0495, respectively. The bottom panel shows the trace obtained from 
a mixture of GluRS2 and Hp0495. The calculated molecular masses for GluRS2 was ~42 kDa 
and Hp0495 was ~10 kDa. Fractions were collected for each peak and analyzed by SDS-
PAGE: these gels are shown in the inset, next to each trace, lane numbers corresponds to 
peaks. No complex formation between GluRS2 and Hp0495 was observed. MWs were 
calculated by comparison to the elution times of molecular weight standards, data not shown. 
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Fig 2.15. SEC analyses of EF-Tu, GluRS2, and Hp0495 interactions. The top two panels 
show SEC traces for GluRS2 and the EF-Tu•Hp0495 complex, respectively. The bottom panel 
shows the trace obtained from a mixture of GluRS2, EF-Tu, and Hp0495. The calculated 
molecular mass for GluRS2 was ~42 kDa and for EF-Tu•Hp0495 was 52 ~kDa. Fractions were 
collected for each peak and analyzed by SDS-PAGE: these gels are shown in the inset, next 
to each trace, lane numbers corresponds to peaks. Since GluRS2 and the EF-Tu•Hp0495 
complex elute at approximately the same time, it was inconclusive whether all three proteins 
assembles as a ternary complex or not. MWs were calculated by comparison to the elution 
times of molecular weight standards, data not shown. 
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Fig 2.16. SEC analyses of AdT, EF-Tu, and Hp0495 interactions. The top two panels show 
SEC traces for AdT and EF-Tu•Hp0495 complex, respectively. The bottom panel shows the 
trace obtained from a mixture of AdT, EF-Tu, and Hp0495. Two peaks were observed for AdT 
with calculated molecular masses of ~132 kDa (AdT monomer) and ~422 kDa (AdT oligomer). 
The calculated molecular mass for EF-Tu•Hp0495 was ~52 kDa. Fractions were collected for 
each peak and analyzed by SDS-PAGE: these gels are shown in the inset, next to each trace, 
lane numbers corresponds to peaks. No ternary complex formation between AdT, EF-Tu, and 
Hp0495 was observed. MWs were calculated by comparison to the elution times of molecular 
weight standards, data not shown. 
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Fig 2.17. SEC analyses of AdT, GluRS2, and Hp0495 interactions. The top two panels 
show SEC traces for AdT and mixture of GluRS2 and Hp0495, respectively. The bottom panel 
shows the trace for a mixture of AdT, GluRS2, and Hp0495. Two peaks were observed for AdT 
as shown in previous chromatograms, but only the monomer peak with calculated molecular 
mass of ~132 kDa is shown for simplicity purpose. GluRS2 and Hp0495 eluted in two separate 
peaks with calculated molecular masses of ~42 kDa and ~10 kDa respectively. Fractions were 
collected for each peak and analyzed by SDS-PAGE: these gels are shown in the inset, next 
to each panel, lane numbers corresponds to peaks. No ternary complex formation between 
AdT, GluRS2, and Hp0495 was observed. MWs were calculated by comparison to the elution 
times of molecular weight standards, data not shown. 
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2.3.7 Hp0495 interacts with GluRS2 in the presence of tRNAGln 
Because Hp0495 showed specificity for the Glx system (Dr. Keng-Ming Chang, 
data not shown) we asked whether Hp0495 interacts with GluRS1 or GluRS2 using a 
GST-pull down assay. GST-Hp0495 was immobilized on glutathione resin and incubated 
separately with GluRS1 and GluRS2. After washing, the resin was analyzed by SDS-
PAGE gel (Fig 2.18). GluRS2 bound to this GST-Hp0495 resin only in the presence of 
tRNAGln (lane 3). GluRS1 did not interact with Hp0495 (lane 2) in the presence of 
tRNAGln. We concluded that Hp0495 has another protein partner, GluRS2, and formation 
of this GluRS2•Hp0495 complex is tRNAGln-dependent.  
Since, tRNAGlu1 and tRNAGlu2 are the natural substrates for GluRS1, we also 
tested Hp0495 interactions with GluRS1 in the presence of these tRNAs. Furthermore, 
we examined Hp0495 interactions with ND-AspRS in presence of both tRNAAsp and 
tRNAAsn, and with AdT in the presence of all five tRNAs (tRNAGln, tRNAGlu1, tRNAGlu2, 
tRNAAsp, and tRNAAsn) (data shown in an appendix to this chapter, Fig 2.26A to E). 
Neither ND-AspRS nor AdT showed interactions with Hp0495 in the presence of tRNAs.  
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2.3.8 Hp0495’s role as a kinase was inconclusive  
Glu binding to Hp0495 requires ATP. However, whether Hp0495 hydrolyzes ATP 
either to ADP + Pi or to AMP + PPi is not known. Dr. Keng-Ming Chang (Hendrickson lab 
alumni) used an enzyme-coupled assay previously optimized in our group (181) and 
TLC to check for hydrolysis of ATP by Hp0495 (51). Attempts to confirm the production 
of either ADP or AMP were unsuccessful, suggesting that Hp0495 does not hydrolyze 
ATP. Binding, without hydrolysis, is consistent with Hp0495 being an ACT/RAM domain, 
as these domains are not known to mediate catalysis. In parallel, the Pro-Q diamond 
phosphoprotein gel stain was used to evalute whether Hp0495  phosphorylates any of its 
protein partners (EF-Tu and GluRS2). This method selectively stains phosphoproteins in 
 
Fig 2.18. tRNAGln-dependent complex formation between Hp0495 and 
GluRS2. Glutathione sepharose resin was incubated with GST-tagged 
Hp0495. Potential binding partners were subsequently added to the resin. 
The figure shows 15% SDS page analysis of the resin after washing. GluRS2 
coeluted with GST-Hp0495 only in the presence of tRNAGln (lane 3). GluRS1 
was used as a control (lane 4).   
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polyacrylamide gels and allows for direct in gel fluorescent staining of phosphate group 
on proteins without a requirement for antibodies or radioisotopes (182,183).   
 We incubated Hp0495 with EF-Tu•GDP (Fig 2.19), EF-Tu•GTP (Fig 2.20), 
GluRS2 (Fig 2.21), and GluRS1 (Fig 2.22) in kinase buffer supplemented with ATP and 
then examined these proteins by SDS-PAGE with the Pro-Q diamond stain (lane 3, 
panel A in each figure). Since Hp0495 binds Glu in the presence of tRNAGlu1/Gln and ATP, 
the phosphorylation of these proteins by Hp0495 was also tested in the presence of 
tRNAGln and Glu (lane 4 in each figure). In all cases, a second gel was run and stained 
with Coomassie in parallel to confirm the presence of proteins (panel B in each figure).  
We used cAMP-dependent protein kinase (PKA) and myelin basic protein (MBP) 
as a kinase-substrate control (provided by Dr. Pflum lab) (183). In the absence of PKA, 
MBP was not phosphorylated (lane 5); in the presence of PKA, phosphorylated MBP 
was stained by the Pro-Q diamond stain (lane 6). 
Unfortunately, the Pro-Q diamond stain showed non-specific staining of EF-
Tu•GDP, EF-Tu•GTP, GluRS2, and GluRS1, even though it was highly specific for the 
phosphorylated form of MBP. These results suggest that all the proteins tested may 
have undergone phosphorylation during overexpression in E. coli.  
EF-Tu is known to be phosphorylated at multiple sites (160-163,176). In addition, 
there are examples of aaRSs being phosphorylated at different residues by kinases. For 
example, Ser146 residue is phosphorylated in human cytosolic AspRS (184). In E. coli, 
GluRS and ThrRS are phosphorylated, and some heat shock proteins, like DnaK and 
DnaJ, were identified as the kinases responsible for phosphorylation (185). Extracellular 
signal-related kinase (ERK) phosphorylates MetRS at Ser209 and Ser825 (186).  
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Fig 2.19. Hp0495 does not effect the phosphorylation status of EF-Tu•GDP. A. Pro-Q 
diamond stained and B. Coomassie stained 10% SDS-PAGE gels. EF-Tu•GDP 
phosphorylation by Hp0495 was tested in the presence and absence of Glu and tRNAGln. 
PKA-MBP, a kinase-substrate pair, was used as a positive control for phosphorylation. MW 
= Molecular weight markers in kDa. Hp0495 and EF-Tu•GDP should migrate with molecular 
weights of ~10 kDa and ~43 kDa respectively. MBP should migrate with a molecular weight 
~18.5 kDa. 
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Fig 2.20. Hp0495 does not effect the phosphorylation status of EF-Tu•GTP. A. Pro-Q 
diamond stained and B. Coomassie stained 10% SDS-PAGE gels. EF-Tu•GTP 
phosphorylation by Hp0495 was tested in the presence and absence of Glu and tRNAGln. 
PKA-MBP, a kinase-substrate pair, was used as a positive control for phosphorylation. MW 
= Molecular weight markers in kDa. Hp0495 and EF-Tu•GTP should migrate with molecular 
weights of ~10 kDa and ~43 kDa respectively. MBP should migrate with a molecular weight 
~18.5 kDa. 
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Fig 2.21. Hp0495 does not effect the phosphorylation status of GluRS2. A. Pro-Q 
diamond stained and B. Coomassie stained 10% SDS-PAGE gels. GluRS2 phosphorylation 
by Hp0495 was tested in the presence and absence of Glu and tRNAGln. PKA-MBP, a 
kinase-substrate pair, was used as a positive control for phosphorylation. MW = Molecular 
weight markers in kDa. Hp0495 and GluRS2 should migrate with molecular weights of ~10 
kDa and ~52 kDa respectively. MBP should migrate with a molecular weight ~18.5 kDa. 
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Fig 2.22. Hp0495 does not effect the phosphorylation status of GluRS1. A. Pro-Q 
diamond stained and B. Coomassie stained 10% SDS-PAGE gels. GluRS1 phosphorylation 
by Hp0495 was tested in the presence and absence of Glu and tRNAGln. PKA-MBP, a 
kinase-substrate pair, was used as a positive control for phosphorylation. MW = Molecular 
weight markers in kDa. Hp0495 and GluRS1 should migrate with molecular weights of ~10 
kDa and ~51 kDa respectively. MBP should migrate with a molecular weight ~18.5 kDa. 
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Fig 2.23. Dephosphorylation of Hp0495, EF-Tu•GTP, and GluRS2 by CIP. A. Pro-Q 
diamond stained and B. Coomassie stained 10% SDS-PAGE gels. Hp0495, EF-Tu•GTP, 
and GluRS2 was dephosphoraylated using CIP (lanes 2, 4, and 6 respectively). PKA-MBP, 
a kinase-substrate pair, was used as a positive control for phosphorylation (lanes 7 and 8). 
p-MBP was dephosphorylated using CIP (lane 10). MW = Molecular weight markers in kDa. 
Hp0495, EF-Tu•GTP, and GluRS2 should migrate with a molecular weight ~10 kDa, ~43 
kDa and ~52 kDa respectively. MBP should migrate with molecular weights of ~18.5 kDa. 
CIP buffer is supplemented with bovine serum albumin (BSA, ~67 kDa and is known to be 
phosphorylated). 
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Unfortunately, these results led us to conclude that this method is not appropriate 
until we dephosphorylate each protein first. We tried treating Hp0495, EF-Tu•GTP, and 
GluRS2 with calf intestinal phosphatase (CIP) for dephosphorylation (Fig 2.23, lane 2-7) 
without success. However, CIP was able to dephosphorylate phosphorylated MBP (p-
MBP) (lane 10). Thus we concluded that CIP may not be the appropriate phosphatase 
for dephosphorylating Hp0495, EF-Tu, and GluRS2. Alternatively, these proteins may 
simply be sensitive to the ProQ diamond stain for unknown reasons.   
2.3.9 Analysis of conserved residues in Hp0495 and mutagenesis 
 A multiple sequence alignment of Hp0495 orthologs from all sequenced ɛ-
proteobacteria showed only six conserved residues (Fig 2.24), among which five are 
clustered together. Four of the five clustered residues (Tyr12, Trp16, Tyr18, and Arg69) 
were selected for mutagenesis (Fig 2.25A). We hypothesized that these four residues 
form a putative active site and may be the Glu or tRNA binding site. The two tyrosine 
residues and tryptophan were mutated to phenylalanine and arginine was mutated to 
alanine; mutants were constructed by Dr. Keng-Ming Chang. These mutants were 
overexpressed in E. coli and purified to homogeneity (Fig. 2.25B). These mutants will be 
used in the future for EF-Tu, GluRS2, Glu, ATP, and tRNA/aa-tRNA interaction studies. 
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Fig 2.24. Multiple sequence allignment of Hp0495 and its orthologs from all sequenced ɛ-proteobacteria. The six conserved 
residues are shown in red, including Tyr12, Pro13, Try16, Tyr18, Ser49 and Arg69. The four selected for mutagesesis are marked 
with green arrow (Try12, Trp16, Try18 and Arg69). The numbers on the top represents the position of Hp0495 in genome. 
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Fig 2.25. Hp0495 putative amino acid or tRNA binding site. A. A cartoon representation of 
Hp0495 with its six conserved residues shown as sticks (Tyr12, Pro13, Try16, Tyr18, Ser49 and 
Arg69). A closeup of four clustered residues is shown shown in the inset and were selected for 
mutagenesis. These residues were selected for mutagenesis. B. SDS-PAGE gel of each mutant 
Hp0495 after purification. 
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2.3.10 Hp0495 interacts with tRNAs and aa-tRNAs  
Glu binding of Hp0495 was observed only in the presence of tRNAs, specifically 
with tRNAGln and tRNAGlu1. We next examined whether Hp0495 interacts with tRNAs or 
aa-tRNAs specifically. Since Hp0495 contains a single conserved tryptophan residue, 
we took advantage of the fluorescent properties of this amino acid to study Hp0495 
interactions with tRNA and aa-tRNA. Experiments were done with tRNAGlu1, tRNAGlu2, 
tRNAGln, tRNAAsp and tRNAAsn and their corresponding aminoacylated forms. Interactions 
were also analyzed in the presence of Glu. In this case, fluorescence buffer was 
supplemented with 10 mM Glu to saturate the Glu-binding site of Hp0495. If Glu and the 
tRNA/aa-tRNA binding sites of Hp0495 were the same then we expected this added Glu 
to disrupt tRNA binding.  
All tRNAs and aa-tRNAs tested showed interactions with Hp0495. The binding 
constant (Kd) for each interaction was calculated by plotting fraction of tRNA or aa-tRNA 
bound to Hp0495 against increasing concentration of tRNA or aa-tRNA (Table 2.3 and 
data shown in an appendix to this chapter, Fig 2.27-A2.36). Data workup demonstrated 
that the Kd values obtained in the absence and presence of Glu were similar (within 
error) for all the tRNAs and aa-tRNAs. These results suggest that Hp0495 may have two 
different binding sites, one specific for Glu and other for tRNA/aa-tRNA.  
The comparison of Hp0495 and tRNAs Kd values also revealed that tRNAGln and 
tRNAGlu1 bind with nanomolar affinity, while the other tRNAs had low micromolar range 
Kd, consistent with our previous results. In addition, tRNAGlu1 binds Hp0495 more tightly 
(Kd = 380 ± 50 nM) than tRNAGln does (Kd = 710 ± 70 nM), suggesting that tRNAGlu1 is 
the more probably ligand for Hp0495. The Kd obtained for tRNAGlu2 was ~ 1.0 µM, 
indicating that Hp0495 prefers only one tRNAGlu isoacceptor, namely tRNAGlu1. The 
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G1:C72 identity element and the U35:U36:C37 anticodon are the same in H. pylori 
tRNAGlu1 and tRNAGlu2 and these tRNAs share 78% sequence identity (180). Thus it is 
unclear how Hp0495 achieves its specificity for tRNAGlu1 over tRNAGlu2. The Kd’s values 
for both tRNAAsp and tRNAAsn, Kd’s were low micromolar range, indicative of weaker 
binding.  
Interestingly, Hp0495 binds with all the aa-tRNAs tested with micromolar affinity, 
lowest Kd obtained was for Glu-tRNAGlu1 (1.5 ± 0.2 µM). Like tRNAs, a similar trend of 
binding was observed with aa-tRNAs, Glu-tRNAGlu1 being the best substrate, followed by 
Glu-tRNAGln (Kd = 2.3 ± 0.2 µM). This strengthened our result that Hp0495 prefers 
tRNAGlu1 over other tRNAs and Glu-tRNAGlu1 over other aa-tRNAs. For Glu-tRNAGlu2, 
Asp-tRNAAsp, and Asp-tRNAAsn, Hp0495 binding affinities were in high micromolar range. 
Overall, these results imply that Hp0495 is a general tRNA binding protein with 
preference for tRNAGlu1. These experiments were done in triplicate with each tRNA and 
corresponding aa-tRNA.  
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Table 2.3. Dissociation constant (Kd) values for Hp0495 and tRNA/aa-tRNA 
complexes in the presence and absence of Glu. All values are listed in 
micromolar. Plus and minus Glu indicate the presence and absence of 10 mM 
glutamate in the assay buffer.  
 
tRNA aa-tRNA 
-Glu +Glu -Glu +Glu 
tRNAGln 0.71 ± 0.07   0.59 ± 0.05   2.3 ± 0.2  2.3 ± 0.4  
tRNAGlu1 0.38 ± 0.05  0.38 ± 0.05  1.5 ± 0.2  1.8 ± 0.3  
tRNAGlu2 1.00 ± 0.08  1.01 ± 0.08   8.7 ± 1.5   8.2 ± 0.9  
tRNAAsp 4.0 ± 0.4 3.6 ± 0.5      > 10    > 10    
tRNAAsn 5.9 ± 1.0   9.8 ± 1.7   8.2 ± 0.7  13.2 ± 1.1   
 
2.3.11 Hp0495 binding studies with tRNAs and aa-tRNAs using SPR 
Hp0495 interactions with all five tRNAs (tRNAGln, tRNAGlu1, tRNAGlu2, tRNAAsp, 
and tRNAAsn) and corresponding aa-tRNAs were also studied using SPR. The data 
workup gave us Kd’s which were very different from Kd’s that we obtained for similar 
complexes using fluorescence technique (Table 2.4 and data shown in an appendix to 
this chapter, Fig 2.37-2.46). Very weak interactions between Hp0495 and tRNAs or aa-
tRNAs were observed with Kd in high micromolar range. Among tRNAs, the strongest 
interaction and lowest Kd was for Hp0495 and tRNAGln, the Kd = 26.0 ± 9.0 µM. In 
comparison to tRNAGln, Glu-tRNAGln showed stronger affinity for Hp0495, with 
approximate five fold decrease in Kd (5.0 ± 0.8 µM). No trend was observed in Kd values 
for both tRNAs and aa-tRNAs. However, these results still suggest that Hp0495 interacts 
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with tRNAs and aa-tRNAs independently, and did not require presence of other ligands 
(Glu and/or ATP) or proteins (EF-Tu and/or GluRS2).  
The reason for variations in Kd values for Hp0495 and tRNA or aa-tRNA 
complexes for the two different binding techniques used (fluorescence vs SPR) was hard 
to explain. One possibility may be the Hp0495 state of existence, in fluorescence 
studies, Hp0495 was in free form in solution, whereas in SPR studies, Hp0495 was 
immobilized on sensor chip. For immobilization of Hp0495 on SPR sensor chip, we used 
amine coupling, which utilize the surface lysine of protein for its covalent attachment to 
the sensor chip surface through amide bond formation. Based on surface charge 
distribution, Hp0495 was proposed to be a nucleic acid binding protein. Our results also 
suggest that Hp0495 is a tRNA binding protein, even though we did not still know how 
and where tRNA binds with Hp0495. Usually, positive charged residues on protein 
surface (rich in lysine and arginine) constitute the nucleic acid binding site. Therefore, it 
is possible that some of the surface lysine of Hp0495, which are important for tRNA 
binding, are involved in immobilization chemistry and prevents the interaction of Hp0495 
with tRNAs. It is possible that only a small fraction of immobilized Hp0495 was in proper 
orientation with surface that binds with tRNA exposed, allowing the observed interaction 
with high substrate concentration. In the case of fluorescence studies, there is more 
probability that all the Hp0495 molecules are in desired conformation and are available 
for interaction.  
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Table 2.4. Dissociation constant (Kd) values for Hp0495 and tRNA/aa-tRNA 
complexes using SPR. All values are listed in micromolar. 
 tRNA aa-tRNA 
tRNAGln 26.0 ± 9.0  5.0 ± 0.8  
tRNAGlu1 55.0 ± 14.0  87.0 ± 23.0 
tRNAGlu2 97.0 ± 31.0   36.0 ± 5.0  
tRNAAsp 12.0 ± 4.0  80.0 ± 18.0   
tRNAAsn 23.0 ± 5.0  144.0 ± 27.0  
 
2.4 Conclusions and hypotheses for the role(s) of Hp0495   
Hp0495 interacts with EF-Tu in a 1:1 stoichiometry both in vitro and in vivo. It 
binds more tightly to EF-Tu•GTP (Kd = 284 ± 18 nM) than it does to EF-Tu•GDP (Kd = 
3.6 ± 0.2 µM). Hp0495 also binds GluRS2 but only in the presence of tRNAGln. We do 
not yet know if EF-Tu and GluRS2 compete for the same binding site on Hp0495. 
Hp0495 interacts with all five tRNAs and aa-tRNAs tested but it does not affect 
aminoacylation kinetics of GluRS2. L-Glu, ATP, tRNAGlu1, and tRNAGln, but not tRNAGlu2 
are ligands for Hp0495. 
As discussed in the introduction, Hp0495 showed structural similarity to ACT or 
RAM domains of protein. These domains typically function to regulate different aspects 
of amino acid and nucleotide metabolism (137-147). We identified Glu and ATP as small 
molecule ligands of Hp0495. Examples of ACT domains binding more than one ligand 
are available (146,150). For example, Arabadopsis aspartate kinase has two ligand 
binding sites one for L-lysine and one for SAM (150) and the ACT domain of 
formyltetrahydrofolate deformylase binds both Met and Gly (146). Hp0495 does not 
107 
 
 
 
contain either of the conserved glycine residues that define the ligand binding sites for  
ACT and RAM domains. Based on the discovery that Glu and ATP bind Hp0495, we 
speculate that Hp0495 might be a regulatory protein. However, which residues are 
important for ligand binding is yet not clear and need to be characterized.  
Hp0495 was predicted to be a nucleic acid binding protein based on surface 
charge analysis (135,136). Our results confirm that Hp0495 is tRNA binding protein, with 
preference for tRNAGlu1 and tRNAGln (Kd values were in nanomolar range) over tRNAGlu2, 
tRNAAsp, and tRNAAsn (Kd values were in micromolar range). In all cases, aminoacylated 
tRNAs bound less tightly than their deacylated counterparts.  
Since Hp0495 has specificity for tRNAGlu1 (Kd = 380 ± 50 nM) and tRNAGln (Kd = 
710 ± 70 nM), we hypothesize that Hp0495’s function is to direct tRNAGlu1 into a function 
outside protein translation. The hp0495 gene is in an operon with mraY and murD (132). 
These two enzymes are involved in cell wall biosynthesis, indicating that the role of 
Hp0495 may be in H. pylori cell wall biosynthesis. Also, roles for EF-Tu and aa-tRNAs in 
cell wall biosynthesis is not unprecedented (176,177,115). In this circumstance, one can 
envision that Hp0495 cannot discriminate well between tRNAGlu1 and tRNAGln. 
Consequently, when bound to tRNAGln, Hp0495 forms a complex with GluRS2 to insure 
that this tRNA is available for catalysis. In fact, Uhlenbeck and colleagues speculated 
that H. pylori tRNAGlu1 would not be used in translation based on the identity of the base 
pairs in the TΨC stem of this tRNA (187).  
Since Hp0495 interacts with both EF-Tu and GluRS2, it would be important to 
determine whether a single complex forms that includes EF-Tu, Hp0495, GluRS2 and 
tRNAGln or two separate complexes form in competition (one between Hp0495 and EF-
Tu and another between involving Hp0495, GluRS2 and tRNAGln). One big complex 
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involving EF-Tu and misacylating GluRS2 is hard to envision, because this will bring 
misacylated Glu-tRNAGln in close proximity to EF-Tu, not advantageous for protein 
translation.  
Alternatively, Hp0495 could be involved in directing tRNAGlu1, Glu-tRNAGlu1, 
tRNAGln or Glu-tRNAGln to an alternative function outside of translation, e.g. cell wall 
biosynthesis. The hp0495 gene is in an operon with mraY (the gene encoding phosphor-
N-acetylmuramoyl pentapeptide transferase) and murD (the gene encoding UDP-N-
acetylmuramoyl-L-alanyl-D-glutamate synthetase), two enzymes involved in cell wall 
biosynthesis. Use of aa-tRNAs in cell wall biosynthesis is not unprecedented. In 
Streptococcus pneumoniae Ser-tRNASer and Ala-tRNAAla are used in peptidoglycan 
biosynthesis (188,117). Interestingly, EF-Tu also plays a role outside of protein 
translation in coordinating cell shape in B. subtilis (177). It is possible that Hp0495 is 
shuttling Glu-tRNAGlu1 and/ or Glu-tRNAGln to the enzymes involved in cell wall 
biosynthesis.  
To date, the functions of stand-alone ACT or RAM domains have remained 
undiscovered. If Hp0495 belongs to this class of proteins, then it will be interesting to 
see how such a small protein manages and facilitates protein-protein interaction (with 
EF-Tu and GluRS2), protein-RNA interactions (with tRNAs and aa-tRNAs), and small 
molecule interactions (Glu and ATP). What kind of regulatory function Hp0495 serves in 
bacteria remains to be discovered.  
2.5 Experimental procedures 
2.5.1 Overexpression and purification of H. pylori EF-Tu and Hp0495 
The hp0495 gene was cloned into a pGEX-4T-3 vector to introduce a thrombin 
cleavage site between the glutathione-S-transferase (GST) tag and Hp0495. The protein 
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was overexpressed in E. coli by induction with IPTG for 4 hours and then it was purified 
using glutathione sepharose resin (4 Fast Flow, Amersham) as per the manufacturer’s 
instructions. Unless otherwise noted, prior to all experiments, the GST tag was removed 
by treatment with thrombin (1 unit/µL). The protein was further purified to homogeneity 
by SEC (Superdex 200 gel filtration column, Amersham). His6 tagged H. pylori and E. 
coli EF-Tu were purified and converted to their GTP forms as previously described (134). 
Hp0495 and both EF-Tu orthologs were purified to homogeneity as judged by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, data not shown). 
2.5.2 Overexpression and purification of H. pylori tRNAGlu1, tRNAGlu2, tRNAGln, 
tRNAAsp, tRNAAsn 
Each tRNA was overexpressed in vivo and purified as previously described 
(134). 
2.5.3 Overexpression and purification of H.pylori GluRS1, GluRS2, ND-AspRS 
Each aaRS was overexpressed and purified as previously described (134). 
2.5.4 Size exclusion chromatography (SEC) for EF-Tu•Hp0495 complex 
stoichiometry 
H. pylori Hp0495 and EF-Tu were combined in an equimolar ratio (50 µM each), 
diluted to 1 mL in SEC buffer (50 mM Hepes (pH 7.2), 30 mM KCl, 6 mM MgCl2, 0.1 mM 
EDTA, 5 mM β- mercaptoethanol) and incubated at 4 °C for 30 min. This sample was 
injected onto a Biorad FPLC system (Biorad) using a Superdex 200 gel filtration column 
(Amersham), and the fractions collected were analyzed by SDS-PAGE. 
Similarly, for interaction studies of Hp0495 with EF-Tu, GluRS, and AdT as 
binary and ternary complexes (combinations shown in Table 1.2), each protein mixture 
was combined in equimolar ratio (50 µM each), diluted to 1 mL in SEC buffer and 
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injected onto the SEC column. Fractions were collected that corresponded to each peak 
and were analyzed by SDS-PAGE. 
2.5.5 Mass spectrometry for EF-Tu•Hp0495 complex stoichiometry 
H. pylori EF-Tu alone and its complex with Hp0495 were analyzed by Dr. Keng-
Ming Chang (Hendrickson lab alumni), by electrospray ionization mass spectrometry 
(ESI-MS) using a state-of-the-art Waters Synapt G2 mass spectrometer in collaboration 
with Professor Sarah Trimpin and her group.  
2.5.6 Co-expression and purification the EF-Tu•Hp0495 complex  
The hp0495 gene was sub-cloned into pCDF-1b, which has a FLAG-tag 
upstream of its multiple cloning site. Sequential digestions of pCDF-1b and hp0495 in a 
TOPO plasmid were performed in order to obtain vector (3629 bp) and insert (311 bp) 
respectively using NcoI and BamHI restriction enzymes. The restriction enzyme 
digestion products were analyzed by agarose gel (2%) and the desired bands 
(corresponding to vector and insert) were extracted from the gel followed by overnight 
isopropanol precipitation. The DNA was pelleted by centrifugation (10,000 rpm for 5 min) 
and resuspended in water. The vector (0.6 pmole) and insert (0.1 pmole) were ligated 
together using T4 DNA ligase, and the ligation mixture was transformed on 
spectinomycin Luria broth (LB) plates. The cloned plasmid was confirmed by colony 
PCR (T7F and K27R primers), restriction enzyme digestion (NcoI and BamHI restriction 
enzymes) and sequencing of the complete open reading frame. FLAG-tagged Hp0495 
was co-expressed and co-purified separately with either E. coli or H. pylori EF-Tu (each 
with an N-terminal 6-His tag) by Ni-NTA spin column (Qiagen) as per the manufacturer’s 
instruction. SDS-PAGE and α-FLAG Western blots were performed to confirm the 
interaction of EF-Tu and Hp0495 in vivo. 
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2.5.7 Immobilization of Hp0495 on a CM5 sensor chip by amine coupling for real 
time SPR binding assays 
SPR was performed at 25 °C using the department’s Biacore 2000 system. The 
CM5 sensor chip was used for the immobilization of Hp0495 protein through amine 
coupling following the manufacturers’ instructions. The dextran surface of the chip was 
activated by treatment with 35 µL of a solution containing 0.2 M 1-ethyl-3-(3-dimethyl-
aminopropyl)-carbodimide hydrochloride (EDC) and 0.05 M N-hydroxysuccinimide 
(NHS), at a flow rate of 5 µL/min in HBS running buffer (10 mM HEPES, pH 7.5, 150 mM 
NaCl, 3.0 mM EDTA and 0.005% (v/v) surfactant P20). Hp0495 (50 µL of a 0.1 mg/mL 
solution in 10 mM sodium acetate, pH 5.0) was injected to complete the modification. 
The final extent of modification yielded 3000 RUs of surface coverage. Excess remaining 
reactive groups on the surface of the chip were deactivated by injecting 30 µL 1 M 
ethanolamine hydrochloride-OH (pH 8.5) over the chip at a flow rate of 5 µL/min. 
2.5.8 SPR binding assays with H. pylori EF-Tu•GDP, EF-Tu•GTP, tRNAs, and aa-
tRNAs with the immobilized Hp0495  
H.pylori EF-Tu•GDP and EF-Tu•GTP at concentrations of 0 to 5 µM and 0 to 1 
µM respectively in running buffer (0.05 M NaH2PO4, 0.3 M NaCl, pH 7.4) were injected at 
a flow rate of 50 µL/min onto the sensor chip that contained Hp0495. The dissociation 
constant (Kd) data obtained were fitted either to a 1:1 Langmuir binding model using 
BIAevaluate (v. 4.0.1) software or by plotting the equilibrium response units versus 
analyte concentration with fitting to the equation H•A = [A0]•RMax/(Kd + [A0]) in 
Kaleidagraph, v. 4.0. 
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Similarly, different concentrations of tRNAs (tRNAGln: 0-40 µM, tRNAGlu1: 0-30 
µM, tRNAGlu2: 0-100 µM, tRNAAsp: 0-50 µM, and tRNAAsn: 0-50 µM) and aa-tRNAs (Gln-
tRNAGln: 0-40 µM, Glu-tRNAGlu1: 0-50 µM, Glu-tRNAGlu2: 0-80 µM, Asp-tRNAAsp: 0-50 µM, 
and Asp-tRNAAsn: 0-80 µM) in running buffer were seperately injected at a flow rate of 50 
µL/min onto the chip immobilized with Hp0495. Equilibrium response units at different 
concentrations of tRNAs or aa-tRNAs were obtained from the sensorgram and were 
plotted against the concentration of tRNA or aa-tRNA. These plots were fitted to the 
equation H•A = [A0]•RMax/(Kd + [A0]) in Kaleidagraph, v. 4.0 as above to calculate the 
dissociation constant (Kd).  
2.5.9 Glu precipitation with Hp0495 assays  
Glu co-precipitation was performed by first incubating 20 mM Hepes pH 7.5, 10 
uM Glu (9.5 uM unlabeled Glu + 0.5 uM tritiated labeled Glu), 2 mM ATP, 0.5 uM 
tRNAGln for 20 mins; after which, the reaction was started by adding 4 µM Hp0495. Time 
points were taken by spotting reaction aliquots onto filter paper (soaked in 5% 
trichloroacetic acid (TCA)) each minute for up to 4 mins. The filter paper was then 
washed with 5% TCA three times, and then the pads were quantified by scintillation 
counting.  
2.5.10 GluRS2 kinetic assay for tRNAGln in the presence and absence of Hp0495 
GluRS2 aminoacylation assays were done at different concentrations of tRNAGln 
(2-40 µM) in the presence and absence of Hp0495. Aminoacylation experiments were 
conducted in 40 mM HEPES-OH, pH 7.5, 4 mM ATP, 8 mM MgCl2, and 2 µM 3H-Glu. 
GluRS2 was added to a final concentration of 25 nM. Hp0495 was added to half of these 
reactions to a final concentrations of 25 nM. BSA was added to the other half of these 
reactions (no Hp0495 controls) at a final concentrations of 25 nM. For each experiment 
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10 µL of reaction mixture were quenched at different time intervals on filter paper soaked 
in 5% TCA. The filter papers were washed with 5% TCA, three times, and then 
quantified by scintillation counting.  
2.5.11 GST-Hp0495 pull down assay 
Glutathione sepharose resin (20 µL) was loaded with 10 µM of GST-Hp0495 for 
20 min in a column with a 22 µm syringe filter. Transfer tRNAGln (10 µM ) and GluRS2 
(10 µM) were added sequentially to this column, with 20 min incubations each, while 
keeping the total volume equal to 20 µL. The column was centrifuged at 3000 rpm for 1 
min and the supernatant was collected. The supernatant was analyzed in a 15% SDS-
PAGE. The resin was washed twice with 50 µL SEC buffer with centrifugation at 3000 
rpm for 1 min. Then resin was resuspended in 20 µL SEC buffer and was analyzed by 
15% SDS-PAGE . 
The above described protocol was performed with GluRS1, ND-AspRS, and AdT 
in the presence of their different tRNA substrates. All five deacylated tRNAs were tested 
with AdT. 
2.5.12 Identification of phosphoproteins by Pro-Q Diamond phosphoprotein gel 
stain method 
To check whether Hp0495 phosphorylates EF-Tu•GDP, different protein samples 
were prepared: Hp0495 alone, EF-Tu•GDP alone, Hp0495 with EF-Tu•GDP and Hp0495 
with EF-Tu•GDP, Glu and tRNAGln. All protein concentration were held at 25 µM, Glu 
concentration was 4 µM, and tRNAGln was added at a final concentration of 10 µM. Each 
25 µL reaction mixture was prepared in 1X kinase buffer (50 mM Tris-HCl, 10 mM 
MgCl2, pH 7.5, 20 mM ATP. Reactions were incubated at 30 °C for 30 min.   
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The above described protocol was also performed with EF-Tu•GTP, GluRS2, and 
GluRS1. 
In parallel, cAMP-dependent protein kinase (PKA, NEB, provided by Dr. Pflum) 
and myelin basic protein (MBP, NEB, provided by Dr. Pflum), a known kinase-substrate 
pair was used as a control (47). Two reaction mixtures were prepared, containing MBP 
alone and MBP with PKA, following the same protocol as described above. The final 
concentration of MBP was 0.1 mM and 500 units of PKA were used.  
All reactions were denatured by boiling (10 min) with 5 µL SDS-gel loading dye 
and then separated in a 10% SDS-PAGE gel. After elution, the gel was fixed in 100 mL 
50% methanol and 10% acetic acid solution, twice for 30 minutes. Before staining, the 
gel was washed with 100 mL ultrapure water, 3 times for 10 minutes, then stained in 50 
mL Pro-Q diamond stain solution (Life Technologies) for 90 minutes in the dark. For 
destaining, a solution of 20% acetonitrile and 50 mM sodium acetate at pH 4 solution 
was used (100 mL, 3 times for 30 minutes each). The gel was washed again with 100 
mL ultrapure water, 2 times for 5 minutes each, and then the gel was imaged (excitation 
at 532-560 nm with an emission maximum at ~ 580 nm). An identical second gel was run 
and stained with Coomassie dye in parallel to confirm the presence of proteins, since 
Pro-Q diamond stain should be specific for phosphorylated proteins only. For Coomassie 
staining, SDS-PAGE gels were stained by soaking in a solution of 0.1% Coomassie 
Brilliant Blue G250 (Bio-Rad) in 45% methanol (Fisher), 45% water, and 10% glacial 
acetic acid (Fisher) for an hour. Then destained in 45% methanol, 45% water, and 10% 
glacial acetic acid solution, at least 3 times, for 30 minutes each.  
 For dephosphorylation, calf-intestinal phosphatase (CIP, NEB) was used. 
Hp0495, EF-Tu•GTP, and GluRS2 were treated with 10 units CIP in 1X CIP buffer (50 
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mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 100 µg/µL 
BSA, pH 7.9), reactions were incubated at 37 °C for 30 min. All protein concentrations 
were held at 13 µM and reaction volume was adjusted to 25 µL. 
2.5.13 Fluorescence studies of H. pylori Hp0495 with tRNAGlu1, tRNAGlu2, tRNAGln, 
tRNAAsp, tRNAAsn  and different aa-tRNA’s 
For Hp0495 fluorescence studies, 100 µL of a 20 µM Hp0495 in binding buffer 
(0.05 M NaH2PO4, 0.3 M NaCl, pH 7.4) were scanned for tryptophan fluorescence at an 
excitation wavelength of 280 nm and a scanning emission wavelength ranging from 300 
nm to 500 nm on a Cary Eclipse spectrophotometer from Varian. The observed λmax 
(emission) for Hp0495 was 350 nm. The binding of Hp0495 to tRNA or aa-tRNA was 
studied in a similar way by adding increasing concentrations of tRNA or aa-tRNA’s (0-10 
µM) in solutions containing 20 µM Hp0495. The dissociation constant (Kd) of binding was 
obtained by plotting the fraction bound versus tRNA or aa-tRNA concentration. The 
resulting plot was fit to the equation y=x/(m1+x) in Kaleidagraph, v. 4.0. In this equation, 
y is the fraction bound, x is the concentration of tRNA or aa-tRNA, m1 is the dissociation 
constant (Kd). The y-axis fraction bound is calculated using the equation [Fraction 
bound]=Fmax-Fx/Fmax-F0. In this equation, Fmax is the maximum fluorescence of Hp0495 at 
λmax (350 nm), Fx is the maximum fluorescence of Hp0495 in the presence of the highest 
concentration of tRNA or aa-tRNA at Hp0495 λmax, and F0 is the maximum fluorescence 
of Hp0495 in the absence of tRNA or aa-tRNA.  
For Hp0495 interactions with tRNA or aa-tRNAs in the presence of Glu, the 
above described procedure was followed using binding buffer that had been 
supplemented with 10 mM Glu.  
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Appendix 1. GST-Pull down assays to detect the interactions between Hp0495 with 
GluRS1, GluRS2, ND-AspRS, and AdT in the presence of tRNAs 
 
 
Fig 2.26. Evaluation of tRNA dependent complex formation between Hp0495 and GluRS2, 
GluRS1, ND-AspRS, and AdT. Glutathione sepharose resin was incubated with GST-Hp0495. 
Each figure shows a 15% SDS-PAGE analysis of the supernatant (S) and resin (R) after washing. 
GluRS2 coeluted with GST-Hp0495 only in the presence of tRNAGln. None of the other proteins 
showed interactions with GST-Hp0495 in the presence of tRNA.  
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Appendix 2. Hp0495 binding studies with tRNAs and aa-tRNAs using fluorescence 
spectroscopy 
 
 
 
 
 
 
 
Fig 2.27. Complex formation between Hp0495 and tRNAGln in the absence and 
presence of Glu. Each graph represents the fraction of tRNAGln bound to Hp0495 (shown 
on the Y-axis) with increasing concentrations of tRNAGln (0-10 µM on X-axis). Hp0495 binds 
with tRNAGln with high nanomolar affinity;a slight decrease in Kd was observed in the 
presence of Glu. 
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Fig 2.29. Complex formation between Hp0495 and tRNAGlu2 in the absence and 
presence of Glu. Each graph represents the fraction of tRNAGlu2 bound to Hp0495 (shown 
on the Y-axis) with increasing concentrations of tRNAGlu2 (0-10 µM on X-axis). Hp0495 binds 
with tRNAGlu2 with high nanomolar affinity; similar Kd was observed in the presence of Glu. 
 
Fig 2.28. Complex formation between Hp0495 and tRNAGlu1 in the absence and 
presence of Glu. Each graph represents the fraction of tRNAGlu1 bound to Hp0495 (shown 
on Y-axis) with increasing concentrations of tRNAGlu1 (0-10 µM on X-axis). Hp0495 binds 
tRNAGlu1 with nanomolar affinity; similar Kd was observed in the presence of Glu. 
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Fig 2.31. Complex formation between Hp0495 and tRNAAsn in the absence and 
presence of Glu. Each graph represents the fraction of tRNAAsn bound to Hp0495 (shown 
on Y-axis) with increasing concentrations of tRNAAsn (0-10 µM on X-axis). Hp0495 binds  
tRNAAsn with micromolar affinity; a slight increase in Kd was observed in the presence of Glu. 
 
Fig 2.30. Complex formation between Hp0495 and tRNAAsp in the absence and 
presence of Glu. Each graph represents the fraction of tRNAAsp bound to Hp0495 (shown 
on Y-axis) with increasing concentrations of tRNAAsp (0-10 µM on X-axis). Hp0495 binds with 
tRNAAsp with micromolar affinity; within the error binding affinities were same in the presence 
and absence of Glu. 
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Fig 2.33. Complex formation between Hp0495 and Glu-tRNAGlu1 in the absence and 
presence of Glu. Each graph represents the fraction of Glu-tRNAGlu1 bound to Hp0495 
(shown on Y-axis) with increasing concentrations of Glu-tRNAGlu1 (0-10 µM on X-axis). 
Hp0495 binds Glu-tRNAGlu1 with micromolar affinity; within the error binding affinities were 
same in the presence and absence of Glu. 
Fig 2.32. Complex formation between Hp0495 and Glu-tRNAGln in the absence and 
presence of Glu. Each graph represents the fraction of Glu-tRNAGln bound to Hp0495 
(shown on Y-axis) with increasing concentrations of Glu-tRNAGln (0-10 µM on X-axis). 
Hp0495 binds Glu-tRNAGln with micromolar affinity; within the error binding affinities were 
same in the presence and absence of Glu. 
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Fig 2.35. Complex formation between Hp0495 and Asp-tRNAAsp in the absence and 
presence of Glu. Each graph represents the fraction of Asp-tRNAAsp bound to Hp0495 
(shown on Y-axis) with increasing concentrations of Asp-tRNAAsp (0-20 µM on X-axis). 
Hp0495 binds Asp-tRNAAsp with micromolar affinity; within the error binding affinities were 
same in the presence and absence of Glu. 
Fig 2.34. Complex formation between Hp0495 and Glu-tRNAGlu2 in the absence and 
presence of Glu. Each graph represents the fraction of Glu-tRNAGlu2 bound to Hp0495 
(shown on Y-axis) with increasing concentrations of Glu-tRNAGlu2 (0-20 µM on X-axis). 
Hp0495 binds Glu-tRNAGlu2 with micromolar affinity; within the error binding affinities were 
same in the presence and absence of Glu. 
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Fig 2.36. Complex formation between Hp0495 and Asp-tRNAAsn in the absence and 
presence of Glu. Each graph represents the fraction of Asp-tRNAAsn bound to Hp0495 
(shown on Y-axis) with increasing concentrations of Asp-tRNAAsn (0-20 µM on X-axis). 
Hp0495 binds Asp-tRNAAsn with micromolar affinity; a slight increase in Kd was observed in 
the presence of Glu. 
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Appendix 3. Hp0495 binding studies with tRNAs and aa-tRNAs using surface 
plasmon resonance.  
 
Fig 2.37. Hp0495 binds tRNAGln with micromolar affinity. Hp0495 was immobilized on a 
CM5 sensor chip and increasing concentrations of tRNAGln (0-40 µM) were delivered as 
analyte. Equilibrium response units was obtained from the sensorgram shown in Panel A and 
were plotted against the tRNAGln concentration (Panel B) to calculate the dissociation 
constant (Kd), 26.0 ± 9.0 µM.  
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Fig 2.38. Hp0495 binds tRNAGlu1 with micromolar affinity. Hp0495 was immobilized on a 
CM5 sensor chip and increasing concentrations of tRNAGlu1 (0-20 µM) were delivered as 
analyte. Equilibrium response units was obtained from the sensorgram shown in Panel A and 
were plotted against the tRNAGlu1 concentration (Panel B) to calculate the dissociation 
constant (Kd), 5.0 ± 0.8 µM.  
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Fig 2.39. Hp0495 binds tRNAGlu2 with micromolar affinity. Hp0495 was immobilized on a 
CM5 sensor chip and increasing concentrations of tRNAGlu2 (0-100 µM) were delivered as 
analyte. Equilibrium response units was obtained from the sensorgram shown in Panel A and 
were plotted against the tRNAGlu2 concentration (Panel B) to calculate the dissociation 
constant (Kd), 97.0 ± 31.0 µM.  
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Fig 2.40. Hp0495 binds tRNAAsp with micromolar affinity. Hp0495 was immobilized on a 
CM5 sensor chip and increasing concentrations of tRNAAsp (0-50 µM) were delivered as 
analyte. Equilibrium response units was obtained from the sensorgram shown in Panel A and 
were plotted against the tRNAAsp concentration (Panel B) to calculate the dissociation 
constant (Kd), 12.0 ± 4.0 µM.  
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Fig 2.41. Hp0495 binds tRNAAsn with micromolar affinity. Hp0495 was immobilized on a 
CM5 sensor chip and increasing concentrations of tRNAAsn (0-50 µM) were delivered as 
analyte. Equilibrium response units was obtained from the sensorgram shown in Panel A and 
were plotted against the tRNAAsn concentration (Panel B) to calculate the dissociation 
constant (Kd), 23.0 ± 5.0 µM.  
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Fig 2.42. Hp0495 binds Glu-tRNAGln with micromolar affinity. Hp0495 was immobilized on 
a CM5 sensor chip and increasing concentrations of Glu-tRNAGln (0-20 µM) were delivered as 
analyte. Equilibrium response units was obtained from the sensorgram shown in Panel A and 
were plotted against the Glu-tRNAGln concentration (Panel B) to calculate the dissociation 
constant (Kd), 5.0 ± 0.8 µM.  
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Fig 2.43. Hp0495 binds Glu-tRNAGlu1 with micromolar affinity. Hp0495 was immobilized 
on a CM5 sensor chip and increasing concentrations of Glu-tRNAGlu1 (0-50 µM) were 
delivered as analyte. Equilibrium response units was obtained from the sensorgram shown in 
Panel A and were plotted against the Glu-tRNAGlu1 concentration (Panel B) to calculate the 
dissociation constant (Kd), 55.0 ± 14.0 µM.  
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Fig 2.44. Hp0495 binds Glu-tRNAGlu2 with micromolar affinity. Hp0495 was immobilized 
on a CM5 sensor chip and increasing concentrations of Glu-tRNAGlu2 (0-80 µM) were 
delivered as analyte. Equilibrium response units was obtained from the sensorgram shown in 
Panel A and were plotted against the Glu-tRNAGlu2 concentration (Panel B) to calculate the 
dissociation constant (Kd), 36.0 ± 5.0 µM.  
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Fig 2.45. Hp0495 binds Asp-tRNAAsp with micromolar affinity. Hp0495 was immobilized 
on a CM5 sensor chip and increasing concentrations of Asp-tRNAAsp (0-50 µM) were 
delivered as analyte. Equilibrium response units was obtained from the sensorgram shown in 
Panel A and were plotted against the Asp-tRNAAsp concentration (Panel B) to calculate the 
dissociation constant (Kd), 80.0 ± 18.0 µM.  
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Fig 2.46. Hp0495 binds Asp-tRNAAsn with micromolar affinity. Hp0495 was immobilized 
on a CM5 sensor chip and increasing concentrations of Asp-tRNAAsn (0-80 µM) were 
delivered as analyte. Equilibrium response units was obtained from the sensorgram shown in 
Panel A and were plotted against the Asp-tRNAAsn concentration (Panel B) to calculate the 
dissociation constant (Kd), 144.0 ± 27.0 µM.  
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CHAPTER 3:  STUDY OF HP0100 INTERACTIONS WITH ND-ASPRS, 
ADT AND TRNAASN AND ITS POSSIBLE ROLE AS KINASE (189) 
3.1 Summary 
Many bacteria lack genes encoding asparaginyl- and/or glutaminyl-tRNA 
synthetase (AsnRS and GlnRS, respectively) and consequently rely on an indirect path 
for the synthesis of both Asn-tRNAAsn and Gln-tRNAGln. In some bacteria such as 
Thermus thermophilus (T. thermophilus), a stable tRNA-dependent macromolecular 
complex called the Asn-tranamidosome is formed. This complex allows for passive, 
efficient transfer of Asp-tRNAAsn from the non-discriminating aspartyl-tRNA synthetase 
(ND-AspRS) to the amidotransferase AdT, where it is converted to Asn-tRNAAsn.  
Previous characterization of an analogous Asn-transamidome in Helicobacter 
pylori (H. pylori) revealed that, at best, this complex is dynamic in nature and cannot be 
isolated, which led us to hypothesize that maybe H. pylori use an alternative mechanism 
to facilitate assembly of a stable transamidosome complex. From a yeast two-hybrid 
(Y2H) interaction profile of the H. pylori proteome, we identified a protein called Hp0100 
and demonstrated that Hp0100 facilitates assembly of a stable, tRNA-independent Asn-
transamidosome in H. pylori (189). This complex contains ND-AspRS, AdT, and Hp0100 
but does not require tRNAAsn for assembly.  
This chapter describes our application of surface plasmon resonance (SPR) to 
quantitatively assess binary interactions between Hp0100 and ND-AspRS, between 
Hp0100 and AdT, and between Hp0100 and tRNAAsn. Our results show that both AdT 
and ND-AspRS separately interact with Hp0100 with low micromolar Kd values (1.6 ± 0.3 
and 1.3 ± 0.2 μM, respectively). Only weak interactions between Hp0100 and tRNAAsn 
were observed (Kd > 10 μM).  
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Additionally, functional characterization of Hp0100 by Dr. Gayathri Silva revealed 
that Hp0100 is a misacylated-tRNA-dependent ATPase. A Conserved Domain analysis 
identified α-adenosine nucleotide hydrolase (AANH) and P-loop consensus motifs 
(132,189-192). Dr. Silva has shown that Hp0100 catalyzes the hydrolysis of ATP to ADP 
and Pi, an activity that is activated in the presence of Asp-tRNAAsn and Glu-tRNAGln. 
Here, we also describe our examination of the possibility that Hp0100 catalyzes the 
phosphorylation of either of its protein binding partners (ND-AspRS or AdT). Evidence 
for direct phosphorylation was not found. This result is consistent with our working 
hypothesis that Hp0100 uses ATP hydrolysis to load each misacylated tRNA onto AdT 
for transamidation.   
3.2 Introduction 
3.2.1 Mechanism for efficient and accurate synthesis of Asn-tRNAAsn and Gln-
tRNAGln in H. pylori  
H. pylori solely rely on indirect tRNA aminoacylation for Asn-tRNAAsn synthesis, 
since it lacks the genes encoding for AsnRS and Asn synthetase (AsnS) (189). AsnS 
catalyzes the production of asparagine from aspartate, glutamine, and one molecule of 
ATP (193); in its absence, asparagine biosynthesis only occurs via transamidation of 
Asp-tRNAAsn to produce Asn-tRNAAsn. H. pylori also lack GlnRS and indirectly produce 
Gln-tRNAGln. During indirect aminoacylation, Asp-tRNAAsn and Glu-tRNAGln are 
generated as intermediates by misacylation reactions catalyzed by ND-AspRS and 
GluRS2 respectively. Subsequently, these intermediates are converted to Asn-tRNAAsn 
and Gln-tRNAGln by AdT (194,36). H. pylori must rely on mechanisms that prevent these 
misacylated tRNA intermediates from entering the ribosome where their use would 
cause translational errors.  
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Elongation factor-Tu (EF-Tu) provides one such mechanism (75,78,195), 
because it discriminates against Asp-tRNAAsn and Glu-tRNAGln in favor of accurately 
aminoacylated tRNAs. In some organisms (e.g. T. thermophilus), translation accuracy is 
promoted by formation of the Asn-transamidosome. The T. thermophilus Asn-
transamidosome is composed of AspRS2 (an archaeal-type ND-AspRS), AdT and 
tRNAAsn (77,86). It also contains two tRNAs bound as scaffolding elements and two 
oriented to serve as substrates for both AdT and AspRS2. The formation of the 
transamidosome presumably ensures the stability of the aminoacyl ester bond of the 
Asp-tRNAAsn and prevents its delivery to EF-Tu until it is converted to Asn-tRNAAsn. The 
first biochemical evidence for the existence of an Asn-transamidosome in H. pylori was 
reported in 2007: when it was observed that in the presence of physiological 
concentration of ND-AspRS, the affinity of AdT for Asp-tRNAAsn is increased (93). 
However, it has also been argued based on quantitative, steady state kinetic 
measurements that the H. pylori transamidosome is dynamic and transient in nature 
compared to the stable transamidosome observed in T. thermophilus (94).  
Two Gln-tranamidosomes, consisting of AdT, ND-GluRS, and tRNAGln from T. 
maritima, and of ND-GluRS, GatDE, and tRNAGln from M. thermautotrophicus have also 
been reported (89,92). In 2011, the first characterization of the putative H. pylori Gln-
transamidosome (consisting of AdT, GluRS2, and tRNAGln) was published. Like the H. 
pylori Asn-transamidosome, the H. pylori Gln-transamidosome is more dynamic and less 
stable than other known Gln-transamidosome complexes (91). The integrity of this 
ternary complex depends on an optimum concentration of tRNAGln. When this 
concentration is exceeded, formation of two separate binary complexes between each 
enzyme and tRNAGln is favored.  
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In organisms like T. thermophilus, the transamidosome is clearly used to prevent 
translational errors. However, as discussed above, formation of these stable complexes 
in H. pylori has not been demonstrated. Unlike T. thermophilus, which utilizes an 
archaeal-type ND-AspRS, H. pylori have a bacterial-type ND-AspRS (77,86), which has 
an extra domain (~140 amino acid) (see Fig 1.6 in chapter 1). Given the location of this 
domain, it seems likely that it causes steric hindrance, leading to the unstable 
association of ND-AspRS and AdT.  
T. thermophilus has a functional GlnRS and consequently does not require AdT 
for Gln-tRNAGln biosynthesis nor does it need to sequester Glu-tRNAGln (77,86). In 
contrast, H. pylori is missing both AsnRS and GlnRS. So, H. pylori requires AdT for 
transamidation of both Asp-tRNAAsn and Glu-tRNAGln. This dual substrate specificity adds 
an extra layer of complication to the need for mechanisms to promote translational 
accuracy because H. pylori must use strategies to isolate both of these misacylated 
tRNAs. Therefore, whether H. pylori use two separate transamidosomes (an Asn- and a 
Gln-transamidosome) or a single, bifunctional Asn/Gln complex for both Asp-tRNAAsn 
and Glu-tRNAGln remains unknown. We hypothesized that H. pylori must utilize 
alternative mechanisms to facilitate stable assembly of one or more transamidosome 
complexes. Evaluation of this hypothesis led us to the discovery of Hp0100, as 
discussed later in this introduction.  
3.2.2 Requirement of proteins of unknown function into indirect tRNA 
aminoacylation 
 In certain organisms, non-aaRS accessory proteins are exploited, for the 
assembly of multi-synthetase complexes (macromolecular complexes that contain two or 
more aminoacyl-tRNA synthetases). For example, in yeast, Arc1p facilitates the 
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assembly of a multi-synthetase complex between GluRS and MetRS (16,104). In 
humans and other metazoa, a large multi-synthetase complexes exists that contains at 
least nine aaRSs (bifunctional glutamyl-prolyl-tRNA synthetase:GluRSProRS, Aspartyl-
tRNA synthetase:AspRS, metheionyl-tRNA synthetase:MetRS, argininyl-tRNA 
synthetase:ArgRS, isoleucyl-tRNA synthetase:IleRS, leucyl-tRNA synthetase:LeuRS, 
lysyl-tRNA synthetase:LysRS, and GlnRS) and three accessory proteins (p18, p38, and 
p43) (16,104,107,196). In M. thermautotrophicus, an archaeal multi-synthetase has been 
identified involving LysRS, LeuRS, ProRS and elongation factor (EF-1α) (108). However, 
the existence of such multi synthetase complexes in bacteria is controversial. In 2009, S. 
Kühner and co workers showed a physical connection between six aaRSs and four 
accesory proteins during their study of proteome organization in Mycoplasma 
pneumoniae using tandem affinity purification-mass spectrometric (TAP-MS), providing 
first evidence that higher order multi-synthetase complexs in bacteria might exist (192). 
The formation of binary complexes between aaRSs and accessory protein is 
more common. Most of these accessory proteins are involved in increasing the efficiency 
of aminoacylation, editing, and substrate channeling, to improve the overall accuracy of 
protein synthesis. For example, prolyl-tRNA synthetase (ProRS) employs both pre and 
post-transfer editing mechanisms for correction of misacylated Ala-tRNAPro. During pre-
editing enzyme hydrolyzes the alanyl adenylate (Ala-AMP) intermediate, while during 
post-editing hydrolysis of Ala-tRNAPro occurs. Often, these editing reactions are 
catalyzed by an editing domain (INS) in prolyl-tRNA synthetase (ProRS) enzyme. 
However, 34% of bacteria are missing this INS domain and rely on an accessory protein 
known as ProXp-ala, an INS-like protein that hydrolyzes Ala-tRNAPro in trans. Along with 
Ala-tRNAPro, ProRS also generates misacylated Cys-tRNAPro. ProXp-ala hydrolyzes Ala-
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tRNAPro not Cys-tRNAPro. Another single domain homolog of the INS domain, YbaK, 
clears the Cys-tRNAPro in trans (95-100).  
AdT interacts with the accessory protein YqeY, which enhances the binding of 
tRNAGln to AdT (101). To date, there is no evidence either for the assembly of a multi-
synthetase complex or interaction of accessory proteins with the components of indirect 
translational machinery in H. pylori.  
H. pylori may use other proteins or enzymes either for the assembly of a 
transamidosome-like complex or for delivery of misacylated tRNAs from each 
misacylating aaRS (ND-AspRS or GluRS2) to AdT. We examined this hypothesis by 
mining the Y2H interaction profile of the H. pylori proteome (111), looking for possible 
protein partners that could play one or both of these roles: several proteins of unknown 
function were identified as putative participants (111). The proteins Hp0100 and Hp1259 
were selected for further studies because these two proteins connected ND-AspRS and 
GluRS2 to AdT respectively (see section 1.9 of chapter 1). The observed Y2H network 
of interaction between Hp0100, Hp1259, ND-AspRS, GluRS2, and AdT also hints at the 
possibility of assembly of a multi-synthetase containing ND-AspRS and GluRS2.  
The characterization of Hp1259 and its possible role in Gln-transamidosome 
assembly will be discussed in detail in chapter 5. This chapter focuses on Hp0100, 
because of its intriguing interaction profile by Y2H (Fig 1, https://pimr.hybrigenics.com) 
(197), wherein it showed connections to both ND-AspRS (hp0617, AspS) and the GatA 
subunit of AdT (hp0830, gatA). We hypothesized that Hp0100 would bridge the gap 
between ND-AspRS and AdT to enable the assembly of an Asn-transamidosome.  
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Most of our characterization of Hp0100 was completed by Dr. Gayathri Silva 
(189). She discovered that Hp0100 is required for the assembly of a stable, tRNA-
independent Asn-transamidosome, consisting of ND-AspRS, AdT, and Hp0100. Hp0100 
enhances the capacity of AdT to convert Asp-tRNAAsn to Asn-tRNAAsn and Glu-tRNAGln to 
Gln-tRNAGln but has no effect on ND-AspRS activity. My role, as presented here was to 
analyze the binary complexes between Hp0100 and ND-AspRS, AdT, and tRNAAsn by 
SPR.   
 
 
 
Fig 3.1. Hp0100 protein interaction map from yeast-two hybrid proteome analysis. A. 
Hp0100 shows strong A-level interactions with the GatA (Hp0830) subunit of AdT and with 
ND-AspRS (Hp0617, aspS). B. Color code indicating the reported strength of each Y2H 
interaction (https://pimr.hybrigenics.com). Note: the algorithm used to calculate these 
interactions has been changed since the original report. This figure is based on the more 
recent method of calculations. 
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3.2.3 Surface plasmon resonance 
Surface plasmon resonance was chosen to study the binary interactions between 
Hp0100 and AdT, ND-AspRS, and tRNAs because it is an ideal technique for monitoring 
interactions between macromolecules in real time. SPR involves immobilization of one of 
the interacting partners (the ligand: Hp0100 in our case) on the sensor chip and then 
passing the other partner (the analyte: ND-AspRS, AdT, or a tRNA) over the surface. 
Because the ligand is immobilized on the sensor surface, the refractive index at the 
interface between the surface and the running buffer is perturbed, changing the angle at 
which polarized light is reflected from the surface. This evolving response is proportional 
to the bound mass and is recorded in a sensorgram. When analyte in the running buffer 
is passed over the sensor chip with immobilized ligand, the sensorgram will depict an 
increase in response units as the analyte binds to the ligand until equilibrium is reached, 
at which point the response will become constant over time. By switching to running 
buffer without analyte, dissociation will occur and the response units will return to basal 
levels. This data profile of association, equilibrium, and dissociation can be used to 
calculate the dissociation constant (Kd) of the interaction partners.  
We used the 1:1 Langmuir binding model in the BIAevaluation software to 
calulate the Kd of the interaction partners. This model exhibits the simplest situation of an 
interaction between analyte and immobilized ligand and is based on the proposed 
Langmuir model for adsorption to a surface. In Langmuir adsorption model, at 
equilibrium rate of adsorption of molecules onto the surface is exactly equivalent to the 
rate of desorption back into the gas phase. At equilibrium, the rate of association (ka) 
and the rate of dissociation (kd) are equivalent (198).  
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3.2.4 Phosphorylation of aminoacyl-tRNA synthetases and amidotransferases 
In this chapter, I will also briefly discuss the possibility that Hp0100 acts as a 
kinase enzyme. We hypothesized that Hp0100 might be uses ATP hydrolysis to 
phosphorylate ND-AspRS or AdT, its two protein interaction partners. This hypothesis 
was built from the fact that Hp0100 hydrolyzes ATP to ADP (112) and literature 
precedent for the phosphorylation of aaRSs and accessory proteins: some examples are 
briefly presented here. 
In 1983, phosphorylation of tryptophanyl-tRNA synthetase (TrpRS) was reported 
(199). Phosphorylated derivatives of TrpRS were discovered in the presence of ATP, 
tryptophan, and Mg2+; the conditions of substrate amino acid activation. Tryptophanyl 
adenylate synthesis was accompanied by covalent attachment of pyrophosphate (PPi: 
the product of ATP hydrolysis via aminoacyl adenylate formation) to a carboxylic acid 
group of the enzyme via phosphoanhydride a bond (199).  
Multiple reports demonstrate that the aaRSs can be regulated by phosphorylation 
in multi-synthetase complexes. In early the 1970’s, Berg proposed that 
phosphorylation/dephosphorylation of the aaRSs is a major regulatory mechanism in 
eukaryotic protein synthesis (200). However, there was no direct evidence of either a 
specific protein kinase phosphorylating an aaRS or a direct correlation between 
synthetase activity and phosphorylation state. In 1985, Pendergast and Traugh 
demonstrated the direct phosphorylation GluRS, IleRS, MetRS, and LysRS by casein 
kinase I in the presence of ATP (200). Their observations provided evidence that 
phophorylation decreases the tRNA binding properties of the synthetase complex as well 
as reduces all the synthetase aminoacylation activities in the complex (200).  
142 
 
 
 
The valyl-tRNA synthetase:Elongation factor-1 (ValRS:EF-1) complex, isolated 
from rabbit reticulocytes, contains five polypeptides including ValRS and the four 
subunits of EF-1. Phosphorylation of ValRS and three EF-1 subunits (alpha, beta, and 
delta) were identified in vivo. Phosphorylation was accompanied with a 1.7 fold increase 
in the aminoacylation activity of ValRS as well as 2.0-2.2 fold increase in EF-1 activity for 
poly(U)-directed polyphenylalanine synthesis (201). Glutamyl-prolyl tRNA synthetase 
(EPRS) is a component of the human multi-synthetase complex and the gamma-
interferon-activated inhibitor of translation (GAIT) complex (202,203). The sequential 
phosphorylation of Ser886 and Ser999 in EPRS lead to its release from the parent multi-
synthetase complex and direct the formation of the GAIT complex, repressing 
translation. In this way, a two-site phosphorylation event provides structural and 
functional flexibility to EPRS, to coordinate between its canonical and non-canonical 
translational control activities (202,203).  
Similarly, phosphorylation Ser146 in the cytosolic aspartyl-tRNA synthetase 
(AspRS) provokes its separation from the human multi-synthetase complex and creates 
a new binding site for an interaction partner with unpredicted function (185).  
Upon reactive oxygen species (ROS) stress, extracellular signal-related kinase 
(ERK) phosphorylates methionyl-tRNA synthetase (MetRS) at Ser209 and Ser825 (188). 
This phosphorylated MetRS showed lower affinity for cognate tRNAMet with increased 
affinity for non-cognate tRNAs, eventually leading to mistranslation of methionine into 
cellular proteins. Thus, phosphorylation of MetRS (responsible for controlled mis-
methionylation) serves as a defense mechanism against oxidative stress. Some heat 
shock proteins, like DnaK and DnaJ in Escherichia coli K-1, phosphorylate GlnRS and 
ThrRS (186). It was proposed that absence of phosphorylation of GlnRS and and ThrRS 
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may lead to the accumulation of both uncharged tRNAGln and tRNAThr, which 
consequently triggers the accumulation of (p)ppGpp. However, the complete picture of 
impact of phosphorylation and dephosphorylation of these two aaRSs was not clear at 
that time. Recently, molecular model explaining the cellular consequences of GluRS 
phosphorylation by HipA (Ser/Thr kinase) in E. coli was proposed (174,175). When HipA 
is present, GluRS is inactivated by phosphorylation causing accumulation of uncharged 
tRNAGlu. These uncharged tRNAGlu loads at empty A-site of ribosome (“hungry” codons), 
which in turn triggers the release and activation of RelA (174,175). The RelA activation 
dramatically increases the (p)ppGpp level that causes inhibition of multiple essential 
cellular processes and subsequently leads to slow cell growth and persistence 
(multidrug tolerance) (174,175).  
Phosphorylation of aaRSs also facilitates the non-canonical functions of aaRSs. 
For example, Zamecnik and co-workers showed that several synthetases synthesize P1, 
P4-bis(5'-adenosyl)-tetraphosphate (Ap4A), involved in the regulation of cell proliferation 
and initiation of DNA synthesis (204). In vitro phosphorylation of threonyl- and seryl-
tRNA synthetase by cAMP-dependent protein kinase enhanced the rate of Ap4A 
production, with no effect on the aminoacylation activities of these aaRSs (204).  
To our knowledge, there is no evidence for the phosphorylation of AdT in the 
literature. However, some amidotransferases phosphorylated. For example, 
Glutamine:fructose-6-phosphate amidotransferase 1 (GFAT1) can be phosphorylated at 
Ser243 by AMP-activated protein kinase (AMPK) and calcium/calmodulin-dependent 
kinase II (205,206). GFAT1 catalyzes the first and rate-limiting step in the hexosamine 
biosynthetic pathway. Phosphorylation causes a 1.4-fold increase in enzymatic activity in 
vitro (206).  
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Building from these literature examples, we choose to examine the possibility 
that Hp0100 would phosphorylate either ND-AspRS or AdT. Our lab has shown that 
Hp0100 has two functional ATPase active sites: an α-adenosine nucleotide hydrolase 
(AANH) and a P-loop domain (112). Typically, AANH domains hydrolyze ATP to AMP 
and PPi. This domain is found in enzymes like argininosuccinate synthetase, 
asparagines synthetase, ATP sulfurylase, and GMP synthetase (191). P-loops are 
general ATP binding domains, and some are known to hydrolyze ATP to ADP and 
inorganic phosphate (Pi) (190,191). This domain is found in nitrilase/amidases, type I 
and II amidotransferases, and class I tRNA synthetases (191). All these P-loop domains 
are evolved from common ancestral domain, known as HUP domain. HUP domain has a 
Rossmann fold configuration and core consists of a set of beta sheets, in a 5-4-1-2-3 
configuration, surrounded by e alpha helices on outer sides (192). Dr. Gayathri Silva 
discovered that Hp0100 catalyzes the hydrolysis of ATP to ADP and Pi in the presence 
of Asp-tRNAAsn or Glu-tRNAGln. I used the Pro-Q diamond phosphoprotein gel stain 
method to examine whether or not Hp0100 phosphorylates either of its protein partners 
(ND-AspRS or AdT) in the Asn-transamidosome; in other words, I investigated whether 
Hp0100 is an ATPase or a kinase. The results presented here are most consistent with 
the hypothesis that Hp0100 is an ATPase, hydrolyzing ATP apparently to drive 
transamidation of both Asp-tRNAAsn and Glu-tRNAGln.  
3.3 Results  
3.3.1 Hp0100 binds ND-AspRS and AdT with low micromolar affinity 
Hp0100 separately interacts with ND-AspRS and AdT, both with low micromolar 
Kd values (Fig 2A and B). From SPR, for Hp0100 and ND-AspRS, the Kd = 1.3 ± 0.2 µM 
and for Hp0100 and AdT, the Kd =1.6 ± 0.3 µM. These Kd values are equivalent within 
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error. Very weak interactions between Hp0100 and tRNAAsn were observed (Kd > 10 µM, 
Fig 2C). We were not able to determine the exact Kd for Hp0100 and tRNAAsn because 
the maximum tRNAAsn concentration used in these SPR studies was 10 µM and this level 
was insufficient for saturation. 
 
 
 
Fig 3.2. Hp0100 binds ND-AspRS and AdT with low micromolar affinity. Hp0100 was 
immobilized on a CM5 sensor chip and increasing concentrations of ND-AspRS (0-30 µM) (A), 
AdT (0-20 µM) (B), or tRNAAsn (0-10 µM) (C) were delivered as analyte. Equilibrium response 
units were obtained (see insets) and plotted against analyte concentration to calculate the 
dissociation constant (Kd). SPR sensograms for ND-AspRS and AdT were also fitted using a 
1:1 Langmuir binding model using the BIAevaluation software (version 4.0.1). Similar Kd values 
were obtained using each method.  
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3.3.2 Hp0100’s role as kinase was inconclusive  
Hp0100 catalyzes the hydrolysis of ATP to ADP and Pi. If Hp0100 is a kinase 
then it might use this ATP hydrolysis to phosphorylate one of its protein interaction 
partners, ND-AspRS and/or AdT. To test this hypothesis we incubated Hp0100 with ND-
AspRS (Fig 3A, lane 3), and with the addition of Asp-tRNAAsn (Fig 3A, lane 4) in kinase 
buffer supplemented with ATP and then examined these proteins by SDS-PAGE with the 
Pro-Q diamond stain (Fig 3A). The same procedure was used to look for 
phosphorylation of AdT by Hp0100 (Fig 4A, lane 3), and with the addition of Asp-
tRNAAsn (Fig 4A, lane 4). In both the cases, a second gel was run and stained with 
Coomassie in parallel to confirm the presence of proteins (Fig 3B and 4B).  
We used cAMP-dependent protein kinase (PKA) and myelin basic protein (MBP) 
as a kinase-substrate control (184). In the absence of PKA, MBP was not 
phosphorylated (Fig 3A and 4A, lane 5); in the presence of PKA, phosphorylated MBP 
was stained by the Pro-Q diamond stain (Fig 3A and 4A, lane 6). 
Unfortunately, the Pro-Q diamond stain showed non-specific staining of ND-
AspRS and AdT, even though it was highly specific for the phosphorylated form of MBP. 
These results suggest that ND-AspRS and AdT may undergo phosphorylation during 
overexpression in E. coli.  
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Fig 3.3. Hp0100 does not effect the phosphorylation status of ND-AspRS. A. Pro-Q 
diamond stained and B. Coomassie stained 10% SDS-PAGE gels. ND-AspRS 
phosphorylation by Hp0100 was tested in the presence and absence of Asp-tRNAAsn. The 
PKA-MBP kinase-substrate pair was used as positive control for phosphorylation. MW = 
Molecular weight marker in kDa. Hp0100 and ND-AspRS should migrate with molecular 
weights of ~43 kDa and ~72 kDa respectively. MBP should migrate with a molecular weight 
~18.5 kDa. 
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Fig 3.4. Hp0100 does not effect the phosphorylation status of AdT. A. Pro-Q diamond 
stained and B. Coomassie stained 10% SDS-PAGE gels. AdT phosphorylation by 
Hp0100 was tested in the presence and absence of Asp-tRNAAsn. The PKA-MBP kinase-
substrate pair was used as positive control for phosphorylation. MW = Molecular weight 
marker in kDa. Hp0100 and AdT should migrate with molecular weights of ~43 kDa and ~46 
kDa, respectively. The GatA and GatB subunits of AdT are both ~46 kDa and GatC is ~10 
kDa. MBP should migrate with a molecular weight ~18.5 kDa. 
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3.4 Conclusions and future directions 
One goal of this chapter was to study the interactions between Hp0100 and ND-
AspRS, AdT, and tRNAAsn using SPR. These results have been completed and 
published (1). Our assessment of Hp0100 as s kinase was less conclusive. Results 
suggest that ND-AspRS and AdT are both phosphorylated during expression or undergo 
some other type of modification that renders them sensitive to Pro-Q diamond stain. 
Consequently, we could not determine whether or not Hp0100 phosphorylates either of 
these proteins. In the future, we may elect to utilize more sensitive assays with 
radiolabelled ATP ([γ-32P] ATP) to detect phosphorylation (183).    
3.5 Experimental procedure  
3.5.1 Overexpression and purification of H. pylori ND-AspRS and AdT 
H. pylori ND-AspRS and AdT were overexpressed in E. coli and purified as 
previously described (182,3). Since, the proteins were expressed in E. coli and are 
known to interact with tRNAs, there is a possibility of E. coli tRNA contamination in the 
protein preparation. To avoid tRNA contamination, cell lysates were treated with 
ribonuclease A (RNAse A, 6.25 µg/mL, Affymetrix inc., USB brand) (189,182) prior to 
affinity purification. 
3.5.2 In vivo overexpression and purification of H. pylori  tRNAAsn 
H. pylori tRNAAsn was overexpressed in vivo in E. coli strain MV1184 and 
purified. The concentration of tRNAAsn was determined as previously described (3). 
3.5.3 Overexpression and purification of Hp0100 
N-terminal His6-tagged Hp0100 was overexpressed in E. coli DH5α and purified 
as previously described (189). 
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3.5.4 Immobilization of Hp0100 on a CM5 sensor chip using amine coupling for 
real time (SPR) binding assays 
 SPR was performed at 25 °C using the department’s Biacore 2000 system. The 
CM5 sensor chip was used for immobilization of Hp0100 through amine coupling 
following the manufacturer’s instructions (207). See section 2.2.7 for a similar protocol.  
3.5.5 SPR binding assays with Hp0100 and ND-AspRS, AdT and tRNAAsn  
Increasing concentration of analytes, ND-AspRS (0-30 µM), AdT (0-20 µM), and 
tRNAAsn (0-10 µM), were passed over the Hp0100-modified chip at a flow rate of 50 
µL/min. In order to obtain the Kd, data were fitted using the 1:1 Langmuir binding model 
in the BIAevaluate (v. 4.0.1) software or by plotting the equilibrium response units versus 
analyte concentration with fitting to the equation H•A = [A0]•RMax/(Kd + [A0]) using 
Kaleidagraph, v. 4.0. In this equation, H•A represents the complex between Hp0100 (as 
H) and the analyte (as A), [A0] represents the initial concentration of the analyte in 
solution and RMax is the theoretical response units that would be obtained upon 100% 
complex formation.  
3.5.6 Identification of phosphoproteins by Pro-Q Diamond phosphoprotein gel 
stain 
To check whether Hp0100 phosphorylates ND-AspRS or AdT, different protein 
samples were prepared: Hp0100 alone, ND-AspRS alone, AdT alone, Hp0100 with ND-
AspRS or AdT and Hp0100 with ND-AspRS or AdT and Asp-tRNAAsn. All protein 
concentration were held at 25 µM and Asp-tRNAAsn was added at a final concentration of 
10 µM. Each 25 µL reaction mixture was prepared in 1X kinase buffer (50 mM Tris-HCl, 
10 mM MgCl2, pH 7.5, 20 mM ATP. Reactions were incubated at 30 °C for 30 min.  
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In parallel, cAMP-dependent protein kinase A (PKA, NEB, provided by Dr. Pflum) 
and myelin basic protein (MBP, NEB, provided by Dr. Pflum), a kinase-substrate pair, 
was used as a control (184). Two reaction mixtures were prepared, containing MBP 
alone and MBP with PKA, following the same protocol as described above. The final 
concentration of MBP was 0.1 mM and 500 units of PKA were used in the PKA-
containing reaction.  
All reactions were denatured by boiling (10 min) with 5 µL SDS-gel loading dye 
(5% β–mercaptoethanol, 0.02% bromophenol blue, 30% glycerol, 10% sodium dodecyl 
sulfate, and 250 mM Tris-Cl, pH 6.8) and then separated in a 10% SDS-PAGE gel. After 
elution, the gel was fixed in 100 mL 50% methanol and 10% acetic acid solution, twice 
for 30 minutes. Before staining, the gel was washed with 100 mL ultrapure water, 3 
times for 10 minutes, then stained in 50 mL Pro-Q diamond stain solution (Life 
Technologies) for 90 minutes in the dark. For destaining, a solution of 20% acetonitrile 
and 50 mM sodium acetate at pH 4 solution was used (100 mL, 3 times for 30 minutes 
each). The gel was washed again with 100 mL ultrapure water, 2 times for 5 minutes 
each, then the gel was imaged (excitation at 532-560 nm with an emission maximum at 
~ 580 nm). An identical second gel was run and stained with Coomassie in parallel to 
confirm the presence of proteins, since Pro-Q diamond stain should be specific for 
phosphorylated proteins only. For Coomassie staining, SDS-PAGE gels were stained by 
soaking in solution of 0.1% coomassie brilliant Blue G250 (Bio-Rad) in 45% methanol 
(Fisher), 45% water, and 10% glacial acetic acid (Fisher) for an hour. They were 
destained in 45% methanol, 45% water, and 10% glacial acetic acid solution, at least 3 
times, for 30 minutes each.  
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CHAPTER 4: IS HP0100 ESSENTIAL FOR HELICOBACTER PYLORI 
VIABILITY? 
4.1 Summary 
The sole aim of this project was to determine whether hp0100, the gene 
encoding for the Hp0100 protein, is essential for H. pylori viability. In H. pylori the 
hp0100 gene encodes for a 43 kDa protein, which was structurally and functionally 
characterized in our lab. Hp0100 is an ATPase and a crucial component for the 
assembly of the Asn-transamidosome (112,189).  
Because of Hp0100’s role in transamidation in vitro, we set out here to 
characterize Hp0100 in vivo. Our initial hypothesis was that hp0100 would prove to be 
an essential gene for H. pylori viability. We worked with Prof. Harry Mobley to learn the 
tools necessary for genetic manipulation of H. pylori. Surprisingly, deletion of the hp0100 
gene (replacing it with a chloramphenicol (cat) resistance cassette) demonstrated that 
this gene is not essential for growth under optimal conditions, in disagreement with our 
original hypothesis. RT-PCR, further confirmed the absence of Hp0100 mRNA in this 
∆hp0100 knockout strain. 
It is important to note that our ∆hp0100 knockout strain was constructed and 
initially examined under idealized in vitro growth conditions that may be too permissive 
to reveal the importance of Hp0100 during colonization or growth in humans. 
Consequently, we initiated experiments to test the viability of this deletion strain for 
growth with a small series of more restrictive growth conditions. Again, strain viability 
was not impacted. Further efforts to screen the viability of this ∆hp0100 knockout strain 
in defined minimal media are currently underway in our lab.  
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4.2 Introduction 
4.2.1 Hp0100 is an ATPase and an essential component of the H. pylori Asn-
transamidosome in vitro 
H. pylori colonize the human stomach and live in the mucus layer of gastric 
epithelial cells. This adverse environment (particularly the low pH in the stomach) 
creates a barrier to bacterial colonization. The stomach pH varies from 4.0 to 6.5 in the 
mucus layer, with occasional decreases to 2.0 (208). Still, H. pylori manages to survive 
and colonize the stomach, avoiding removal by the continuous flow of mucus and the 
low pH of gastric acid. The high expression levels of urease and bacterial motility are the 
key colonization factors for H. pylori, helping this organism to overcome the physical 
barrier of the mucus layer and survive at low pH (209-211).  
Urease converts urea into ammonia and carbon dioxide, increasing the pH of the 
local microenvironment (209). Urease activity is the main mechanism developed by H. 
pylori to buffer against gastric acid for intracellular pH homeostasis. However, studies 
with H. pylori ureI mutants (urease negative strains) have shown a urease-independent 
acid resistance mechanism (212,213). Moreover, H. pylori use acid resistance 
mechanisms to maintain internal pH (214). These acid resistance mechanisms are 
characterized by vigorous changes in transcription and protein translation.  
Interestingly, many H. pylori proteins are either downregulated or upregulated in 
response to harsh environmental conditions (212-215). For example, the arginine 
decarboxylase gene, speA (hp0422 in H. pylori 26695) is involved in acid resistance. 
Under acid stress, speA mRNA and protein expression are induced (216). The specific 
activities of several other enzymes also respond to changes in pH of the growth 
environment (209,217). For example, transfer to an acidic environment induces 
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ammonia-producing pathways (218), changes lipopolysaccharide composition (219), and 
increases the expression of chaperone-like proteins (220). These observations suggest 
that H. pylori utilize different survival mechanisms for varied stress conditions. The 
impact of acidic growth conditions on H. pylori viability remain the most well explored. 
Other stress conditions like oxidative stress, high salt, different metal ions, etc. are also 
beginning to receive attention. Further studies are necessary to explore the mechanisms 
that H. pylori use for survival under stress conditions. Since protein expression levels in 
H. pylori respond to environmental challenges, there is the possibility that certain 
proteins become essential under stress conditions.  
In this chapter, I discuss our forays into examining Hp0100 in vivo in H. pylori. 
Our lab has demonstrated in vitro that Hp0100 is a component of a tRNA-independent 
Asn-transamidosome complex. This complex enhances the rate of AdT’s transamidation 
of Asp-tRNAAsn by ~35 fold and Glu-tRNAGln by ~3 fold. Hp0100 also hydrolyzes ATP in 
the presence of either Asp-tRNAAsn or Glu-tRNAGln and this hydrolysis drives the 
acceleration of AdT with both tRNA substrates (112). This work shows that proteins of 
unknown function, like Hp0100, can be a part of the protein translational machinery and 
can play unprecedented roles in central processes like tRNA aminoacylation (189).  
My goal herein was to determine whether or not the hp0100 gene is essential for 
H. pylori viability. Because of Hp0100’s role in indirect tRNA aminoacylation, we 
hypothesized that hp0100 would be an essential gene. To test this hypothesis, a plasmid 
was constructed to knock out the hp0100 gene, replacing it with a cat cassette. Genetic 
complementation experiments were conducted following a protocol from (and in 
collaboration with) the Mobley lab at the University of Michigan (221,222). A control 
experiment was run in parallel by knocking out the hp1512 gene, which is non-essential 
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(221). As shown here, under optimal growth conditions, hp0100 unexpectedly proved to 
be non-essential. Experiments to further examine this surprising result are underway in 
the lab. The results presented in this chapter have led to the revised hypothesis that 
hp0100 will be essential under one or more specific stress conditions. There is evidence 
of  mRNA and protein expression being specifically induced under certain stress 
conditions in H. pylori (216,218-220), which supports our revised hypothesis.  
4.3 Results and discussion 
4.3.1 Design of the pUC57-Hp0100::cat plasmid 
The hp0100 gene (from H. pylori strain 26695) was disrupted using a pUC57 
plasmid with an insert constructed from 500 bp upstream and downstream of the hp0100 
open reading frame (Fig 4.1). All but the first and last 50 bp of the hp0100 gene were 
replaced with a cat cassette. The cat cassette was identical to that originally cloned from 
Campylobacter jejuni plasmid pNR9589 (223), including a 30 nt promoter region, 
followed by a ribosomal binding site and the cat open reading frame (ORF) of 627 bp. 
The sequences upstream and downstream of the ORF, containing several direct and 
inverted repeats, were also incorporated (224). The base pairs on each side of the cat 
cassette were used to facilitate allelic recombination and genomic replacement of most 
of the hp0100 gene with cat. The designed insert sequence (Appendix 1) cloned in the 
pUC57 vector was purchased from GenScript. 
The pUC57-Hp0100::cat plasmid, containing the hp0100::cat insert, was 
transformed into H. pylori. In parallel, the pCR2.1-Hp1512::cat plasmid, from the Mobley 
lab (221), was also used for transformation as a control. This plasmid disrupts the 
hp1512 gene with the same cat cassette. The hp1512 gene encodes for an outer 
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membrane nickel transport protein: hp1512 is not essential for H. pylori viability (221), so 
this plasmid served as a non-essential control for our experiments.  
4.3.2 Allelic recombination in H. pylori 26695 
The pUC57-Hp0100::cat and pCR2.1-Hp1512::cat plasmids were introduced into 
H. pylori by electroporation. Cells were recovered on nonselective agar plates (brucella 
broth supplemented with 10% fetal bovine serum (BBF)) for 17 to 24 hours, and then 
tranferred to BBF plates supplemented with chloramphenicol (20 µg/mL). The cloned 
insert from the plasmid can be incorporated into the recipient genome via two crossover 
events with the corresponding sequence in the recepient chromosome namely via 
 
Fig 4.1. Schematic representation of the pUC57-Hp0100::cat 
plasmid. The insert was designed by replacing most of the hp0100 gene 
with a cat cassette from C. jejuni. This cassette was flanked with 500 bp 
upstream and downstream of the hp0100 gene and included the first and 
last 50 bp from hp0100 itself. See Appendix 1 for the complete 
sequence. 
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homologous recombination (Fig 4.2). Since the plasmid cannot replicate in H. pylori, 
selection of mutants relies on the incorporation of the cat cassette into the H. pylori 
chromosome and selection on chloramphenicol. Colonies were obtained for both 
transformations (pUC57-Hp0100::cat and pCR2.1-Hp1512::cat) after 3-4 days incubation 
at both 37 °C and 42 °C. The growth of these mutants (∆hp0100 and ∆hp1512 strains 
respectively) on chloramphenicol is an indication of incorporation of the cat cassette (see 
below for additional characterization of these strains). The number of colonies obtained 
with wild-type H. pylori (in the absence of chloramphenicol), and the ∆hp0100 and 
∆hp1512 strains were approximately the same. Glycerol stocks of the ∆hp0100 and 
∆hp1512 strains were prepared and used for later experiments.  
 
 
Fig 4.2. Construction of the Hp0100::cat mutant in H. pylori 26695 via 
homologous recombination. Schematic outline of H. pylori Hp0100::cat mutant 
construct prepared through allelic replacement of hp0100 in H. pylori 26695.  
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4.3.3 Hp0100 is not essential for viability of H. pylori under ideal conditions  
If Hp0100 is essential for H. pylori viability then successfull transformation of the 
pUC57-Hp0100::cat plasmid and allelic recombination (Fig 4.2) should have prohibited 
growth when challenged with chloramphenicol. However, colonies were obtained after 
transformation both at 37 °C and at 42 °C, which suggests that Hp0100 is not essential 
for viability. Colonies were also obtained for the ∆hp1512 mutant, our non-essential gene 
control. Specific primers (Table 4.1) and PCR were used to confirm that allelic 
recombination had occurred and that the hp0100 gene had been replaced by the cat 
cassette. These experiments were essential to eliminate the possibility of co-inheritance. 
In other words, to conclude that hp0100 is not essential, we set out to verify that 
allelic exchange took place as designed without misincorporation of the cat cassette in 
lieu of disruption of hp0100.  
Correct insertion of the cat cassette with disruption of hp0100 was confirmed 
using primers designed to distinguish between the wild type and the deletion strains 
(Table 4.2). The increase in PCR product size with Hp0100 specific and flanking primers 
and the presence of a small PCR product with cat specific primers confirmed that single 
allelic replacement of the Hp0100 gene had occurred (Fig 4.3, lanes 1-5 in each panel). 
The viability of the hp0100::cat strain demonstrates that Hp0100 is not essential under 
these growth conditions.  
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Table 4.1: Primers used in PCR to confirm the allelic recombination of hp0100  
 
 
 
 
 
 
 
 
 
 
 
Primers 
Direction of 
primer 
Sequence (5’          3’) 
Hp0100 specific primers 
SF17F-5 Forward CCACCCTTATAGCGAATACTTGTTGCG  
SF16R-5 Reverse CTGTGCGTTCTTCTAGCACGATAATAGG  
Flanking primers 
SF18F Forward CGTCTAATTTTGCCAAAGATTTAGCGAACG  
SF18R Reverse CCGACTTTAGGGTGGTTTCTTAAAAAATGC 
cat specific primers 
Cat-F Forward CGAGTATTTGGACTGAGTTTACAGCAGAC  
Cat-R Reverse GCTTGTCCACGGTATCATAGAAACAGGG  
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Table 4.2: Amplification products for PCR to confirm the allelic recombination of 
hp0100 using Hp0100 specific, flanking, and cat-specific primers 
Primers WT H. pylori ∆hp0100 ∆hp1512 
pUC57-Hp0100::cat 
plasmid 
Hp0100 specific 
primers 
935 bp 1051 bp 935 bp 1051 bp 
Flanking primers 2252 bp 2368 bp 2252 bp No amplification 
cat specific 
primers 
No Amplification 152 bp 152 bp 152 bp 
 
 
Fig 4.3. PCR amplification to verify disruption of the hp0100 gene. Genomic DNA from 
∆hp0100 (lanes 1-5), WT H. pylori (lane 6), ∆hp1512 (lanes 7-10), and the pUC57-
Hp0100::cat plasmid (lane 11) were analyzed with Hp0100 specific primers (left), flanking 
primers (right), and cat specific primers (bottom). 
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4.3.4 Reverse transcriptase-polymerase chain reaction (RT-PCR) to examine the 
absence of Hp0100 mRNA expression in ∆hp0100 strain 
We also used RT-PCR to verify that hp0100 mRNA was not being expressed in 
our ∆hp0100 strain, further confirming the successful construction of this strain. If 
hp0100 is replaced with the cat cassette after allelic recombination, then we should not 
see hp0100 gene expression in our ∆hp0100 strain. Total RNA was isolated from the 
∆hp0100 strain and RT-PCR for mRNA detection was performed using Hp0100 gene 
specific and flanking primers (Table 4.1) and the Moloney Murine Leukemia Virus (M-
MuLV) reverse transcriptase following the manufacturer’s protocol. Messenger RNA 
isolated from an E. coli strain overexpressing GatCAB was used as a control with GatB-
specific primers (obtained from Dr. Gayathri Silva) (Fig 4.4). As expected, no 
amplification was detected with mRNA from the ∆hp0100 strain (lane 1) while a faint 
band at 1500 bp was observed for GatB (lane 1). No RNA, no reverse transcriptase, and 
no Taq polymerase control experiments were performed (lanes 2, 3 and 4 respectively, 
Fig 4.4) with both mRNA samples. A prominent 1500 bp band was observed in the case 
of the no reverse transcriptase control for the GatB mRNA (lane 3), which may be 
because of DNA contamination or experimental error.  
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. 
Standard PCR was also performed to verify that the mRNA was not 
contaminated with genomic DNA, using genomic DNA from H. pylori WT, ∆hp0100, 
∆hp1512 and the pUC57-Hp0100::cat plasmid as controls along with mRNA samples, 
before and after DNase treatment 
 
 
 
 
  
Fig 4.4. RT-PCR analysis of hp0100 and gatB mRNA. RT-PCR was 
performed with RNA samples from the ∆hp0100 strain and from an E. coli strain 
expressing GatCAB mRNA. Lane 1: GatCAB, Lane 2: no RNA control, Lane 3: 
no reverse transcriptase control, Lane 4: no Taq polymerase control. Hp0100 
specific primers were used for the reactions on the left and GatB-specific 
primers were used for the reactions on the right. As expected, amplified product 
was not observed with the ∆hp0100 strain mRNA sample.  
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Table 4.3 summarizes the predicted results from these PCR experiments and the 
observed results are shown in Fig 4.5. Both genomic DNA and mRNA from the ∆hp0100 
strain produced the same PCR product at 1051 bp, consistent with the presence of 
genomic DNA in this RNA sample (lane 5, Fig 4.5). However, as expected, after DNase 
treatment this band was not observed (lane 6, Fig 4.5), which led us to conclude that our 
RNA preparation was free of DNA contamination and suitable for the RT-PCR 
experiments described above.  
Similar results were obtained for flanking primers; the PCR amplified products 
were of the expected size (Table 4.3 and Fig 4.5). Some non-specific amplification was 
observed when the pUC57-Hp0100::cat plasmid was used as template (lane 4). Also, 
with flanking primers amplified product was not observed with the RNA sample before 
DNase treatment (lane 5, 2368 bp amplified product expected), which was surprising 
because the RNA sample used for Hp0100 gene specific and flanking primers were the 
same.  
However, since with both the primer sets, no amplification was observed for RNA 
samples after DNase treatment (lane 6, Fig 4.5), as predicted, it was concluded that 
these mRNA samples were DNA free and they were used for the RT-PCR experiments 
described above. 
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Table 4.3: Amplification products for standard PCR to confirm the DNA 
contamination in RNA samples using Hp0100 specific and flanking primers 
Primers WT H. pylori ∆hp0100 ∆hp1512 
pUC57-Hp0100::cat 
plasmid 
Hp0100 specific 
primers 
935 bp 1051 bp 935 bp 1051 bp 
Flanking primers 2252 bp 2368 bp 2252 bp No amplification 
 
 
 
 
 
 
 
Fig 4.5. PCR amplification to verify that the RNA samples used for RT-PCR were 
free of genomic DNA contamination. Samples were as follows: Lane 1: Genomic DNA 
from WT H. pylori; Lane 2: Genomic DNA from the ∆hp0100 strain; Lane 3: Genomic 
DNA from the ∆hp1512 strain; Lane 4: pUC57-Hp0100::cat plasmid; Lane 5: mRNA 
before DNAse treatment; Lane 6: mRNA after DNAse treatment. Each sample was 
analyzed using Hp0100 specific primers (left) and flanking primers (right).  
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4.3.5 Analysis of the impact of different stress conditions on the viability of the 
∆hp0100 and ∆hp1512 strains 
The discovery that Hp0100 was non-essential was unexpected, given Hp0100’s 
role in indirect aminoacylation (189). However, this result raises important questions, like 
when and why is Hp0100 utilized? Is it conditionally essential? We hypothesize that our 
hp0100 knockout experiments were conducted under conditions that were too 
permissive. Consequently, we set out to check the viability of the ∆hp0100 strain under 
more stringent conditions. We performed a small series of preliminary experiments 
testing the impact of different compounds on the viability of our ∆hp0100 strain. Since, 
Hp0100 is involved in indirect aminoacylation of Asp-tRNAAsn or Glu-tRNAGln, we tested 
media supplemented with higher concentrations of the amino acids Asp, Glu, and Gln.  
Furthermore, Hp0100 has a putative metal binding site (112). Preliminary 
analyses by Dr. Gayathri Silva showed that Hp0100 binds Fe(II), Zn(II), and Ni(II) (112). 
Metal homeostasis is crucial for the adaptation of H. pylori to its gastric environment 
(225). Import, storage, and the efflux of metal ions (e.g. iron, copper, and nickel) are 
strictly regulated (226). Iron and nickel acquisition have been well characterized 
(226,227). For these reasons, the addition of ferric and ferrous chloride to the H. pylori 
growth medium were examined with the ∆hp0100 strain. High salt concentrations and 
different pH values were also tested.  
In summary, the viability of the ∆hp0100 strain was examined on BBF growth 
media with each of the following different additives: 2 mM aspartate, 2 mM glutamate, 2 
mM glutamine, pH 5.0, 2 mM NaCl, 1 mM FeCl2, and 1 mM FeCl3. All conditions were 
examined at both 37 °C and at 42 °C. It is important to note that these conditions were 
meant to serve as an initial rapid screen of ∆hp0100 strain viability and they do not 
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mimic the actual stress that H. pylori faces in its life cycle. Growth occurred in all cases, 
suggesting either that Hp0100 is not essential or that BBF medium remains too rich to 
elucidate the importance of Hp0100 for viability. Similar experiments using chemically 
defined, minimal media are currently underway in our lab.  
4.4 Conclusions and future directions 
The major goal of this project was to determine if hp0100 is essential for H. 
pylori. Surprisingly, our results demonstrate that Hp0100 is not essential under the rich 
medium conditions tested herein. PCR and RT-PCR results further confirm the absence 
of Hp0100 mRNA in this ∆hp0100 strain, confirming that hp0100 was deleted as 
designed. The loss of hp0100 gene expression due to cat insertion was successful 
however the viability results were in disagreement with our original hypothesis. We 
expected that hp0100 would be essential, based on its important role in indirect 
aminoacylation (189). Since our hp0100 knockout was examined under idealized in vitro 
growth conditions, in rich medium, we conducted a small preliminary screen of a number 
of conditions to look at the possibility conditionally essentiality. Unfortunately, our 
∆hp0100 strain showed growth in all cases, suggesting that Hp0100 does not become 
essential in any of these tested stress conditions. However, it is important to note that 
this was an initial rapid screen and BBF medium may be too rich to elucidate the 
importance of Hp0100 for viability. In the future, our efforts will focus on using chemically 
defined minimal medium.  
Given the impact of Hp0100 on indirect aminoacylation, the observation that this 
gene is not essential was surprising. However, the natural H. pylori niche is the stomach 
mucus layer where the environment is significantly more hostile, particularly with respect 
to pH and other stressors. Consequently, it will be important to screen the essentiality of 
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hp0100 under a variety of more stringent stress conditions. Our revised hypothesis is 
that the growth conditions used in these experiments were too permissive and did not 
adequately reflect the stress conditions faced by H. pylori in its human niche. H. pylori is 
able to persistently colonize the human stomach. In addition to pH, ionic composition, 
osmotic pressure and other constantly changing host-dependent factors contribute to the 
hostile H. pylori growth environment. Furthermore, there is evidence demonstrating that 
environmental factors like diet, stress and others also modulates H. pylori colonization in 
humans (228-235).  
Therefore, our next goal will be to screen the impact of a variety of stress 
conditions on the viability of our ∆hp0100 strain. These experiments will be conducted 
using chemically defined media so that the impact of each additive can be more 
quantitatively assessed. Stress conditions to be tested will include changes in growth 
temperature, and the introduction of oxidative stress, high salt, different metal ions, low 
pH, etc. These experiments will reveal whether or not Hp0100 is conditionally essential 
under a variety of physiologically relevant stress conditions. There is precedent for this 
strategy. For example, H. pylori urease is not essential in standard rich medium but is 
essential for colonization and pH tolerance (213).  
In the future, nutritionally defined media will be used in place of the rich 
undefined BBF medium used throughout the work described in this chapter (236-239). 
Since, H. pylori is a capnophile and grows in the presence of high levels of CO2 (as 
compared to O2), 5% O2 is ideal for growth (240). Growth of our ∆hp0100 strain will be 
tested under O2 conditions ranging from 1% to 20%. Strain viability will also be examined 
at different growth temperatures (ranging from 30-42 °C), with varying concentrations of 
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NaCl, NaNO2, urea, glycerol, HCl, chloroamphenicol, and other antibiotics, as well in the 
presence of heavy metals and amino acids.  
We will monitor growth in terms of survivability, colony morphology, and time of 
appearance of colonies (236). As controls, parallel experiments will be conducted with 
WT H. pylori 26695 and the ∆hp1512 strain, which will help us to identify any specific 
phenotypes related to Hp0100. Phenotypes that appear specific to hp0100 will be 
verified by complementation: a new copy of the hp0100 gene will be inserted in the 
intergenic space between hp0203 and hp0204 (using a kanamycin resistant cassette) 
following the same strategy as shown in Fig 4.2. This region has been validated for 
complementation and Prof. McGee has provided us with this complementation plasmid 
(241). We expect that insertion of wild type hp0100 in the chromosomal DNA of our 
∆hp0100 strain will eliminate any Hp0100 specific phenotype by restoring a copy of the 
hp0100 gene. This approach will confirm that the observed phenotype is because of the 
loss of Hp0100 and not because of any other unexpected chromosomal mutations 
outside the hp0100 open reading frame.  
4.5 Experimental procedures 
4.5.1 Bacterial strain and growth 
Helicobacter pylori strain 26695 was revived from -80 stocks on Columbia blood 
agar (CBA) base (Difco) supplemented with 10% defibrinated sheep blood (Hemostat 
Laboratories) under 10% CO2 and 5% O2 at 37 °C. Brucella broth (Difco) agar plates 
were supplemented with 10% fetal bovine serum (BBF) (Gibco) and antibiotic (20 µg/mL 
chloramphenicol) when required. BBF plates with and without antibiotic were used in our 
complementation experiments.  
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4.5.2 Construction of the pUC57-Hp0100::cat plasmid 
The pUC57-Hp0100::cat plasmid construct was ordered from Genscript. We 
designed the insert by removing all except the first and last 50 bp of the hp0100 gene 
and replacing the rest of the gene with the cat cassette from C. jejuni. DNA (500 bp) 
immediately upstream and downstream of the hp0100 gene were also included to 
facilitate allelic recombination. This insert sequence was cloned into the EcoRV site of 
pUC57 to create the pUC57-Hp0100::cat plasmid (Fig 4.1 and Appendix 1). 
Chloramphenicol resistance was used for allelic exchange mutagenesis for hp0100 gene 
inactivation. The plasmid (4 µg) was dissolved in 20 µL water (stock concentration 0.2 
µg/µL) and 1 µL of this solution was transformed into E. coli DH5α. These cells were 
used for plasmid preparation and 3-8 µg of plasmid was used for transformation into H. 
pylori. 
4.5.3 Construction of the ∆hp0100 strain and genetic techniques 
H. pylori competent cells were prepared from BBF agar plates as follows: 
bacteria were scraped from the surface of the plate (one plate was used) and washed 
three times with a cold sterile solution of 9% sucrose and 15% glycerol (10 mL per 
wash). After centrifugation at 3000 rpm for 10 min in a 15 mL falcon tube, the bacterial 
sediment was resuspended in 600 µL 9% sucrose and 15% glycerol solution, and then 
incubated at 4 °C for 5 min before electroporation. For H. pylori electroporation, 3-8 µg 
of pUC57-Hp0100::cat plasmid DNA were added to H. pylori competent cells. The 
mixture was gently agitated, and incubated at 4 °C for 20 mintues. The cell suspension 
was electroporated at 25 µF capacitance, 600 Ω resistance, and 2.5 kV, and 700 µL 
BBF liquid medium were added. Cells were recovered by growing statically at 37 °C for 
24 hours to enhance the efficiency of transformation. This liquid medium was transferred 
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to nonselective BBF agar plates on filter paper (0.45 micron, Millipore) and again 
recovered for 17 to 24 hours. Then, the filter paper was transferred to BBF agar plates 
supplemented with chloramphenicol (20 µg/mL). Parallel control experiments were 
conducted using pCR2.1-Hp1512::cat plasmid DNA (provided by Prof. Harry Mobley) 
and water was used as a no plasmid control. Transformed colonies were isolated from 
plates after incubation for 3-4 days. Genomic DNA from wild-type and chloramphenicol 
resistant colonies were isolated as previously described (242) and transformants were 
screened for correct allelic replacement via PCR to verify incorporation of Hp0100::cat 
into the H. pylori chromosome (using the primers listed in Table 4.1). Transformation 
experiments were repeated in triplicate and colonies were randomly picked for PCR 
verification. In addition, after transformation cells were allowed to grow at 37 °C and at 
42 °C. 
4.5.4 PCR amplification  
The genomic DNA isolated from WT H. pylori (grown on BBF plates in the 
absence of chloramphenicol) and the ∆hp0100 and ∆hp1512 strains were used as  
templates. Forward and reverse primers are listed in Table 4.1. PCR conditions were as 
follows: Window 1 (1 cycle): Initial denaturation at 95 °C, 5 min. Window 2 (35 cycles): 
Denaturation at 95 °C, 30 sec; primer annealing at 62 °C, 30 sec; primer extension at 72 
°C, 2:30 min. Window 3 (1 cycle): Final extension at 72 °C, 10 min. PCR reactions were 
performed with GoTaq® Green Master Mix (Promega) and samples were analyzed by 
agarose gel electrophoresis. 
4.5.5 RNA extraction, purification and RT-PCR 
A combination of the TRIzol reagent (Invitrogen) followed by QIAGEN RNeasy 
column purication (QIAGEN) was used for total RNA isolation from H. pylori cells. Cells 
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scraped from one plate were resuspended in 500 µL TRIzol at 65 °C, mixed by pipetting 
and vortexing, and then incubated at room temperature for 5 min. After incubation, the 
suspension was extracted twice with 100 µL chloroform, mixed thorougly by inverting, 
and centrifuged for 10 min at 11,500 rpm and 4 °C. Ethanol (250 µL, 100%) was added 
to the supernatant, mixed by pipetting, and then the solution was applied to an RNeasy 
column. The manufacturer’s protocol was followed and the RNA was eluted in 50 µL 
RNase-free water. DNase I digestion was performed by adding 4 µL RQ1 RNase-free 
DNase I (40 U, Promega) and 6 µL RQ1 RNase-free DNase I 10X reaction buffer to this 
sample and incubating the solution for 30 min at 37 °C. The reaction was terminated with 
6 µL stop solution (20 mM EGTA, pH 8.0), followed by incubation at 65 °C for 10 min.  
Standard PCR was performed following the protocol described in section 4.4.4 to 
verify that the mRNA was not contaminated with genomic DNA, using mRNA sample 
from ∆hp0100 strain before and after DNase treatment. Genomic DNAs from H. pylori 
WT, ∆hp0100, ∆hp1512 and the pUC57-Hp0100::cat plasmid was used as positive 
control in PCR. These DNA-free RNA samples were used later for RT-PCR.  
RT-PCR was performed with 0.5-2.0 µg of total RNA from the ∆hp0100 strain 
using M-MuLV Reverse Transcriptase (NEB). RT-PCR was carried out in 18 µL 
reactions with mRNA template (1.0 µg), dNTPs (2.5 µg each), forward primer specific for 
either hp0100 or gatB (50 ng) and the manufacturer’s recommended RT buffer. The RT-
PCR cycle was set up as follows: (1) primer annealing at 25 °C, 10 min (2) elongation at 
50 °C, 60 min and (3) reaction termination at 94 °C, 5 min. Next, the resultant cDNAs 
were amplified by adding Taq polymerase (2.5 units) and reverse primers specific for 
either hp0100 or gatB (50 ng). PCR amplification was performed for 40 cycles as 
follows: (1) denaturation at 94 °C, 15 sec (2) primer annealing at 50 °C, 30 sec (3) 
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elongation at 72 °C, 90 sec, followed by a final extension at 72 °C for 5 min. No RNA, no 
reverse transcriptase, and no Taq polymerase control experiments were also performed 
following the above described protocol by eliminating RNA, reverse transcriptase, and 
Taq polymerase, respectively.   
4.5.6 Preliminary stress condition experiments 
BBF plates with and without antibiotic (20 µg/mL chloramphenicol) were 
prepared. For stress condition plates, the following solutions were prepared in water and 
sterile filtered: 2 mM aspartate, 2 mM glutamate, 2 mM glutamine, 2 mM NaCl, 1 mM 
FeCl2 and 1 mM FeCl3, and citrate buffer pH 5.0. Next, 200 µL of each solution was 
added to the top of individual premade BBF agar plates (both with and without 
chloramphenicol), spread, and allowed to dry. Individual colonies of H. pylori WT (from 
BBF plates without chloramphenicol), and the ∆hp0100 and ∆hp1512 strains (from BBF 
plates supplemented with chloramphenicol) were picked and streaked on different stress 
plates. Plates were incubated in 10% CO2 and 5% O2 at 37 °C for 3-4 days. Plates were 
monitored for growth. All experiments were performed in duplicate.  
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Appendix 1: Sequence of the designed insert for hp0100 knockout 
 
ctgcagAACTCCCAACACAAAAGCTTGATGGAAACTTCCAAAACGATAGAAAATATCAC
CACTTCCATTCAAGGCGTGAGCTCTCAAAGTGAAGCCATGATTGAACAAGGGCAAG
ACATTAAAAGCATTGTAGAAATCATTAGAGATATTGCTGATCAAACCAATCTTTTAGC
CTTAAACGCCGCTATTGAAGCCGCAAGGGCCGGCGAGCATGGCAGAGGCTTTGCG  
GTGGTGGCTGATGAGGTAAGAAAGCTCGCTGAAAGGACGCAAAAATCGCTCAGCG
AGATTGAAGCCAATATCAATATTTTAGTGCAAAGCATTTCAGACACGAGCGAAAGCA
TTAAAAACCAGGTTAAAGAAGTGGAAGAAATCAACGCTTCTATTGAAGCCTTAAGAT
CGGTTACTGAGGGCAATCTAAAAATCGCTAGCGATTCTTTAGAAATCAGTCAAGAAA
TTGACAAAGTTTCTAACGATATTTTAGAAGATGTGAATAAAAAGCAGTTTTAATGCTC
ATTCATATTTGCTGCTCAGTGGATAACCTCTATTTTTTAAAAAAGGCTAAAGAGGCTT
TTGCGGGTGAAAAAATTGTAGGGTTTTTTTATAACCCCAATATCCACCCTTATAGCG
AATACTTGTTGCGTTTAGAAGACGTGAAACCCGGGgaattccgtcgtcggtatcgtatggagcgga
caacgagtaaaagagtgaccgccgagataacccattgctcggcggtgttcctttccaagttaattgcgtgatatagattgaa
aagtggatagatttatgatatagtggatagatttatgatataatgagttatcaacaaatcggaatttacggaggataaatgatg
caattcacaaagattgatataaataattggacacgaaaagagtatttcgaccactattttggcaatacgccctgcacatatag
tatgacggtaaaactcgatatttctaagttgaaaaaggatggaaaaaagttatacccaactcttttatatggagttacaacgat
catcaatcgacatgaagagttcaggaccgcattagatgaaaacggacaggtaggcgttttttcagaaatgctgccttgctac
acagtttttcataaggaaactgaaaccttttcgagtatttggactgagtttacagcagactatactgagtttcttcagaactatca
aaaggatatagacgcttttggtgaacgaatgggaatgtccgcaaagcctaatcctccggaaaacactttccctgtttctatga
taccgtggacaagctttgaaggctttaacttaaatctaaaaaaaggatatgactatctactgccgatatttacgtttgggaagt
attatgaggagggcggaaaatactatattcccttatcgattcaagtgcatcatgccgtttgtgacggctttcatgtttgccgtttttt
ggatgaattacaagacttgctgaataaataaaatcccagtttgtcgcactgataaaaaccctttaggaactaaagggcgca
cttctatactctctgtcgagagtagtgcgtcctgcggGGATCCCCCGGGAATTATGAAGAAGAGTTGTC
TTTAAGGGCGTTAGTGAGCGGGAGCGAGAGTATTAACCCTATTATCGTGCTAGAAG
AACGCACAGAAAAGACCCTTTTTGTAGAAATTAAAAGCGTTTTTCAAGAAGAAAAGG
TGTTTTATTTGCTGTAAGCTAAACTTTAATTAGGCGATAAATTCTTGTAATGAAAAAT
GATTAAAGTTGGCTTTAGTTATCCATGCTTGATGGGAACAAAACCTCAATAAATTGT
ATTTTAAAATATAGCGTTGCGTGTGAGTGGGGGGTTATAGTAAAAACATGCAAGTAA
TTTAAAGTTAATTTAAGATAATTAGGCACAATAGCCACAAAAAGTTTAAGGCTGTATT
TGAAAACTCTATTTAGTATTTATCTCTTTTTATCGTTGAACCCACTCTTTTTAGAAGCT
AATGAAATCACTTGGTCTAAATTCTTGGAAAATTTTAAAAACAAGAATGATGATGACA
AACCTAAACCCCTAACTATTGATAAAAACAATGAAAAACAGCAAATCTTAGACAAAAA
CCAGCAAATCTTAAAAAGGGCTTTGGAAAAAAGCCTTAAATTCTTTTTCATTTTTGGA
TACAACTATTCGCAAGCCACTTTTTCAACTTCTAACCAAACCTTGACTTTTGTActcgag 
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CHAPTER 5: STRUCTURAL AND FUNCTIONAL CHARACTERIZATION 
OF HP1259 
5.1 Summary 
Previous characterization of the H. pylori Gln-transamidosome revealed that it is 
dynamic and unstable (91). Since Hp1259 showed weak interactions with both GluRS2 
and AdT by Y2H (111), we hypothesized that Hp1259 might facilitate the assembly of 
Gln-transamidosome. Hp1259 shares homology with sirtuins, NAD+ dependent 
deacetylases. Obtaining pure Hp1259 was a challenge, majority of protein remains 
insoluble. Growing cells at low temperature (19 °C) showed improvement in the solubility 
of Hp1259. Preliminary GluRS2 aminoacylation experiments showed a ~50% increase in 
the rate of aminoacylation of tRNAGln when Hp1259 was added to aminoacylation assay. 
However, why a sirtuin-like protein would interact with an aaRS or affect aminoacylation 
is hard to explain. Nevertheless, with the rapid increase in the discovery of new sirtuin 
targets, GluRS2 and AdT could be a possibility (243-245). In the future, Hp1259 
interactions with GluRS2 and AdT will be examined for the possibility of Hp1259 
mediated assembly of Gln-transamidome.  
5.2 Introduction 
5.2.1 Selection of Hp1259 as a protein of interest 
In H. pylori, a stable transamidosome complex involving GluRS2, AdT, and 
tRNAGln has not been observed (91). Even though Hp0100 enhances AdT-mediated 
transamidation of Glu-tRNAGln into Gln-tRNAGln, preliminary efforts to detect direct 
interactions between Hp0100 and GluRS2 were unsuccessful (112). These results 
suggest that Hp0100 helps in the assembly of an Asn-tranamidosome but not a Gln-
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transamidosome and imply that other proteins of unknown function might be involved in 
delivering Glu-tRNAGln from GluRS2 to AdT.  
The protein Hp1259 showed weak D-level interactions with both GluRS2 and 
AdT by yeast-two hybrid assay (Y2H, Fig 5.1) (111), suggesting that Hp1259 might 
bridge the gap between GluRS2 and AdT, either to transfer Glu-tRNAGln between these 
two enzymes or to facilitate the assembly of a Gln-transamidosome.  
 
 
 
 
 
 
 
Fig 5.1. Hp1259 protein interaction map from yeast-two hybrid proteome analysis. A. 
Hp1259 showed weak D-level interactions with the GatA subunit of AdT and with GluRS2 
(gltX2). It also showed strong A-level interactions with itself suggesting that it assembles into 
an oligomer. B. Color code indicating the strength of the interactions observed by yeast-two 
hybrid assay (111).  
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Hp1259 is 205 amino acids long (Fig 5.2A) and shares homology with the 
Sir2/CobB family of deacetylases (Hp1259 shares 42% sequence identity with E. coli 
CobB) (Fig 5.2D). Sir2 (silent information regulator 2) proteins or sirtuins are NAD+ 
dependent deacetylases and are conserved in all three kingdoms of life (243). Apart 
from deacetylation, Sir2 proteins also catalyze other reactions for example, ADP-
ribosylation, desuccinylation, and demalonylation (244,245). Sirtuins are regulatory 
proteins and function in important cellular processes such as transcription, cell cycle 
control, DNA repair, oxidative stress, insulin secretion, and the urea cycle, etc (246). The 
deacetylation reaction catalyzed by sirtuins involves transfer of an acetyl group from 
acetyl-lysine in a protein substrate to NAD+, resulting in deacetylated lysine, free 
nicotinamide and 2’-O-acetyl-ADP-ribose products (246).  
The crystal structures of several free and liganded forms of sirtuins have been 
solved, including E. coli CobB (247). CobB, a bacterial sirtuin, deacetylates an active site 
acetyl-lysine in acetyl-CoA synthetase. The overall structure of the catalytic core of the 
CobB is similar to other known sirtuin protein structures. The catalytic core is composed 
of two domains, a large conserved Rossmann fold (blue) and a small variable zinc-
binding domain (yellow) (Fig 5.2A). The two domains are connected to each other with 
several loops (red) forming the hydrophobic binding site for NAD+ and acetyl-lysine 
substrate (green, 11-residue peptide containing 12-19 residue sequence from histone 4). 
In CobB, there are four loops connecting the small and large domains, forming a cleft 
where substrates bind and catalysis occurs. The zinc ion (grey sphere), being too 
remote from the active site, plays an indirect role in deacetylation. Zinc is essential to 
maintain the stable structure of catalytic core (248). Removing the zinc ion, either by 
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mutating its cysteine ligands or using chelating agents, results in the collapse of the 
structure and inactivation of the enzyme (249).  
A sequence alignment of Hp1259 with E. coli CobB showed 42% sequence 
identity (Fig 5.2D). For structural prediction of Hp1259, we submitted the Hp1259 
sequence to the Robetta server (250), which generates the structural models using 
either de novo structure prediction methods or comparative modeling. Comparative 
modeling is used when a positive match for the submitted protein occurs with a known 
structure, using BLAST, PSI-BLAST, 3D-jury or FFAS03. When no confident match is 
found, Robetta relies on the de novo Rosetta fragment insertion method for structural 
predictions (251). The Hp1259 Robetta model is similar to CobB with some differences 
(Fig 5.2B), domains are color-coded using the CobB crystal structure as a reference. 
The small zinc-binding domain (lime yellow) of Hp1259 is composed of three antiparallel 
beta sheets and four alpha helices, compared to five and three beta sheets and helices 
respectively in CobB. The secondary structure of the Rossmann fold (purple) in Hp1259 
is similar to that of CobB. In addition, this domain looks like a classical Rossmann fold 
for NAD+ binding, composed of a central beta-sheet with five parallel beta strands, 
shielded by a few alpha helices (252). In comparison to CobB, Hp1259 showed only 
three loops (raspberry) connecting the two domains. A structural alignment of the 
Hp1259 Robetta model and E. coli CobB is shown in Fig 5.2C.           
Despite our hypothesis that Hp1259 might be involved in production of Gln-
tRNAGln by GluRS2 and AdT, this protein is found in organisms that have glutaminyl-
tRNA synthetase (GlnRS) and do not have AdT. In other words, these organisms do not 
require indirect tRNA aminoacylation to produce Gln-tRNAGln. Nevertheless, because of 
the intriguing interactions observed by Y2H between Hp1259 and GluRS2 and AdT, our 
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aim for this project was to investigate whether or not a stable Gln-transamidosome 
would form consisting of GluRS2, tRNAGln, Hp1259 and AdT. Further, because Hp1259 
showed interactions with GluRS2 and AdT, the effect of this protein on GluRS2 
aminoacylation and AdT transamidation will be evaluated.  
 
 
 
Fig 5.2. Structural and sequence alignment of Hp1259 and E. coli CobB. A. Crystal 
structure of E. coli CobB. Overall structure of CobB showing the conserved large Rossmann 
fold domain in blue, the small zinc binding domain in yellow (with Zn ion in grey); these two 
domains are connected by loops (red). A bound acetyl-lysine substrate (within a histone H4 
peptide) is shown in green (PDB: 1S5P) (247). B. Robetta model of Hp1259. Modelled 
structure of Hp1259 showing the conserved large Rossmann fold domain in purple, the small 
zinc binding domain in lime yellow, and the two domains connected by loops (raspberry) 
(250). C. Superimposition of Hp1259 robetta model and E. coli CobB crystal structure. 
Bound acetyl-lysine substrate was omitted from the superimposition for clarity. D. Sequence 
alignment of a region of Hp1259 and E. coli CobB. Alignment showed 42% sequence 
identity (residues in between, 67/161) with 4% gap (8/161). The + symbol indicates conserved 
residues (NCBI BLAST).    
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5.3 Results and discussion 
5.3.1 Purification of His6-tagged Hp1259  
His6-tagged Hp1259 was overexpressed by induction with 1 mM IPTG for 4 
hours; 1 mL culture samples were lysed before and during induction and were analyzed 
by 15% SDS-PAGE (Fig 5.3). Successful expression of His6-Hp1259 was expected to 
be indicated by a protein band at approximately 25 kDa after IPTG induction. Weak 
expression of a band of this size was observed. This band was tentatively identified as 
His6-Hp1259. Induction of a protein with a molecular weight approximately 50 kDa was 
also observed; the possibility that this band may represent an Hp1259 dimer was 
considered, even though this gel was conducted under denaturing conditions.  
Efforts to purify His6-Hp1259 by affinity chromatography were made using a 
larger culture. Expression of His6-Hp1259 was inconsistent, as a band corresponding to 
the size of Hp1259 (25 kDa) was not observed after 4 hr induction and either in the 
lysate or pellet fraction (Fig 5.4).  
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Fig 5.3. SDS-Page (15%) evaluation of His6-Hp1259 overexpression. Small cell culture 
samples were lysed before, during, and after induction of His6-Hp1259 overexpression with 
IPTG. MW = Molecular weight marker in kDa. His6-Hp1259 should migrate with a molecular 
weight of ~25 kDa.  
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Fig 5.4. SDS-Page (15%) evaluation of His6-Hp1259 overexpression. Small cell culture 
samples were lysed before and after induction of His6-Hp1259 overexpression with IPTG. 
Both the pellet and lysate was analyzed after lysis. MW = Molecular weight marker in kDa. 
His6-Hp1259 should appear in lysate and migrate with a molecular weight of ~25 kDa.  
  
182 
 
 
 
Different methods were tested to optimize expression and purification including 
Ni2+ batch versus spin column purification; Co2+ affinity purification (data not shown); 
overnight incubation on the Ni2+ affinity resin; and elution with an imidazole gradient; all 
without success (Fig 5.5A and B). A 50 kDa protein was observed following elution with 
an imidazole gradient, suggesting the possibility of a very stable Hp1259 dimer. 
Additional efforts to denature this protein in SDS-loading dye with 8 M urea were 
unsuccessful, leading us to conclude that this protein is not Hp1259 (Fig 5.5C). With 
these negative results, we shifted our attention to the use of a glutathione-S-transferase 
affinity tag in place of the His6 tag.  
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Fig 5.5. SDS-PAGE (15%) for His6-Hp1259 purification. A. Imidazole gradient elution 
after 1 hr incubation on Ni2+ resin. B. Imidazole gradient elution after overnight 
incubation on Ni2+ resin. The imidazole gradient was from 20 mM to 300 mM. In both 
cases a prominent ~50 kDa protein was detected rather than the 25 kDa His6-Hp1259 that 
was expected. C. Boiled elutions and resin. Elutions and resin were boiled for ~ 20 min 
with and without 8 M urea. No denaturation of the 50 kDa protein was observed, suggesting 
that this protein was not an Hp1259 dimer. MW = Molecular weight marker in kDa. 
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5.3.2 Purification of GST-Hp1259 
GST-tagged Hp1259 expression was also tested (Fig 5.6A). The presence of 
GST-Hp1259 (~50 kDa) was confirmed with an anti-GST western blot (Fig 5.6B), (lanes 
2 and 3-5). Overexpression of GST-Hp1259 looked promising; however, the majority of 
the protein remained in the pellet after lysis (compare lanes 6 and 7 in Fig 5.6). In 
addition, the GST-Hp1259 in the supernatant appears to have degraded (Fig 5.6A and 
B, putative degradation products are visible at the bottom of lane 7). Since, some protein 
was detected in the lysate fraction, efforts to release Hp1259 from the glutathione 
sepharose resin using thrombin were also performed (Fig 5.6C and D). A small amount 
of GST-Hp1259 (lanes 4 and 5) was visible; however, after thrombin digestion, untagged 
Hp1259 was not recovered (lanes 6 and 7). The little GST-Hp1259 purified was later 
used in preliminary aminoacylation studies (discussed in detail in section 5.2.3).  
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Fig 5.6. Overexpression and purification of GST-Hp1259. A. Coomassie stained 
12% SDS-PAGE for overexpression of GST-Hp1259. B. Anti-GST Western blot of 
the gel from panel A. For panels A and B. Non-induced (lane 1), Induced (lanes 3-5), 
Pellet (lane 6), Lysate (lane 7), and GST (control, lane 8). Overexpression of GST-
Hp1259 (50 kDa) was observed after induction by both coomassie and western blot. After 
lysis, GST-Hp1259 was predominantly observed in the pellet. C. Coomassie stained 
15% SDS-PAGE for purification of GST-Hp1259 and untagged Hp1259. D. Anti-GST 
Western blot of the gel from panel C. For panels C and D. Induced (lane 2), Pellet 
(lane 3), purified GST-Hp1259 (lanes 4 and 5), untagged Hp1259 (after thrombin 
digestion) (lanes 6 and 7), and GST (control, lane 8). GST-Hp1259 (50 kDa) was 
obtained after purification, however untagged Hp1259 (25 kDa) was not recovered after 
thrombin digestion. Molecular weight markers are shown in lane 1 as labelled.  
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Finally, different optimization methods were tested to improve the soluble 
expression of GST-Hp1259, including lowering the growth temperature to 30 °C, 
lowering the IPTG concentration to 0.05 mM, and adding detergent during lysis. Optimal 
conditions occurred when cells were incubated at 30 °C to an OD600 nm of 0.8-1.0, 
induced with 1 mM IPTG for 4 hours, then sonicated without detergent (Fig 5.7 and 5.8). 
We also examined the impact of incubation time on glutathione resin (1 hr, 2 hr, and 
overnight) (Fig 5.9A and B). Unfortunately, the yield and purity of GST-Hp1259 obtained 
was still very low. Further optimization of the purification of GST-Hp1259 is required. 
 
Fig 5.7. Optimization to increase the yield of soluble GST-Hp1259. A. Cells grown at 37 
°C. B. Cells grown at 30 °C. Small cell culture samples were lysed before and after induction 
of GST-Hp1259 overexpression and were analyzed along with pellet (P) and lysate (L) 
fractions after lysis. Different lysis methods, that is sonication with and without detergent, 
were tested to improve the solubility of GST-Hp1259. Both pellet (P) and lysate (L) were 
analyzed after lysis. GluRS2 (~52 kDa) was used as size control and MW = Molecular weight 
markers in kDa. GST-Hp1259 migrates with a molecular weight ~50 kDa. Very little soluble 
GST-Hp1259 was observed in the lysate without detergent sonication.  
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Fig 5.8. Optimization to increase the yield of soluble GST-Hp1259. Cultures were grown 
at 30 °C and induced at OD600 0.8-1.0 with different concentrations of IPTG. A. [IPTG] = 
0.05 mM. B. [IPTG] = 0.1 mM. Small cell culture samples were lysed after induction (4 hr) 
and fractionated into pellet (P) and lysate (L) and analyzed by SDS-PAGE. GluRS2 (~52 kDa) 
was used as size control and MW = Molecular weight marker in kDa. GST-Hp1259 migrates 
with a molecular weight ~50 kDa.  
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Fig 5.9. Purification of GST-Hp1259. A and B. Lysate was incubated for 2 hr and 
overnight on glutathione sepharose resin, respectively. Fractions at each step of the 
purification were saved and were analyzed by SDS-PAGE. Lysate (lane 1), Pellet (lane 
2), Flow-through (lane 3), Wash (lane 4), Resin (lane 5), Elution (lane 7 and 8). 
Molecular weight marker (lane 6). GST-Hp1259 migrates with a molecular weight ~50 
kDa. Increasing the incubation time on the resin did not improve the binding of protein to 
resin or the yeild of pure protein.  
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5.3.3 Effect of lower temperature and additives on GST-Hp1259 protein expression 
During our previous efforts to purify GST-Hp1259, the majority of this protein 
remained in the insoluble fraction after lysis (Fig 5.6B). Multiple rescue methods, 
including decreasing culture temperature, and the presence of additives, were attempted 
to increase the solubility of this protein (253,254). Growing cells at 19 °C and the 
addition of 10% glycerol enhanced the solubility of GST-Hp1259, with the majority of the 
protein appearing in the soluble supernatant (Fig 5.10A and B). The addition of 1 M 
xylitol to the culture and the lysis buffer showed little improvement in solubility (Fig 
5.11C). The addition of trehalose was not helpful because it slowed the growth of the 
cells, even though it did appear to improve the solubility of GST-Hp1259 (Fig 5.11D). 
Since growing at lower temperature alone dramatically improved solubility, in the future, 
cells will be  grown at 19 °C for protein purification purposes.  
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Fig 5.10. Overexpression of GST-Hp1259: Coomassie stained 10% SDS-PAGE and 
anti-GST western blot respectively in each panel, A (at 19 °C) and B (at 19 °C with 
10 % w/v glycerol). Small cell culture samples were lysed before, during, and after 
induction of GST-Hp1259 overexpression with IPTG. Both pellet (P) and lysate (L) 
fractions were analyzed. MW = Molecular weight marker in kDa. GST-Hp1259 should 
migrate with a molecular weight ~50 kDa.  
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Fig 5.11. Overexpression of GST-Hp1259: Coomassie stained 10% SDS-PAGE and 
anti-GST western blot respectively in each panel, A (at 19 °C with 1 M xylitol) and B 
(at 19 °C with 0.7 M trehalose). Small cell culture samples were lysed before, during, and 
after induction of GST-Hp1259 overexpression with IPTG. Both pellet (P) and lysate (L) 
fractions were analyzed. MW = Molecular weight marker in kDa. GST-Hp1259 should 
migrate with a molecular weight ~50 kDa.  
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5.3.4 Effect of GST-Hp1259 on GluRS2 aminoacylation kinetics 
We tested the impact of GST-Hp1259 on GluRS2 aminoacylation activity. 
GluRS2 aminoacylates tRNAGln with Glu to generate Glu-tRNAGln. Based on the 
observed Y2H interaction between Hp1259 with GluRS2, we evaluated the Glu-tRNAGln 
forming ability of GluRS2 in the presence and absence of GST-Hp1259 (Fig 5.12, green 
and black data, respectively). Preliminary experiments did showed the effect of GST-
Hp1259 on GluRS2 aminoacylation for tRNAGln. As expected, GST-Hp1259 itself did not 
aminoacylate tRNAGln (blue data). However, the addition of GST-Hp1259 to GluRS2 
increased the rate of aminoacylation by about 50% (compare the black and green data 
sets in Fig 5.12), from 1.3 to 2.0 pmoles/min. This rate enhancement by GST-Hp1259 
may be due to an increased local concentration of tRNA substrate, facilitating GluRS2 
activity, for example. To further examine this phenomenon, the binding constants of 
GluRS2 and Hp1259 in the presence and absence of tRNAGln will be determined in the 
future. Also, further experiments will be done with lower concentrations of GST-Hp1259 
and untagged Hp1259.  
Experiments to test our hypothesis that Hp1259 changes the substrate specificity 
of GluRS2, ability of GluRS2 to synthesize Gln-tRNAGln rather than Glu-tRNAGln, using 
Gln instead of its usual substrate Glu, in the presence of GST-Hp1259 was conducted 
(Fig 5.13). Buffer containing 3H-Gln was used to evaluate 3H-Gln-tRNAGln formation by 
GluRS2 in the presence and absence of GST-Hp1259 (green and black data, 
respectively). As previously reported, no Gln-tRNAGln formation was detected by GluRS2 
alone (black data) (2) and this substrate specificity was not affected by the presence of 
GST-Hp1259 (green data). GST-Hp1259 itself did not aminoacylate tRNAGln, also as 
expected (blue data). From this preliminary experiment, no Gln-tRNAGln formation was 
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observed, suggesting that Hp1259 does not change the amino acid substrate specificity 
of GluRS2.  
 
 
 
 
 
 
 
Fig 5.12. Effect of GST-Hp1259 on GluRS2 aminoacylation of tRNAGln with 
glutamate.  
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5.4 Conclusions and future directions 
Hp1259 showed structural and sequence similarity with sirtuin proteins. It is 
difficult to hypothesize why a sirtuin-like protein might interact with an aaRS or affect 
aminoacylation. Sirtuins are regulatory proteins and were originally classified as NAD+ 
dependent histone deacetylase. However, over the last decade, a number of non-
histone sirtuin substrates have been identified (255). Interestingly, other than reversible 
acetylation/deacetylation of lysine, sirtuins can also catalyze processes like 
ribosyltransferase, demalonylase and desuccinylase reactions. Until today, no sirtuin 
protein regulating an aaRS by acetylation/deacetylation has been reported. 
 
Fig 5.13. Effect of GST-Hp1259 on GluRS2 aminoacylation of tRNAGln with 
glutamine.  
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Nevertheless, with the rapid increase in newly discovered sirtuin target substrate, aaRSs 
as substrates could be a possibility.  
From GluRS2 aminoacylation experiments, the presence of GST-Hp1259 
showed a ~50% increase in the rate of aminoacylation of tRNAGln. These assays were 
very preliminary studies because the protein was hard to purify. Other accessory 
proteins are known to impact tRNA aminoacylation, consistent with our results with 
Hp1259 and GluRS2. For example, Arc1p, a family of non-catalytic tRNA binding 
proteins, interacts with different tRNAs and aaRSs (102). For example, in the yeast 
Arc1p-MetRS-GluRS complex, the catalytic efficiency of MetRS is increased by more 
than 300-fold, including a 5-fold increase in kcat alone, compared to catalysis by MetRS 
alone (256,257). In the same complex, Arc1p improves the aminoacylation activity of 
GluRS by 10-fold (256,257). Our current working hypothesis is that Hp1259 is an 
accessory protein with modest effect on GluRS2 activity although significant work has to 
be done in the future to further elaborate on this possible role for Hp1259.   
Obtaining pure Hp1259 was a challenge. Due to its increased solubility when 
cultured at 19 °C, further experiments should focus on following the protocols described 
in section 5.4.2 and 5.4.6. Hp1259 interactions with GluRS2, AdT and tRNAGln should be 
tested to check the possibility of a Gln-transamidosome. Another goal will be to continue 
to evaluate the impact of Hp1259 on GluRS2 aminoacylation and AdT transamidation. 
5.5 Experimental procedures 
5.5.1 Cloning, expression and purification of His6-tagged H. pylori Hp1259 
The hp1259 gene was cloned into the pQE-80L expression vector by Dr. 
Gayathri Silva (112). This vector appends a His6-tag onto the N-terminus of the protein. 
The protein was overexpressed in E. coli DH5α and purified by His6-tag batch 
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purification using cobalt resin (Fisher scientific) or Ni-NTA agarose resin (Qiagen) as 
indicated. Ni-NTA spin columns were also tested (Qiagen). In all cases, unless otherwise 
indicated, cultures were inoculated from overnight cultures and grown at 37 °C in Luria-
Bertani (LB) medium supplemented with 0.1 mg/mL ampicillin and 0.5% glucose. At 
OD600 = 0.4-0.6, protein expression was induced by the addition of 1 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) and cells were harvested after 4 hours. The cell pellets 
were resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 20 
µL/mL saturated phenylmethylsulfonyl fluoride (PMSF), pH 7.4). Lysozyme (20 µg/µL) 
was added and the suspension was incubated on ice for one hour. During this time, 
additional PMSF (20 µL/mL) was added every 15 minutes. The suspension was 
sonicated and then centrifuged at 14,000 rpm for 45 minutes. The lysate was filtered 
through 0.8 micron syringe filters before loading onto the resin (see below).  
For Co2+ and Ni2+ resin batch purifications, each column was prepared by adding 
3 mL of the appropriate to a poly-prep chromatography column (Biorad) and the resin 
was equilibrated with 10 mL lysis buffer. The filtered lysate was loaded onto the 
prepared column and incubated for an hour at 4 °C. After incubation, the lysate was 
drained from the column (and saved) and the resin was washed seven times with 10 mL 
wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 7.4). The His6-
Hp1259 was eluted with 5 mL elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM 
imidazole, pH 7.4) and analyzed by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE).  
In case of imadazole gradient elution, the lysate was incubated on Ni2+ resin at 4 
°C for 1 hour and overnight in two separate experiments and His6-Hp1259 was eluted 
with an imidazole gradient (20-300 mM).  
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Similarly, for Ni-NTA spin column purification, a Ni-NTA spin column was 
equilibrated with 600 µL lysis buffer by centrifuging at 4000 rpm for 5 min at 4 °C. The 
buffer was decanted from the column and up to 600 µL of cleared lysate was loaded. 
The column was centrifuged at 4000 rpm for 5 min at 4 °C and the flow-through was 
decanted (and saved). The above step was repeated to load all the lysate. The column 
was washed with 600 µL wash buffer twice and eluted with 600 µL elution buffer.  
To evaluate the overexpression of His6-Hp1259, small culture aliquots (~ 10 mL) 
from larger culture were evaluated by SDS-PAGE before, during, and after induction with 
IPTG. In addition, to assess the success of different purification protocols, samples at 
each step of purification were saved and analyzed by SDS-PAGE.   
5.5.2 Cloning, expression and purification of GST tag H. pylori Hp1259 
The hp1259 gene was cloned into the pGEX-4t-3 vector, which appends a 
glutathione-S-transferase (GST) tag onto the N-terminus of the open reading frame 
(pSF004). GST-Hp1259 was overexpressed in E. coli DH5α and purified using a 
Glutathione Sepharose 4 Fast Flow column (GE Healthcare Life Sciences). Cultures 
were grown at 37 °C in LB medium supplemented with 0.1 mg/mL ampicillin and 0.5% 
glucose. GST-Hp1259 expression was induced with the addition of 1 mM IPTG at OD600 
= 0.4-0.6. Cells were harvested and lysed as described for His6-Hp1259. The lysate was 
loaded onto 3 mL of glutathione sepharose resin that had been pre-equilibrated with 
glutathione binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM 
KH2PO4, pH 7.3). The resin was incubated for 45 minutes at room temperature. The 
lysate was decanted and the resin was washed seven times with 10 mL binding buffer. 
GST-Hp1259 was eluted with elution buffer (2.76 mL , 50 mM Tris-HCl, 10 mM reduced 
glutathione, pH 8.0), and the purified protein was quantified, supplemented with 50 % 
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glycerol and stored at -20 °C. The eluent was analyzed in a 15% SDS-PAGE after 
denaturation in gel loading buffer. In order to purify untagged Hp1259, the above 
described procedure was followed up through the washing step. Instead of elution, 
thrombin digestion was performed overnight on the resin at room temperature to cleave 
the GST tag to release Hp1259 from the column. In this case, 240 µL of thrombin (1 
unit/µL) and 2.76 mL binding buffer were added to the resin and then incubated with 
rotation at room temperature for 4 hours or overnight. The protein was decanted from 
the resin and was analyzed by 15% SDS-PAGE.   
GST-Hp1259 overexpression was evaluated by analyzing small culture aliquots 
(~10 mL) from before and after induction with IPTG. Lysed cells were analyzed by SDS-
PAGE and anti-GST western blot. Similarly, during GST-Hp1259 purification, samples 
were saved at each step and were analyzed by SDS-PAGE. GST-Hp1259 
overexpression was also tested by growing cells at 30 °C, induction with lower 
concentrations of IPTG (0.1 mM and 0.05 mM), and different incubation times on the 
glutathione resin (1 hr, 2 hr, and overnight).  
5.5.3 Overexpression and purification of H.pylori GluRS2 
H. pylori GluRS2 was overexpressed and purified as previously described (2,78). 
5.5.4 Overexpression and purification of H. pylori tRNAGln 
H. pylori tRNAGln was overexpressed and purified as previously described (2,78).  
5.5.5 Overexpression of GST-Hp1259 in the presence of additives 
In order to increase the solubility of expressed protein, cultures were grown at 
lower temperature (19 °C) in the presence and absence of various additives (10% w/v 
glycerol, 1 M xylitol and 0.7 M trehalose). These additives were included during growth 
and in the cell lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 10 % w/v 
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glycerol or 1 M xylitol or 0.7 M trehalose, pH 7.4). Cells were grown to an OD600nm 
between 0.4-0.6 and protein expression was induced by the addition of 1 mM IPTG. The 
protein was expressed for 4 hours. Every hour, a 10 mL aliquot of each culture was 
removed and cells were harvested (centrifuged at 4000 rpm at 4 °C for 10 min). The cell 
pellets were resuspended in their respective cell lysis buffer (volume of the cell lysis 
buffer was adjusted to a constant OD600), lysozyme was added (1 L per 100 L cell 
lysis buffer) and the samples were incubated on ice for 30 min. These cell suspensions 
were lysed by sonication and centrifuged at 14,000 rpm at 4 °C for 20 minutes. The 
lysates and the separated supernatants and pellets were each evaluated by SDS-PAGE 
and anti-GST western blot.   
5.5.6 GluRS2 aminoacylation assays in the presence and absence of Hp1259 
H. pylori tRNAGln was denatured at 75 °C and cooled to 65 °C; at this point MgCl2 
was added to a final concentration of 2 mM. The solution was slowly cooled to room 
temperature. The reaction mixture was incubated at 37 °C in 40 mM Hepes•OH, pH 7.5, 
4 mM ATP, 8 mM MgCl2, 200 µM glutamic acid, and 50 µCi/mL 3H-Glu. Each 
aminoacylation assay was initiated with 25 nM GluRS2, 80 µM GST-Hp1259, or a 
mixture of the two proteins. Aliquots (10 µL) were removed at specific time points and 
quenched onto filter papers saturated with 5% trichloroacetic acid (TCA). These pads 
were washed three times with a chilled 5% TCA solution, dried, and counted via 
scintillation to determine the amount of 3H-Glu-tRNAGln generated over time. 
 Aminoacylation assays were also conducted as described above only replacing 
the glutamate (both unlabeled and radiolabeled) with glutamine.  
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APPENDIX A: SITE DIRECTED MUTAGENESIS IN GATA AND GATB 
TO CHARACTERIZE THE PUTATIVE AMMONIA TUNNEL IN ADT 
A.1 Introduction 
The aim of this project was to characterize the mechanism of ammonia transport 
in H. pylori AdT’s tunnel. AdT has two active sites one in GatA and one in GatB. The 
crystal structure of S. aureus AdT revealed that these two active sites are connected by 
a 37 Å putative ammonia tunnel (63). This tunnel is lined with highly conserved polar and 
ionic residues and is highly populated with ordered water molecule. The function of the 
tunnel is to sequester and deliver the ammonia generated in the GatA active site (via 
glutamine hydrolysis) to the downstream GatB active site (for transamidation). It was 
proposed that ammonia is delivered through a series of protonation and deprotonation 
mechanism (63). Not much is known about the ammonia delivery mechanism and how 
these two subunits communicate with each other. To probe the essential residues 
involved in ammonia transport, conserved residues long this tunnel were mutated to 
alanine and to closely related amino acids. Dr. Liangjun Zhao assayed these AdT 
mutants for glutaminase, kinase, and transamidation activities to probe the involvement 
of these residues in ammonia transport.  
A.2 Result and discussion 
My role in this project was to design and construct some of the mutations in the 
putative tunnel of AdT (T149A, T149V, R295A, and R295K in GatA). The impact of these 
tunnel mutations on AdT’s kinase activity was characterized and published in 
Biochemistry, 2012, 51, 273-285 (182). Several mutations were detected that caused 
significant decrease in AdT’s kinase activity. Results from these mutations identified two 
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residues, namely Thr149 (37 Å distal to the GatB active site) and Lys89 (located at GatA 
and GatB interface), as of particular interest with respect to interdomain communication.  
A.3 Material and Methods 
A.3.1 Site directed mutagenesis of conserved residues lining ammonia tunnel in 
H. pylori AdT  
In total, 13 conserved tunnel residues were mutated to alanine and closely 
related amino acids. My job was to mutate two residues (T149 and R295) in the GatA 
tunnel (Table A.1). Quikchange primers were designed for each mutation, as listed in 
Table A.1. PCR was carried out using Pfu polymerase (Stratagene, 2.5 U/µL), DNA 
template (pPTC032) (4), dNTPs (1.25 mM) and the manufacturer’s recommended buffer. 
PCR conditions were as follows: Window 1 (1 cycle): Initial denaturation at 95 °C, 5 min. 
Window 2 (30 cycles): Denaturation at 95 °C, 30 sec; primer annealing at 62 °C, 30 sec; 
primer extension at 72 °C, 10 min. Window 3 (1 cycle): Final extension at 72 °C, 10 min. 
All mutations were verified by DNA sequencing prior to use. Characterization of the AdT 
variants encoded by these mutations was carried out by Dr. Liangjun Zhao (182). 
 
 
 
 
 
 
 
 
 
202 
 
 
 
Table A.1. H. pylori GatA mutagenesis primer sequence and plasmid names (red 
letters indicate site of mutagenesis). 
Mutations Primer Primer sequence Plasmid 
T149A 
T149A-F ctttagggagcgatgcgggcgggtctatc 
pSF004 
T149A-R gatagacccgcccgcatcgctccctaaag 
T149V 
T149V-F ctttagggagcgatgtgggcgggtctatc 
pSF005 
T149V-R gatagacccgcccacatcgctccctaaag 
R295A 
R295A-F ggctgaagcgagttcgaatctggccgcatttgatggggtgcgttatggg 
pSF002 
R295A-R cccataacgcaccccatcaaatgcggccagattcgaactcgcttcagcc 
R295K 
R295K-F gcgagttcgaatctggccaaatttgatggggtgcg 
pSF003 
R295K-R cgcaccccatcaaatttggccagattcgaactcgc 
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APPENDIX B: ASSESSMENT OF A SERIES OF SMALL MOLECULES 
DEVELOPED AS POTENTIAL GLNRS ENZYME INHIBITORS 
B.1 Summary 
My goal for this project was to access the impact of six benzimidazole derivatives 
(M2-17, M2-26, M2-46, M2-47, M2-48, and M2-50) as potential GlnRS enzyme 
inhibitors. These six compounds were selected from a library of benzimidazole 
compounds designed from results of a virtual screening against Plasmodium falciparum 
(P. falciparum) glutaminyl-tRNA synthetase (PfGlnRS). We used E. coli GlnRS and 
evaluated the impact of these compounds on GlnRS aminoacylation activity to 
synthesize Gln-tRNAGln. None of these compounds showed any impact on GlnRS 
activity, leading us to conclude that these compounds are not inhibitors of E. coli GlnRS. 
B.2 Introduction 
Malaria is the most common infectious disease in the world. Approximately 1 
million people die annually because of malarial infection (258). Effective antimalarial 
drugs are available, but resistance to these available drugs continues to grow. 
Therefore, there is a requirement for the development of new anti-malarial drugs. At 
present, over 200 species of Plasmodium are known; at least 11 of which can infect 
humans. Of these, Plasmodium falciparum is responsible for 90% of malaria-related 
deaths (258).  
Several potential drug targets were revealed from the P. falciparum genome 
project (259-261). Most of these targets were essential enzymes that act in the 
apicoplast (derived from endosymbiosis of cyanobacteria) (262). Many of these bacterial 
origin enzymes were different from their human homologues, making them potential drug 
target candidates. For the treatment of malaria, numerous anti-bacterial drugs (e.g. 
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clindamycin, doxycycline, and spiramycin) targeting apicoplastic targets are clinically 
used (263-266).    
Aminoacyl-tRNA synthetases (aaRSs) are well established anti-microbial drug 
targets and are essential enzymes; therefore development of inhibitors against P. 
falciparum aaRSs offers a possible approach for the development of a new anti-malarial 
drug against this parasite. Currently, only one commercially available antibiotic is known 
to acts by inhibiting aaRS (pseudomonic acid or mupirocin, Glaxo Smithkline). It inhibits 
bacterial isoleucyl-tRNA synthetase (IleRS) and shows 8000-fold selectivity over human 
homologues (267). Other natural product based inhibitors of aaRS studied to date 
include cispentacin, indolmycin, ochratoxin A, furanomycin, granaticin, and borrelidin 
(268-272). Most aaRS inhibitors designed so far are based on mimicking the aminoacyl 
adenylate intermediates (AA-AMP). Recently, the drug cladosporin has been reported to 
target P. falciparum cytosolic lysyl-tRNA synthetase (PfLysRS) with 100-fold selectivity 
versus mammalian homologues (273).   
The main challenge of developing drugs against aaRSs as targets is cross-
reactivity with their human homologues. Therefore, developing drugs using apicoplast-
specific P. falciparum aaRSs as targets has gained more attention because of its 
cyanobacterial origin. This approach has the potential to reduce cross-reactivity because 
these apicoplast-specific aaRSs are evolutionary distinct from human aaRSs.  
The work presented here involves a small series of benzimidazole compounds 
that were built from results from a virtual screening of 35,000 compounds against 
PfIleRS, PfGlnRS and PfLysRS by Dr. Lluís Ribas de Pouplana et al (Institute for 
Research in Biomedicine, Barcelona, Spain). They identified a number of diverse 
potential hits for PfGlnRS based on a benzimidazole core structure. Considering this 
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scaffold, they designed and synthesized a library of 50 compounds that were evaluated 
for their capacity to inhibit P. falciparum growth. They discovered 6 compounds with IC50 
between 10-40 µM (Table B.1). They also evaluated the impact of these 6 compounds 
on E. coli growth and for cytotoxicity in to HEK293T mammalian cells. None of these 6 
compounds showed cytotoxicity nor did they inhibit E. coli at concentrations up to 100 
µM. Next, they wanted to test whether these compounds acts as inhibitors of GlnRS. We 
tested these compounds in aminoacylation assays with E. coli GlnRS, keeping in mind 
that there may be differences between E. coli and P. falciparum GlnRS.   
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Table B.1. List of six compounds tested as a potential inhibitor of GlnRS. 
Code Benzimidazole derivatives 
M2-17 
 
M2-26 
 
M2-46 
 
M2-47 
 
M2-48 
 
M2-50 
 
B.3 Result and discussion 
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B.3.1 Purification of E. coli His6-GlnRS 
His6-tagged GlnRS was overexpressed by induction with 1 mM IPTG for 4 hours; 
small culture samples were lysed before and during induction and were analyzed by 
10% SDS-PAGE (Fig B.1A). Successful expression of His6-GlnRS was indicated by a 
protein band at approximately 64 kDa after induction. His6-GlnRS was purified by Ni2+ 
affinity chromatography using a larger culture and was analyzed by 10% SDS-PAGE 
(Fig B.1B). 
 
B.3.2 Effect of benzimidazole derivatives on GlnRS aminoacylation  
We tested the impact of benzimidazole derivatives M2-17, M2-26, M2-46, M2-47, 
M2-48, and M2-50 on GlnRS aminoacylation activity. We evaluated the Gln-tRNAGln 
forming ability of GlnRS in the presence and absence of benzimidazole derivatives. All 
the compounds were dissolved in dimethyl sulfoxide (DMSO) to the desired 
concentration for these assays. Only M2-47 was insoluble in DMSO, no improvement on 
 
Fig B.1. SDS-Page (10 %) evaluation of E. coli His6-GlnRS overexpression and 
purification. A. His6-GlnRS overexpression. Small cell culture samples were lysed 
before, during, and after induction of His6-GlnRS overexpression with IPTG. B. His6-GlnRS 
folowing purification by Ni2+ affinity chromatography. MW = Molecular weight marker in 
kDa. His6-GlnRS should migrate with a molecular weight 64 kDa.  
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solubility was observed even after heating and sonication. Therefore, M2-48 was not 
further used in the aminoacylation assays. 
None of the tested compounds showed any effect on GlnRS aminoacylation for 
tRNAGln at 5 µM concentrations (Fig B.2), suggesting that these compounds are not 
inhibitors of GlnRS under the conditions tested.  
We also tested these compounds at concentrations of 100 µM (Fig B.3) and 200 
µM (Fig B.4). Again no decrease in GlnRS activity was observed leading us to conclude 
that these compounds are not inhibitors of E.coli GlnRS, at least at micromolar 
concentrations.  
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Fig B.2. Effect of 5 µM of benzimidazole derivatives (M2-17, M2-26, M2-46, M2-48, and 
M2-50) on GlnRS aminoacylation of tRNAGln with glutamine.  
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Fig B.3. Effect of 100 µM of benzimidazole derivatives (M2-17, M2-26, M2-46, M2-48, and 
M2-50) on GlnRS aminoacylation of tRNAGln with glutamine.  
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B.4 Conclusion  
Our results suggest that these benzimidazole derivatives (M2-17, M2-26, M2-46, 
M2-48, and M2-50) are not the inhibitors of E. coli GlnRS. These compounds were 
designed to inhibit P. falciparum GlnRS. Consequently, it is possible that they may inhibit 
PfGlnRS since EcGlnRS may simply be too dissimilar.  
 
Fig B.4. Effect of 200 µM of benzimidazole derivatives (M2-17, M2-26, M2-46, M2-48, and 
M2-50) on GlnRS aminoacylation of tRNAGln with glutamine.  
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B.5 Material and Methods 
B.5.1 Overexpression and purification of E. coli GlnRS 
His6-GlnRS (the plasmid pYY105 carrying the glnS gene obtained from Dr. John 
J. Perona, Portland State University) was overexpressed in E. coli DH5α and purified by 
His tag Ni-NTA agarose spin columns (Qiagen). Cultures were grown at 37 °C in Luria-
Bertani (LB) medium supplemented with 0.1 mg/mL ampicillin and 0.5% glucose. At 
OD600 = 0.4-0.6, protein expression was induced by the addition of 1 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) and cells were harvested after 4 hours. To check for 
overexpression after induction, 1 mL aliquots were removed throughout the culture 
growth and cells were harvested (centrifuged at 4000 rpm at 4 °C for 10 min). The cells 
were lysed by adding lysis buffer (100 µL, 50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole, 20 µL/mL saturated phenylmethylsulfonyl fluoride (PMSF, 20 µL per mL of 
lysis buffer), pH 7.4) and boiled with SDS-loading dye (5 µL, 5% β-mercaptoethanol, 
0.02% bromophenol blue, 30% glycerol, 10% sodium dodecyl sulfate, and 250 mM Tris-
Cl, pH 6.8) for 5 minutes. An aliquot of each sample (30 µL) was analyzed by 10% SDS-
PAGE.  
For purification, cell pellets were resuspended in lysis buffer. Lysozyme (20 
µg/µL) was added and the suspension was incubated on ice for an hour; during this 
time, additional PMSF (20 µL/mL) was added every 15 minutes. The suspension was 
sonicated and then centrifuged at 14,000 rpm for 45 minutes. A Ni-NTA spin column was 
equilibrated with 600 µL lysis buffer by centrifuging at 4000 rpm for 5 min at 4 °C. The 
buffer was decanted from the column and up to 600 µL cleared lysate was loaded. The 
column was centrifuged at 4000 rpm for 5 min at 4 °C and the flow-through was 
decanted. The above step was repeated until all of the lysate had been loaded onto the 
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column. The column was washed with 600 µL wash buffer (50 mM NaH2PO4, 300 mM 
NaCl, 20 mM imidazole, pH 7.4) twice and His6-GlnRS was eluted with 600 µL elution 
buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 7.4) twice. The eluted 
fraction was analyzed by SDS-PAGE.  
B.5.2 GlnRS aminoacylation assays in the presence and absence of benzimidazole 
derivatives 
H. pylori tRNAGln (20 µM) was denatured at 75 °C and cooled to 65 °C: at this 
point MgCl2 was added to a final concentration of 2 mM. The solution was slowly cooled 
to room temperature. After tRNA refolding, benzimidazole derivatives (dissolved in 
DMSO) were added to the final concentrations of 5,100, and 200 µM). The reaction 
mixture was incubated at 37 °C in 40 mM Hepes•OH, pH 7.5, 4 mM ATP, 8 mM MgCl2, 
200 µM glutamine, 50 µCi/mL 3H-Gln. Each aminoacylation assay was initiated with 1 
µM GlnRS, keeping the final reaction volume to 100 µL. Aliquots (10 µL) were removed 
at specific time points and quenched onto filter papers saturated with 5 % trichloroacetic 
acid (TCA). These pads were washed three times with a chilled 5% TCA solution, dried 
and counted via scintillation to determine the amount of 3H-Gln-tRNAGln generated over 
time. 
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CONCLUSION 
H. pylori is an important human pathogen and only known carcinogenic 
bacterium (5,6124-128). The detailed understanding of the fundamental biological 
process of this pernicious infectious agent is of paramount importance to ultimately help 
us in identifying novel therapeutic targets for the development of new antibiotic and 
chemotherapeutics. The results of our research will help us understand unusual aspects 
of the H. pylori transamidosome and the roles Hp0100, Hp1259, and Hp0495 play in the 
synthesis of Asn-tRNAAsn and Gln-tRNAGln. Since, H. pylori lacks two important aaRSs, 
AsnRS and GlnRS, efficient synthesis of Asn-tRNAAsn and Gln-tRNAGln while preventing 
misincorporation of Asp and Glu at Asn and Gln codons respectively are challenging 
objectives.  
We have validated the approach of using Y2H data as a mean for identifying new 
novel proteins involved in the H. pylori protein translational machinery (111). In this 
dissertation, we have presented results that support the hypothesis that three different 
proteins of unknown function, Hp0495, Hp0100, and Hp1259, all participate in tRNA 
aminoacylation or metabolism in some way.  
In the H. pylori Y2H proteome analysis, Hp0495 showed interactions with EF-Tu 
(111). These interactions were confirmed in vitro and in vivo, and the stoichiometry of 
this complex was determined to be 1:1. Hp0495 prefers to form a complex with the GTP 
bound state of the EF-Tu (Kd = 285 ± 19 nM nM) over a complex with EF-Tu•GDP (Kd = 
3.6 ± 0.2 µM). It also forms a complex with GluRS2 and is tRNAGln-dependent. Why 
Hp0495 interacts with EF-Tu and a misacylating GluRS2 is still a mystery. In addition, 
whether it is two separate complexes, EF-Tu•Hp0495 and GluRS2•tRNAGln•Hp0495 or 
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one big complex, needs to be determined. Formation of two separate complexes sounds 
more reasonable. 
We discovered that Hp0495 also binds glutamate in the presence of either 
tRNAGlu1 or tRNAGln and requires ATP for glutamate binding. Hp0495 showes clear 
structural similarities with ACT/RAM domains and proteins. These proteins are often 
involved in allosteric regulation (negative feedback) of amino acid and nucleotide 
metabolism, suggesting that Hp0495 is a regulatory protein. Crystal structures of ACT 
domains bound with their ligand are available, but Hp0495 does not share the conserved 
residues identified in these domains for ligand-binding. Therefore, it is hard to predict the 
ligand-binding sites for glutamate, ATP and tRNA in Hp0495.  
Despite its small size, Hp0495 has the features of a general tRNA binding 
protein; it showed independent interactions with tRNAGln, tRNAGlu1, tRNAGlu2, tRNAAsp, 
and tRNAAsn, and the corresponding aa-tRNAs, Glu-tRNAGln, Glu-tRNAGlu1, Glu-tRNAGlu2, 
Asp-tRNAAsp, Asp-tRNAAsn. However, Hp0495 showed slight specificity for binding to 
tRNAGlu1 (Kd = 380 ± 50 nM) and tRNAGln (Kd = 710 ± 70 nM). We hypothesize that 
Hp0495’s function is to direct tRNAGlu1 into a function outside protein translation. The 
hp0495 gene is in an operon with mraY and murD (132). These enzymes are involved in 
cell wall biosynthesis, hinting that the role of Hp0495 may be in H. pylori cell wall 
biosynthesis. Also, roles for EF-Tu and aa-tRNAs in cell wall biosynthesis is not 
unprecedented (177,115). In this scenario, one can imagine that Hp0495 cannot 
discriminate well between tRNAGlu1 and tRNAGln. Consequently, when bound to tRNAGln, 
Hp0495 forms a complex with GluRS2 to insure that this tRNA is available for catalysis. 
In fact, Uhlenbeck and colleagues speculated that H. pylori tRNAGlu1 would not be used 
in translation based on the identity of the base pairs in the TΨC stem of this tRNA (187). 
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Why and how such a small protein (86 amino acids long) interacts with EF-Tu, GluRS2, 
two different tRNAs, and different small molecules (glutamate and ATP) is still not clear.  
The Hp0100 and Hp1259 proteins of unknown function were selected because 
they connected ND-AspRS and GluRS2 to AdT, respectively by Y2H assay (111). Our 
lab discovered that Hp0100 is required for the assembly of a stable, tRNA-independent 
Asn-transamidosome, consisting of ND-AspRS, AdT, and Hp0100 (189). Hp0100 
showed nanomolar affinities for both ND-AspRS and AdT. Assembly of this Asn-
transamidosome was tRNA-independent. However, Hp0100 still showed independent 
interactions with tRNAAsn, with low micromolar affinity. Functional characterization by Dr. 
Gayathri Silva revealed that Hp0100 enhances the capacity of AdT to convert Asp-
tRNAAsn to Asn-tRNAAsn and Glu-tRNAGln to Gln-tRNAGln but has no effect on ND-AspRS 
activity (112). Therefore, Hp0100 not only stabilizes Asn-transamidosome but also 
increases the overall efficiency of AdT transamidation. Dr. Gayathri Silva has also shown 
that Hp0100 has two functional ATPase active sites: an α-adenosine nucleotide 
hydrolase (AANH) and a P-loop domain. Hp0100 catalyzes the hydrolysis of ATP to ADP 
and Pi in the presence of Asp-tRNAAsn or Glu-tRNAGln (112). However, attempts to 
discover whether Hp0100 uses ATP hydrolysis to phosphorylate either of its protein 
partners (ND-AspRS or AdT) were inconclusive. It seems that Hp0100 hydrolyzes ATP 
to drive transamidation of both Asp-tRNAAsn and Glu-tRNAGln.  
Because of Hp0100’s role in transamidation in vitro, we also characterized 
Hp0100 in vivo with the initial hypothesis that hp0100 would be an essential gene for H. 
pylori viability. Surprisingly, deletion of the hp0100 gene (replacing it with a cat cassette) 
demonstrated that this gene is not essential for growth under optimal conditions, in 
disagreement with our original hypothesis. PCR and RT-PCR using genomic DNA and 
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mRNA from this ∆hp0100 knockout strain further confirmed that this strain did not 
contain hp0100. These knockout experiments were done in rich medium to screen for 
hp0100 essentiality. These conditions may have been too permissive and may not have 
adequately reflected the stress conditions faced by H. pylori in its human niche. H. pylori 
niche in the human stomach mucus layer where the environment is significantly more 
hostile, particularly with respect to pH and other stressors. Consequently, it will be 
important to screen the essentiality of hp0100 under a variety of more stringent stress 
conditions. Therefore, efforts to evaluate conditional essentiality of Hp0100 under a 
variety of physiologically relevant stress conditions are currently underway in the lab.  
Previous characterization of the H. pylori Gln-transamidosome revealed that it is 
dynamic and unstable (91). Efforts to detect direct interactions between Hp0100 and 
GluRS2 were unsuccessful, suggesting that Hp0100 helps in the assembly of an Asn-
tranamidosome but not a Gln-transamidosome. Since Hp1259 showed weak interactions 
with both GluRS2 and AdT by Y2H (111), we hypothesized that Hp1259, like Hp0100, 
might facilitate the assembly of Gln-transamidosome. Hp1259 shares homology with 
sirtuins, NAD+ dependent deacetylases. Obtaining pure Hp1259 was a challenge. 
However, preliminary GluRS2 aminoacylation experiments showed a ~50% increase in 
the rate of aminoacylation of tRNAGln when Hp1259 was added to aminoacylation assay. 
Why a sirtuin-like protein would interact with an aaRS or affect aminoacylation is hard to 
explain. Nevertheless, with the rapid increase in the discovery of new sirtuin targets 
these intriguing interactions could be a possibility (243-245). In the future, Hp1259 
interactions with GluRS2 and AdT will be examined for the possibility of Hp1259 
mediated assembly of Gln-transamidome.  
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The observed Y2H network of interactions involving Hp0495, Hp0100, Hp1259, 
ND-AspRS, GluRS2, EF-Tu, and AdT also suggests the possibility that these 
components assemble into a large multi-synthetase complex in H. pylori.  
In spite of more than 40 years of research into tRNA aminoacylation, our results 
highlight the fact that novel proteins involved in tRNA aminoacylation still remain 
undiscovered. Given the fact that accurate tRNA aminoacylation is an important process 
for viability throughout life, discovery of new proteins or enzymes involved in this process 
could lead to new therapies and drug targets. The work in this dissertation has 
contributed to this possibility by elucidating connections between three proteins 
annotated as of unknown function (Hp0495, Hp0100, and Hp1259) as players in tRNA 
aminoacylation.   
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H. pylori is missing the glutaminyl- and asparaginyl-tRNA synthetases (GlnRS and 
AsnRS, respectively). Consequently, H. pylori uses an indirect aminoacylation pathway 
to generate Gln-tRNAGln and Asn-tRNAAsn. Within this process, Asn-tRNAAsn is produced 
by misacylation of tRNAAsn with aspartate by a non-discriminating aspartyl-tRNA 
synthetase (ND-AspRS). Next, the heterotrimeric, glutamine-dependent 
amidotransferase (called AdT or GatCAB) converts the misacylated Asp-tRNAAsn into 
Asn-tRNAAsn. A parallel pathway exists for the synthesis of Gln-tRNAGln, wherein 
misacylation of tRNAGln with glutamate is catalyzed by a tRNAGln-specific glutamyl-tRNA 
synthetase (GluRS2) to generate Glu-tRNAGln; this misacylated intermediate is 
converted to Gln-tRNAGln by the same AdT. This dependence on misacylated 
intermediates for protein synthesis suggests a requirement for additional mechanisms to 
prevent the misincorporation of Glu and Asp into proteins in place of Gln and Asn. H. 
pylori elongation factor (EF-Tu) provides one such machinery, but it is not sufficient to 
maintain translational accuracy, suggesting the need for additional mechanisms.  
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Hp0495 and Hp0100 were identified by yeast two-hybrid (Y2H) as potential new 
players in tRNA aminoacylation and fidelity. By Y2H, Hp0495 showed interactions with 
EF-Tu and Hp0100 was connected to both ND-AspRS and AdT. The work presented in 
this dissertation examined the possible roles of both of these proteins in indirect 
aminoacylation and in promoting tRNA accuracy.   
Using SPR, native gels, and size exclusion chromatography, we have shown that 
Hp0495 forms complexes with EF-Tu in both its GDP and GTP forms, but preferentially 
binds EF-Tu•GTP. In collaboration with a colleague, Dr. Keng-Ming Chang, we have 
discovered that Hp0495 binds ATP, glutamate, and either tRNAGlu1 or tRNAGln and forms 
tRNAGln-dependent complex with GluRS2. Also, Hp0495 binds deacylated tRNAs more 
tightly than aminoacylated tRNAs for the five cases tested in this work. Hp0495 has 
similarities to ACT/RAM domains; these domains typically regulate different aspects of 
amino acid and nucleotide metabolism. Our hypothesis is that Hp0495 might be a 
regulatory protein, sensing tRNAGlu1/tRNAGln and directing one or both it to either 
GluRS1/GluRS2 for aminoacylation or for functions outside protein translation. The 
hp0495 gene is in an operon with mraY and murD, these two enzymes are involved in 
cell wall biosynthesis, suggesting that Hp0495 might be involved in regulating this 
process. There is also precedence for the involvement of EF-Tu in cell wall biosynthesis, 
supporting this hypothesis.  
In collaboration with a colleague, Dr. Gayathri Silva, we have demonstrated that 
Hp0100 is, in fact, an essential component of a tRNA-independent Asn-transamidosome 
complex. This complex contains ND-AspRS, AdT, and Hp0100 and facilitates AdT’s 
transamidation process of Asp-tRNAAsn (~ 35-fold) and Glu-tRNAGln (~ 3-fold). Our work 
characterizing the Asn-transamidosome and transamidation of Asp-tRNAAsn was 
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published in 2013 (Silva, G. N., Fatma, S., et al. J. Biol. Chem. 288, 3816). An hp0100 
knockout suggests that Hp0100 is not essential under robust growth conditions. Our 
revised hypothesis is that the growth conditions used in these experiments were too 
permissive and did not adequately reflect the stress conditions faced by H. pylori in its 
human niche. Viability of our ∆hp0100 strain will be tested under different stress 
conditions with the goal of identifying conditions where Hp0100 is conditionally essential. 
Finally, we have initiated the characterization of third protein of unknown 
function, Hp1259. Preliminary data suggest that it might be involved in the indirect 
aminoacylation of tRNAGln.    
In the H. pylori genome, 499 open reading frames (ORFs) are annotated as 
hypothetical proteins whose functions are not known, including Hp0100 and Hp0495. We 
have assigned an important function to Hp0100, namely promoting tRNA 
aminoacylation, and have identified a new functional characteristics for Hp0495 that 
clearly demonstrate its role in tRNA aminoacylation and/or function. The existence of 
these proteins of unknown function and their interactions with components of the 
translation machinery clearly demonstrate that the classical boundaries of the field of 
tRNA aminoacylation need to be expanded.  
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